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Summary 
 
This thesis has developed to explore a specific intervention in a core context.  
That context is the transition of stroke from hospital to home and from acute 
illnesses to chronic disease.  This includes the change from a rehabilitation focus 
on the physical effects and complications of stroke (during in-patient stroke unit 
care) to the psychological, emotional and social consequences of stroke as well 
as the risk of recurrence. 
Specifically it focuses on an intervention in two key problem areas.  The first is 
the risk of stroke or transient ischaemic attack (TIA) recurrence and risk factor 
modification through lifestyle change.  The second is the area of psychosocial 
problems post stroke.  Both these areas may be addressed by a single 
intervention, and it is that potential intervention that is evaluated in detail in 
this thesis.  Other problem areas such as functional recovery and interventions 
to affect this are set in context, but not specifically covered here.   
Chapter One highlights the association in the literature between the well 
documented social and psychological consequences of stroke and longer term 
health outcomes for patients.  We can see from the literature that there is a 
strong association between depression and worse outcomes in terms of 
rehabilitation, reduced cognitive functioning and increased mortality.  In 
addition patients with poor social support or poor family functioning are 
recognised to have a longer length of hospital stay and poorer rehabilitation 
profile.  Patients who have a poor understanding of their illness are less likely to 
comply with treatment advice or re-attend for further treatment.  There is 
therefore a setting for evaluating an intervention that might seek to impact the 
emotional, informational and social needs of patients post stroke. 
Chapter Two describes a randomised controlled trial of a Stroke Nurse Specialist 
intervention in a behaviour modification programme.   This trial was intended to 
address the risk of Transient Ischaemic Attack (TIA) or Stroke recurrence by 
aiming to improve the information needs of post stroke and TIA patients, hoping 
to improve their compliance, lifestyle modification and ultimately risk factor 
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control.  The primary outcome was the proportion of patients who achieved 
control of all their modifiable risk factors (e.g. smoking, hypertension, diabetes 
and hypercholesterolaemia) according to predetermined criteria.  No significant 
difference was seen between the groups for the primary outcome (proportion 
achieving risk factor control: Experiment 46.4% Vs Control 41.7%, p=0.34).  
Differences were seen between the groups in the reduction in systolic blood 
pressure (Experiment -9.2mmHg, SD 23.3 Vs Control -1.0mmHg, SD 22.4, 
p=0.04).  In addition patients in the experimental group were more likely to 
express satisfaction with aspects of liaison and information provision. 
Chapter Three evaluates the effects of the short term behaviour modification 
intervention (detailed in Chapter Two) at over three years after initial 
enrolment.  Rates of follow up of the initial cohort were lower than the initial 
study (50% compared to 94%).   No significant difference exists at three years 
between the intervention and control groups for the primary outcome of risk 
factor control. Differences were observed between the groups for the rates of 
admission to nursing homes (Experiment 0 Vs Control 5, p=0.02), however the 
small size of this follow up sample limits the conclusions that can be drawn from 
this result. 
Chapter Four attempts to set the randomised controlled trial evaluated in 
Chapters Two and Three in the context of other outpatient rehabilitation 
interventions and tries to establish if there is comparability between the 
interventions and even combinability for subsequent meta-analysis.  This process 
identifies several core themes:  
• Physical fitness training after stroke, 
• Occupational therapy after stroke, 
• Multidisciplinary rehabilitation post stroke,  
• Information provision and education post stroke and 
• Psychological and social support. 
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In addition, several trials targeting intervention aimed at carers only were 
identified. 
Chapter Five describes a systematic review and meta-analysis of Stroke Liaison 
Worker trials – that is trials that evaluated a healthcare worker or volunteer who 
provided social support, information and liaison with the patient after discharge.  
This includes the trial described in Chapter Two.  Individual patient data meta-
analysis was conducted of 16 trials evaluating 18 interventions.  Meta-analysis 
did not demonstrate any benefit of Stroke Liaison Workers compared to usual 
care for the primary outcomes of subjective health status or extended activities 
of daily living.  In addition there was no benefit from Stroke Liaison Worker on 
the outcomes of death, institutionalisation, mental health or dependence.  
Patients were more satisfied that someone had really listened to them.  Carers 
were more satisfied that they had received enough information about the causes 
of stroke, that they had enough information about recovery, that someone had 
really listened, and that they did not feel neglected. Subgroup analysis by 
patient dependence at recruitment revealed that patients with mild to moderate 
dependence had reduced dependence in the intervention group (OR 0.60, 0.44 – 
0.83, p=0.002) as well as a reduction in death or dependence (OR 0.55, 0.39 – 
0.78, p=0.0008). 
In Chapter Six I was keen to evaluate whether the interventions in the literature 
and the framework for combining and evaluating them could be mapped onto 
existing services in Scotland.  This was done through a questionnaire of the 
Scottish Stroke Nurses Forum.  This identified 58 Stroke Liaison Workers from 
around Scotland who identified themselves as providing the services described 
using the review criteria in Chapter Five.  These nurses identified that their 
commonest requests for help relate to psychological or emotional issues.  62% of 
respondents believed that their role was effective for all their patients. 
In conclusion, Stroke Liaison Workers result in greater satisfaction with certain 
aspects of service provision but do not appear to result in changes to patient 
subjective health, extended ADL or carer subjective health.  Subgroup analysis 
suggests that patients with mild to moderate dependence may benefit.  Overall 
there does not appear to be evidence of effectiveness for this complex 
intervention when applied to all patients or carers. 
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status) 
Nottingham EADL Nottingham Extended Activities of Daily Living Scale 
OARS-SR  Older Americans Resources and Services – Social Resources (a 
measure of social support) 
OARS-ADL Older Americans Resources and Services – Activities of Daily 
Living (a measure of physical dependence) 
OARS-Physical Health Older Americans Resources and Services – Physical 
Health (a subjective measure of physical health) 
OARS-Economic Resources Older Americans Resources and Services – Economic 
Resources (a measure of economic strain) 
OR   Odds Ratio 
Pound Satisfaction Scale A satisfaction questionnaire of stroke services 
Questionnaire on Resources and Stress (a measure of subjective health) 
QOL   Quality of Life 
RBG   Random Blood Glucose 
RCT   Randomised Controlled Trial 
REI   Recovery Efficacy Index (a measure of subjective health) 
Rivermead Mobility Index (a measure of mobility and dependence) 
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RNLI Reintegration to Normal Living Index (a measure of 
subjective health) 
RSS   Received Social Support (a measure of social support) 
SCQ Sense of Competence Questionnaire (a measure of subjective 
mental health) 
SF36 Short Form 36 (a measure of subjective health status, 
including sub-domains for mental and physical health etc.) 
SFSW   Stroke Family Support Worker 
SLW   Stroke Liaison Worker 
SMD   Standardised Mean Difference 
SNS   Stroke Nurse Specialist 
Social Functioning Examination (a measure of social support and social 
functioning) 
SSSL-D Social Support List – Discrepancies (a measure of social 
support) 
TIA   Transient Ischaemic Attack 
WMD   Weighted Mean Difference 
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Chapter One:  
Returning to the community 
Introduction 
Stroke is recognised as a global concern.  Worldwide in 2005, the World Health 
Organisation estimated that stroke accounted for 5.7 million deaths (9.9% of all 
deaths)(1).  It is also widely accepted that stroke is a major cause of disability 
and handicap, with an incidence in the United Kingdom of 3 to 5 per 1000 in 
people aged 45 to 84 (2).   
There have been major developments in the field of stroke research over recent 
years with increasing numbers of randomised controlled trials registered with 
the Cochrane Controlled Trials Register (www.cochrane.org).  In addition there 
has been an expansion in secondary research with greater numbers of Cochrane 
reviews published (3).  This evidence has accumulated over time as research has 
continued to evaluate better ways to deliver therapy or services.  Much of this 
research has had a focus on pharmacological interventions for stroke with the 
majority of randomised controlled trials on the Cochrane Controlled Trials 
Register evaluating pharmacological interventions.  Additionally there has been 
a growth of evidence regarding inpatient interventions (such as organised stroke 
unit care) (4).  In response to the growing evidence base for inpatient stroke 
interventions there have been the growth of guidelines (5-7) and the 
development of policy at national level (8) as well as declarations of stroke 
strategy at international level (9). 
These developments are encouraging and should continue to improve outcomes 
for stroke patients and their families.  Large areas of stroke care however lack a 
firm evidence base (10;11).  In particular trials of rehabilitation and longer term 
community support remain an evolving area.  In the absence of robust evidence 
from controlled clinical trials, recommendations regarding growing service 
developments are being made (12).  The scale of post stroke problems and 
community support require that health care providers develop services and 
interventions to meet these needs.  Much of this work may be based on 
presumed best care and remains unevaluated. 
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The majority of people survive their stroke, but a third to a half remain 
functionally dependent after one year (13;14). This is associated with significant 
psycho-social problems for both patients and their carers, which may also occur 
independent of physical disability (15-17). The burden of such problems may 
increase as a result of demographic change and reductions in age-specific stroke 
case fatality (18;19).  Importantly, carers form a significant part of stroke 
patients support networks providing care (20).  To date, little research appears 
to have addressed the needs of this significant group and the impact of 
interventions on carers remains unknown (21). 
Living with Stroke 
For many stroke patients, the real challenges and difficulties may only become 
apparent when they return to the community from a hospital after suffering a 
stroke.  It is at this point that an individual’s impaired activities become 
translated into reduced participation (handicap) and many limits to role related 
responsibilities are unearthed.  For many patients, a stroke may have real 
financial, relationship, and mental health ramifications that become apparent 
on returning to the community, and are simply not addressed during inpatient 
rehabilitation.  The prevalence of significant problems post stroke has been 
documented in the literature.  Stroke may cause significant physical, emotional 
and social difficulties for both patients and their families for years after stroke 
(22;23).  The prevalence of emotional difficulties post stroke has been estimated 
to be between 19 and 62% (24-26).  Depression, for instance after stroke is 
frequent (27) as is social inactivity (28).  Social isolation and impaired social 
interaction are estimated to be present for 18 - 46% of patients (23;28-30).  
Patients seek services and support from healthcare and social services, and this 
is cited as a concern for 13 - 77% of patients.  For example transfer of care was 
identified as a problem in more than 33% of cases and in some contexts was as 
high as 100% (15;31-33).   
Post stroke quality of life has been identified in one series as being strongly 
associated with perceived emotional support, depression and functional abilities 
(34).  The same study found that family relationships were a main source of 
satisfaction with life. 
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Resources and Threats 
The long-term outcome for stroke patients appears to depend on a recognised 
number of resources and threats.  Patients with adequate resources appear to 
suffer fewer negative consequences of stroke, whilst real threats to a positive 
long-term outcome appear to be recognisable and quantifiable.  These could 
broadly be described as being inversely related.  When patient’s resources are 
low, a correlation appears to exist with a poorer outcome.  Several key areas of 
resource and threat appear to occur repeatedly in the stroke literature (See 
Figure 1.1). 
Family and Social Support 
Social support is a broad term that encompasses a wide range of relationships 
and social networks.  It has been defined as: 
“The feeling of being loved and cared for, valued and esteemed, and 
able to count on others should the need arise” (35) 
For the majority of stroke patients this might be seen as the key role that an 
immediate family network might provide.  For patients without immediate 
family, the definition might appropriately be expanded to include a wider circle 
of relationships. 
Stroke patients generally experience a decline in their social activity after 
stroke as well as a reduction in their social network (28). 
A number of studies have sought to identify and quantify social support and its 
impact on stroke patients.  These studies have then sought to correlate social 
support with defined outcomes. 
Social support and poor outcomes 
Social support has been found to be important in influencing healthcare 
outcomes (36).  Patients with poor social support networks are said to have an 
increased mortality after both cardiovascular disease and malignancy or a worse 
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recovery from cardiovascular illness (37-39).  Lower social support is also 
associated with poorer adjustment to illness or bereavement (40-42) and 
increased carer burden and depression (43).  
Stroke can be considered as having a significant impact on existing social support 
networks.  For a significant proportion of stroke patients who live at home with 
their families, stroke can have profound influences on families and carers (29) 
including impacts on emotional health (23), relationships and functioning 
(30;44). 
In addition to this stroke patients with lower social support were found to have a 
slower recovery from stroke (45), and were more likely to experience a longer 
length of stay in hospital (46). 
Studies have shown that families with poor family functioning were less likely to 
comply with treatment decisions and less able to help patients with 
rehabilitation efforts (47). Indeed family function in one series proved a better 
predictor of patient length of stay than many typical clinical predictors of stroke 
outcome (46). 
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Good 
Good 
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Figure 1.1: Resources and Threats: Hypothesis 
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Social support networks and good outcomes 
Potential beneficial effects of social support have been observed in several 
studies and include a reduced risk of mortality (37;38;48-50).  Beneficial effects 
have been observed on recovery from serious illness such as cardiovascular 
disease (51-54) including myocardial infarction (55-58) and optimising treatment 
outcomes in other chronic conditions such as arthritis (59;60) and cancer (61-
63).  In addition patients with good social support have been shown to have 
improved recovery from operations (64).  They are said to have enhanced self-
esteem and improved survival in some cancers (39) and in hospital contexts to 
show less distress than patients with lower social support levels (65).  In a 
context of neurological rehabilitation and adjustment, spinal injury patients 
with higher reported levels of social support admitted to fewer medical 
problems and claimed to better adjusted to their spinal injury (42).   
Carers themselves also appear to benefit from wide social support networks.  
Carers of Multiple Sclerosis (MS) patients with higher levels of social support 
reported lower levels of perceived caring burden (40).  Carers of Alzheimer’s 
disease patients with social support were less likely to have depression (43).  
More generally social support appears to mediate the effects of carer burden on 
caregiver’s mental health (66).   
The correlation between social support and poor outcome after stroke has been 
made in a number of population surveys.  One survey of post stroke patients in 
China found that there was a positive correlation between strong social support 
networks and a patient’s functional ability.  The positive association of social 
support on mental health was non significant (67).   
Others found that positive outcomes for functional status, depression and social 
status were significantly associated with higher levels of social support in the 
first six months of recovery after stroke (68).  Only functional status alone was 
improved when adjustments were made for initial stroke severity and it was 
suggested that in severely impaired patients that high levels of family support 
are associated with progressive improvements in functional status early after 
stroke (68).  This finding has been replicated elsewhere (45;69). 
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Social functioning appears to have been improved by social support in some 
studies. One randomised trial of specialist nurse support found that mildly 
disabled stroke patients had improved social functioning when compared to 
controls (70).  Another found that social support was associated with improved 
relationships with professionals, and improved quality of community 
relationships early after stroke, although the effect was not sustained (71). 
Others have reported that social support mediates the impact of handicap over 
quality of life (72). 
Family function may be improved on several domains by a combination of 
education and social work input for carers of stroke patients who also noted 
improved carer knowledge and patient adjustment compared to controls (73).  
Interventions targeted at carers have also shown improved carer confidence in 
knowledge, improved use of coping strategies and increased social support (74).  
Others have shown improved problem solving skills, reduced depression, and 
improvements in social functioning, mental health and reduced limitations due 
to emotional health (75).  One study of a family support worker demonstrated 
reduced anxiety and hassles in the carers of stroke patients, and whilst not 
demonstrating a consistent effect for patients, showed improved satisfaction in 
both groups (76).  These effects are echoed in another study of family support 
organisers that showed improved mental health, reduced pain, improved 
physical function, improved general health perception and quality of life as well 
as improved satisfaction for carers of stroke patients (32). 
 
Mental Health 
Estimates of the rates of depression after stroke vary and are reported to affect  
between 25 and 79% (24).  Most would place the incidence at over 25% in the 
first year (25).  Much of this variation may arise from differences in diagnostic 
classification; however, the prevalence of low mood seems well recognised.   
Mental health and poor outcome 
In an older population, depression and mental health problems have been 
reported to be associated with greater impairment of quality of life than many 
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chronic physical diseases (26).  In older people depressive illness is associated 
with greater morbidity and dependency (77).  This includes increased use of 
drugs and alcohol, greater use of healthcare resources and poorer compliance 
with treatment recommendations (77).  The association between medical co-
morbidity and depression suggests that medical co-morbidity may be more 
influential as a cause or factor in depression than social isolation itself (78). 
In cardiovascular disease, depression post myocardial infarction (MI) is 
recognised as a cause of increased mortality, where in one study the risk was 
more than twice that of non-depressed patients (79).  This increased risk has 
even been noted to exist for patients with mild depressive symptoms not 
traditionally thought to be at risk (80).  Analysis of patterns of ischaemia in 
depressed patients has shown that patients with mild to moderate ischaemia 
exhibit an increase in ischaemic episodes both during mental stress testing and 
during normal life. This has been thought to be a potential explanation for the 
increased mortality in this group (81).  An association has been found between 
depression and sedentary behaviour as well as smoking, though depression 
remained an independent predictor of mortality, incompletely explained by 
these risk factors (82).  Depression also proves a reliable predictor of quality of 
life up to 12 months after a myocardial infarction (83) and may be a factor in 
compliance with cardiac rehabilitation (84) 
Depression prior to surgery has been found to be associated with increased six-
month morbidity in patients undergoing coronary artery bypass graft (CABG) 
surgery including re-hospitalisation, increased surgical pain and failure to return 
to normal activities (85).  In a separate series depression predicted post 
operative angina recurrence (86).  One study found that the presence and 
severity of depression was likely to independently influence the type of 
revascularisation procedure performed, with fewer depressed patients 
undergoing CABG (87). 
There is still controversy in the literature as to whether post stroke depression is 
caused by the stroke lesion itself, or by the patient’s psychological response to 
illness (88).  Regardless of the causes of post-stroke depression, it is known that 
depression may impede rehabilitation (89;90), reduce physical and cognitive 
function (91) and create additional stress for carers (92). 
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A survey conducted among 51,119 US veterans with ischaemic stroke found the 
prevalence of depression to be 5% within three years.  Other mental health 
diagnoses were equally prevalent at 4% within three years of stroke onset.  Both 
post-stroke depression and other mental health diagnoses were associated with 
an increased mortality rate (OR 1.13, 95% CI 1.06-1.21) (93).  This effect was 
independent of other chronic conditions.  This increased mortality rate has been 
reported elsewhere in the literature (94) and is not fully explained by an 
increased risk of suicide (95). 
Patients with mood disorders reported a reduction in the quantity and quality of 
relationships as a result of difficulties with personal and social adjustment 
(96;97). 
Carers are also at high risk of mood disorders as a result of caring for patients 
after stroke, and as a consequence experience impaired social function (15;17). 
Mental health and positive outcomes 
From the correlation between poor mental health and poorer outcome it might 
be suggested that “good” mental health might offer a protective effect against 
these hazards.  However a difficulty arises in the definition of “good” mental 
health.  In simple terms, it might be defined as the absence of psychopathology.  
Viewed in this light “good” mental health could be said to be associated with 
improved morbidity, dependency and quality of life in older patients when 
compared to patients with poor mental health (24;77-81).   
Some studies have shown that patients who remain depressed tend to remain 
physically disabled, whilst those whose depression improves demonstrate a 
reduction in disability (98;99).  
Some have tried to define good mental health as the psychosocial resources of 
mastery, self-efficacy and social support, noting that these factors were 
responsible for a significant part in the buffering of psychological distress in 
response to chronic medical conditions (100).     
Likewise for caregivers, psychological coping strategies have been identified as 
potential mediators of the impact of caring on caregiver mental health (66). 
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Using the criterion of good mental health as the inverse of poor mental health, it 
could be argued that good mental health status is associated with protection 
from poor cognitive function, improved physical recovery (91), improved 
rehabilitation (89;90), improved mortality (93) and improved quantity and 
quality of social relationships (96;97).  However, more specifically, some have 
suggested that particular models of psychological resource (such as increased 
efficacy and control, enhanced problem solving and cohesive family systems) 
might have a beneficial effect on an individuals and a family’s recovery from 
stroke (101).  Proof of a causal effect however has not been demonstrated with 
these models of psychological theory. 
Information and Knowledge 
Providing information for patients and carers is considered a key part of services 
for patients and carers (12;102).   Educational interventions in healthcare 
settings can be complex and need evaluated in carefully designed trials 
(103;104).  There is complexity in translating change from education into 
outcomes and this complexity (as illustrated in Figure 1.2) may be the reason for 
the limited results of many patient education trials (105). 
Poor information and outcomes 
Patients with a poor understanding of their illness are less likely to express 
satisfaction with their health care, less likely to comply with treatment advice, 
less likely to re-attend for further treatment and less likely to improve (106). 
One survey of stroke patients and carers found that over one third of patients 
and nearly two thirds of carers would have wished more information about the 
illness (107).  A quarter of patients and nearly two thirds of patients and carers 
respectively had to ask for more information.  The reasons patients and carers 
gave for being unable to get more information were the busyness of hospital 
staff, staff unavailability or lack of knowledge and the use of medical jargon 
that was too difficult to understand (108).   
Patients whose caregivers had little knowledge of stroke were more likely to be 
at risk of sub-optimal home care (109).  Likewise lack of knowledge or 
information about their condition are said to exacerbate patients’ physical 
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limitations and emotional distress (110).  This perceived lack of information 
following discharge was directly correlated with expressed dissatisfaction with 
care for both carers and patients (108).  Patients living in the community also 
express dissatisfaction with the information they had received about stroke 
disease (33) and continued to have unanswered questions up to two years after 
stroke (111). 
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Figure 1.2: Hierarchy of Levels of Education 
Adapted from Kirkpatrick (104;105).  The complexity of evaluating an 
educational intervention on behavioural change can be seen in the assessment of 
that change – as you seek to ascend the outcomes of education, the number of 
potential confounders and the lack of reliable objective measures limit or 
reduce the power of the conclusions about the intervention. 
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Good information and outcomes 
Educational programmes for children and adolescents with asthma have been 
shown to improve lung function, reduce absenteeism from school, and reduce 
visits to accident and emergency departments (112).   
Some nurse led interventions have been shown to be helpful in improving health 
related behaviour in individuals at high risk of coronary heart disease, including 
improved dietary intake, increased exercise, reduced smoking and temporary 
improvements in systolic blood pressure (113).  In patients with coronary heart 
disease, educational interventions have shown improved diet, exercise 
prophylactic drug use and health status (114).  Five-year follow up of this cohort 
even suggested a non-significant reduction in mortality in the intervention group 
(115;116).  Others have shown additional benefits on health status, reduced role 
limitations from physical problems, and reduced worsening of chest pain and 
fewer hospital admissions (117).  A review of disease management programmes 
for coronary heart disease that have included patient education and risk factor 
management showed non-significant reductions in mortality and recurrent 
myocardial infarction, whilst showing significant improvements in drug use and 
hospitalisations (118). 
More generally, advice on dietary salt intake has been shown to enable 
hypertensive patients to maintain a lower blood pressure after the withdrawal of 
antihypertensive therapy and reduce the long term risk of cardiovascular disease 
(119;120).  Additionally advice on the reduction of dietary fat when maintained 
for two years, showed potential benefits in reduction in mortality and 
cardiovascular events (121). 
Outwith vascular disease, training Multiple Sclerosis (MS) sufferers in coping 
skills has been shown to improve their methods of coping, overall satisfaction, 
and satisfaction with family and socio-economic status (122). 
Good knowledge of stroke by stroke carers may improve the quality of discharge 
home from hospital (109).  Patients and carers who feel they have received 
adequate information are apt to feel more satisfied with the quality of their 
care – especially the information provision aspects of it (32;76;123;124)  
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Services 
The interface between informal support in the community (carers and family) 
and formal community support (community care) becomes key to the support of 
many patients with chronic conditions.  Community services can be defined as 
assistance with care-giving tasks, in-home assistance, and adult day care, Meals –
on-Wheels and support groups as well as benefits and financial support (125). 
In one qualitative study, comparison was made between health service provision 
and community or social care provision.  Many older patients identified that 
although a contact point was more readily identifiable for healthcare, users 
were more likely to take an active role in accessing and choosing social services 
than healthcare (126).  This was often despite an apparent lack of necessary 
healthcare provision.  Similarly in another study, elderly patients on discharge 
were more than twice as likely to access community home care or nursing care 
than they were to visit their General Practitioner (127).  Elderly patients 
appeared to value social services and to consider them more accessible than 
healthcare. 
Poor access to resources and outcomes 
A survey of carers of elderly or minority group patients have shown that 51-67% 
of caregivers were in need of one or more community service (including financial 
needs), and that being in need, they were deemed at risk whilst providing care 
giving services themselves (128).  The lack of choice, access and at-risk status of 
those who needed social welfare but could not obtain it has also been identified 
in the qualitative literature (126).  
In a stroke context, poor knowledge of stroke services and benefits is noted to 
be associated with emotional problems and increased physical limitations (129).  
Patients in the community have expressed dissatisfaction with the level of 
information they have received about stroke services and information regarding 
benefits (15;32;33).  
Good access to resources and outcomes  
Caregivers of Alzheimer’s patients in a qualitative study identified that 
community services were associated with the  benefits of renewal, increased 
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knowledge and a sense of community (125).  In addition they perceive their 
relative (the patient) to benefit.  Older patients in particular appear to value 
social service support and are more likely to express satisfaction with social 
services than with primary health care (130).  
There is an increasing body of evidence on the effectiveness of outpatient 
therapy post-stroke and services available to community dwelling stroke 
survivors.  Therapy based outpatient services for instance have been shown to 
reduce deterioration and improve the function of activities of daily living (131).  
Physical fitness training after stroke has been described as increasing strength 
and cardiovascular fitness after stroke (132), and information provision and 
education may benefit both patients and carers (133).  In addition to medical 
and therapy based services, a growing range of locality based social services and 
financial support are available for patients and carers (134). 
Carers 
A Carer has been defined as: 
“the person, other than a healthcare professional, perceived by the 
patient or family as normally being most responsible for day-to-day 
decision making and care (32).”  
Definitions of carers in the literature for older patients, not surprisingly is very 
similar and equally broad: 
“family caregivers are relatives or friends of an older person who 
provide, arrange or oversee services that the older person needs 
because of functional disabilities or health needs (135).”  
Definitions of carers are therefore context specific and not permanent and are 
defined by relationship to the patient. 
Approximately 5.2 million people in the UK are estimated to be providing 
informal care in England and Wales according to the 2001 Census (136).  Informal 
carers provided care that, if costed, would cost the government millions of 
pounds each year.  At any one time 0.5% of the UK population are disabled 
stroke survivors who are dependent on the help of a carer to perform community 
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activities, domestic activities or personal activities of daily living (137).  Carers 
therefore form an integral part of a patient’s support network and may 
significantly impact the welfare of patients, but form a vulnerable population in 
their own right. 
Carers’ needs 
A review of the literature suggests that carers have perceived needs that are 
independent of a patient’s needs and yet are related to their ability to care for 
the patient.  Carers consistently describe needs for information (111;128;138-
141) and they may seek means to acquire that information if it is not provided 
(139).  Information was found in one series to be protective against poor carer 
outcome (141).  Additionally caregiver training has been suggested to 
independently predict a positive outcome for carers at 3 months (140).  Social 
support for carers independent of patients has been identified as important and 
in one series, social support for a carer was associated with improved caregiver 
life satisfaction (142).  Caregivers also describe needs for support from 
community services and in one series between 52 and 67% of clearly identified 
needs were not being met (128). 
Risks for Carers 
Depression is noted to be frequent in carers when compared to matched controls 
(143) with an estimated frequency of anywhere between 34 and 52% (144).  A 
number of observational studies have tried to establish risk factors for 
depression or other markers of poor outcome in carers.  Consistently identified 
factors across many studies appear to be patient dependence 
(15;92;140;144;145), cognitive impairment (92;144;146;147), behaviour 
problems in the patient (92;144;147) and emotional problems in the patient such 
as depression (15;25;144;147). 
Outcomes for Vulnerable Carers 
Carers who are depressed represent a concern not only in terms of their own 
health risk, but also in their ability to care for a dependent friend or relative.  
Depressed carers have been shown to provide poorer standards of caring and, 
are less able to help the patient in rehabilitation (148).  In addition, in a cohort 
of carers followed for four years, caregivers who registered increased levels of 
carer strain had a 63% higher mortality rate than comparable non-caregivers (RR 
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1.63, 95% CI 1.0 to 2.65).  Carers who did not show signs of caregiver strain had 
no significant increase in mortality (149). 
Protective Resources for Carers 
In addition to identifying the risk for carers, a number of studies have identified 
potential protective elements that might be exploited in intervention studies.  
One study identified that carers with a higher perceived self efficacy and greater 
satisfaction with social support, experienced less strain and better mental 
health (147).  Another reported that carer training was associated with a 
positive carer outcome at 3 months post stroke (140).  Others noted that a 
carers ability to cope was enhanced by information as well as positive coping 
strategies (141).   
Interventions for Carers 
These positive associations which suggest a protective effect should offer real 
hope of the development of an intervention to improve outcomes for this 
vulnerable population.  A number of different types of interventions have been 
developed and evaluated in trials.  These types of intervention have included 
education and information provision in the form of written or electronic 
materials (150;151), group educational classes (74;152-155), counselling (73;156-
158), practical caregiver training (21) and liaison (32;70;123).  In Chapter Four I 
will examine where the emerging randomised controlled trials for carers sit 
within the wider context of community stroke rehabilitation trials.  The 
interventions that involve liaison, information provision and social support for 
patients and carers in combination are evaluated in a meta-analysis of Stroke 
Liaison Worker trials in Chapter Five.  
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Figure 1.3: Resources and Threats: Roles for a Stroke Liaison Worker 
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From association to intervention 
(See Figure 1.3) 
No matter how strong an association may appear between risk and outcome, any 
intervention (even ones that perfectly mirror favourable and protective 
elements in the natural world) must be evaluated in appropriately conducted 
randomised controlled trials to ascertain their effectiveness.  Trials evaluating 
therapy based on social interventions face a number of potential limitations that 
can introduce the risk of bias.  These can include selection bias, where the 
patient or carer group recruited does not reflect a generalisable population or 
recruits subjects whose motivation or incentives may be related to personality or 
other factors that will influence the outcomes.  In addition, therapy trials are at 
risk of performance bias where interventions are not standardised or consistently 
delivered.  Ideally these trials need to be appropriately blinded, particularly 
where the intervention is complex and the outcome measures may be open to 
bias.  Blinding complex interventions involving health care personnel is 
potentially difficult (159) but blinding of outcome assessment is usually possible.  
The assessment of these potential interventions will be developed in depth in 
subsequent chapters in this thesis. 
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Chapter Two:  
The Impact of Stroke Nurse Specialist Input on 
Risk Factor Modification: A Randomised 
Controlled Trial 
Introduction 
One of the consistent challenges facing stroke services is in the provision of 
appropriate education and support for stroke patients and their carers 
(107;108;110;160;161).  Research has sought to establish the effectiveness of 
various educational interventions on different aspects of patient’s and carer’s 
health and well being (162;163).  Trials looking at the impact of specific 
education interventions on patients and caregivers knowledge about stroke have 
demonstrated an improved level of knowledge (164;165).  However most have 
failed to show an impact on emotional outcomes (164;166-168), perceived health 
status (164-166;169), physical function (164;168) or health behaviour (165).   
Some trials have observed improvements in family functioning (164), pain, 
physical function, mental health (170) and satisfaction with information received 
(164;167), although this was not universal.  
We know that interventions with an educational or counselling component can 
be effective to encourage smoking cessation (171-174), lower blood pressure 
(175-177), achieve modest reductions in cholesterol (178;179), and promote 
weight loss (180).  Educational interventions in a cardiac patient population have 
demonstrated a measurable impact on blood pressure, exercise, diet and 
mortality (181).  Despite evidence that inadequate provision of information has 
adverse consequences on compliance with secondary prevention and 
psychosocial outcomes (160), evaluation of the impact of education on physical 
outcomes is lacking in stroke disease.   
We describe a single blind randomised controlled trial of a nurse providing 
health education and counselling for patients with stroke or transient ischaemic 
attack (TIA), and its effects on risk factors, satisfaction, mood and perceived 
health status. 
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Subjects and Methods 
Pilot work and statistical power 
We undertook an initial survey of the case-notes of 51 consecutive patients 
attending our stroke and TIA clinic.  We focussed on the more easily measurable, 
significant modifiable risk factors (blood pressure, smoking, cholesterol and 
diabetes).  The average number of risk factors per patient was three.  Of these 
patients, only 20% had achieved complete risk factor control by the time of 
discharge from secondary care.  We defined risk factor control as risk factor 
results that fell within the recommended treatment range according to the 
contemporary national and local treatment guidelines (Table 2.1).  We 
estimated we would need to recruit 89 patients per group to show an increase in 
the proportion of patients whose risk factors were “on target” from 25% to 50% 
with 80% power at the 5% significance level.  The control group rate of 25% is 
supported by our pilot work and on other trial data (170;179;182;183). 
We then conducted a Randomised Controlled Trial to assess the impact of a 
nurse specialist led, health education intervention.  Our primary outcome was an 
increase in collective risk factor control (or the proportion of patients with all 
their risk factors controlled). Secondary outcomes were improvement in 
individual risk factors, clinical outcomes (death, further cerebrovascular or 
other vascular events, hospitalisation), perceived health status (184), Geriatric 
Depression scores (185;186) and satisfaction scores using previously validated 
stroke service questionnaires (187).  Local ethical approval was obtained for the 
study. 
Inclusion and exclusion criteria 
All patients with a diagnosis of TIA or stroke, cerebrovascular disease or 
amaurosis fugax, with any major modifiable risk factor, (blood pressure, 
smoking, cholesterol, and diabetes) were eligible.  Patients with cognitive 
impairment (defined as an Abbreviated Mental Test score <5) were excluded 
(188).  Patients with communication difficulties were not excluded unless, in the 
opinion of a Speech and Language Therapist they were felt unable to 
comprehend the information given or effectively consent to involvement. 
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Randomisation 
Patients were enrolled following the completion of their standard investigations 
and treatment.  After giving informed consent, randomisation was performed by 
opening a sequentially numbered opaque envelope available within the clinic.  
These were generated by the use of computer generated random numbers in 
repeating blocks of six, organised by someone uninvolved in the study.  Baseline 
characteristics demonstrate the similarity of the two groups at randomisation 
(Table 2.2). 
Study participants 
208 patients were recruited at their final visit to the stroke clinic or geriatric 
medical day hospital.  Details of the patient recruitment are illustrated in Figure 
2.1.  Three patients were entered twice in error, both times to the treatment 
group.  These subjects were analysed on their initial data only and subsequent 
data were excluded from the analysis.  One patient in the control group was 
later found to be ineligible based on information unavailable at the time of 
enrolment.  For the purposes of assessment and data analysis, this patient has 
been included on an intention to treat basis.  The diagnostic classifications of 
both groups are illustrated in Table 2.2. 
Intervention 
Patients randomised to control services received usual care, which included 
generic risk factor advice from medical staff as well as the Stroke Nurse 
Specialist (SNS).  Treatment group patients were reviewed at monthly intervals 
by the SNS for additional input, which encouraged empowerment with behaviour 
modification and treatment compliance.  These reviews were conducted within 
the hospital premises as an outpatient consultation; patients were interviewed 
and given individual counselling on lifestyle changes and the importance of 
secondary prevention.  Additional open questions gave patients the opportunity 
to bring up other subjects as the patient felt appropriate.  The average 
consultation length was approximately 30 minutes.  Patients received on average 
three counselling sessions with the SNS.  All verbal information was backed up by 
written information that was selected by the SNS as relevant to the individual 
patient.  Personalised patient held records were also given to patients, detailing 
their risk factors, and the recommended risk factor targets.  This record was 
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updated at each visit, and was considered a key part of the intervention.  The 
SNS did not routinely attempt to contact the patient’s GP or hospital specialist 
in order to influence prescribing.  Where a risk factor (e.g. blood pressure) was 
deemed to be at unacceptable levels, patients were encouraged to consult their 
GPs with that information.  General Practitioners of both treatment and control 
group patients were informed of the study by letter, and of the form of 
intervention.  At the end of the study, a letter summarising the patient’s risk 
factors as well as our recommended risk factor targets was sent to the GPs of all 
the patients (treatment and control groups).  
Follow up and / outcome measures 
All patients were followed up at completion of the study on average 5.3 (SD 1.5) 
months after enrolment by a researcher blinded to the patients’ randomisation 
category.  Assessments included the EuroQOL (184) perceived health status 
questionnaire, Geriatric Depression Score (185;186) and a validated stroke 
services satisfaction questionnaire (187).  Three patients who were enrolled 
twice in error were not reviewed after the second enrolment. 
Analysis 
Data were entered by the principal investigator and analysed using SPSS for 
Windows version 10.0.  Continuous homogeneous variable data were analysed 
using independent T-tests.  Where normality tests were not satisfied, data were 
analysed using and Mann-Whitney U/Wilcoxon Sum Rank test non-parametric 
methods.  Categorical data were analysed using the χ2 test.  Analysis of 
covariance with a general linear model (Ancova) was applied where necessary to 
adjust for differences in baseline variables.  
 
Results 
Primary analysis 
Cumulative risk factor control was defined as the number of patients whose 
major, modifiable risk factors were within national or local guidelines.  The 
number of controlled risk factors per patient is illustrated in Table 2.3.   Analysis 
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by χ2 and Mann-Whitney U non-parametric testing failed to demonstrate a 
statistically significant difference between the two groups.  (Percentage 
controlled 46 %, 95% CI 39 – 54 Vs 42 %, 95% CI 35 – 49, p= 0.36).  (Tables 2.3 and 
2.4) 
Secondary Analysis – Individual Risk Factor Control and Clinical Outcomes 
The initial (planned) analysis of individual risk factors appeared to demonstrate 
a statistically significant reduction in systolic blood pressure in the treatment 
group compared to control (-9.2mmHg, 95% CI -15.0 to -3.5 Vs -1.0mmHg, 95% CI 
-6.3 to 4.3, p=0.04).  However the experimental group appeared to have higher 
baseline systolic blood pressures (156.2mmHg, 95% CI 150.7 – 161.7 vs. 
151mmHg, 95% CI 146.0 to 156.3, p=0.19), and achieved only marginally lower 
mean systolic blood pressures at follow up than the control group (148.0mmHg, 
95% CI 142.0 to 154.0 vs. 150mmHg, 95% CI 144.5 to 155.6, p=0.62).  The 
possibility exists that this result reflects regression to the mean.  Analysis using a 
general linear model (Ancova) to adjust for baseline BP did not suggest that the 
result could be fully explained by regression to the mean.  However analysis with 
adjustment for baseline BP indicated that the difference between groups in 
systolic blood pressure drop was less marked (-7.8mmHg, 95% CI -13.1 to -2.6 Vs 
-2.2mmHg -7.1 to 2.7, p=0.13). 
Changes in diastolic blood pressure (-2.1mmHg, 95% CI -5.7 to 1.5 Vs -1.2mmHg, 
95% CI -4.5 to 4.5, p= 0.71), reported smoking number (-1.6 cigarettes per day, 
95% CI -5.1 to 1.8 Vs -0.4cpd, 95% CI -3.7 to 2.8, p= 0.61), serum cholesterol (-
0.96mmol/L, 95% CI -1.2 to 0.7 Vs -0.87mmol/L 95% CI -0.9 to 1.1, p=0.63), 
random blood glucose (+0.92mmol/L, 95% CI -1.9 to 3.7 Vs +0.89mmol/L, 95% CI 
-1.8 to 3.6, p= 0.99) and HbA1c (-0.25%, 95% CI Vs -0.78 ± 2, p=0.20) did not 
reach statistical significance. 
Other clinical outcomes 
Analysis of clinical outcomes between the groups did not demonstrate any 
significant difference in clinical events not leading to admission (P=0.28) or 
admissions (P=0.56).  There were no deaths in either group during the time-
course of the trial. 
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Medication score 
Patients were asked to recall their current medications.  This list was compared 
to a General Practitioners record of the patients prescribing at the time of 
review.  A medication score was given as a percentage correct recall of relevant 
secondary prevention medication.  There was non-significant difference noted 
between the two groups (Intervention 71% correct, 95% CI 62 to 80 Vs Control 
79% correct, 95% CI 70 to 88, p=0.24). 
Perceived Health Status (EuroQOL) 
Patients were asked to rate their perceived health status (EuroQOL) at baseline 
and at follow up.  There was no significant difference between the groups at 
baseline or follow up when analysed using a χ2 test for the separate health 
categories (mobility, self care, usual activities, pain or anxiety and depression).   
Comparison of perceived health scale (percentage) by independent T-test 
showed a non-significant increase in the treatment group in the EuroQOL visual 
analogue scale (3.5% increase, 95% CI -0.9 to 7.9 Vs 1% increase, 95% CI -3.3 to 
5.3, P=0.43). 
Depression score (Geriatric Depression Score) 
There was no statistically significant difference between the groups in the 
Geriatric Depression Scale (4.26, 95% CI 3.56 to 4.95 Vs 5.06, 95% CI 4.38 to 
5.73, P=0.11).  When predefined cut-offs are used, there were no differences in 
those with a “probable” diagnosis of depression (GDS > 5) between the groups 
(30 Vs 37, p=0.43) or those with a diagnosis of “definite” depression (GDS >10) (5 
Vs 10, p=0.29). 
Stroke services satisfaction questionnaire 
Patients were asked to complete a stroke service satisfaction questionnaire at 
follow up.  There were significant differences between the groups for several of 
the categories (Table 2.5).  Patients in the treatment group were more likely to 
express satisfaction that they had been able to talk to someone (p=0.03), and 
that they knew who to contact if required (p=0.03).  They also expressed greater 
satisfaction with the information they had received, both about the causes of 
stroke (p=0.02) and about their risk factors (p=0.01). 
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Discussion 
Studies examining healthcare workers who typically provide education, liaison 
and social support (these studies are described in more detail in Chapter 5 under 
the umbrella title of Stroke Liaison Worker) have varied in their target 
population, interventions and outcome measures.  Most have assessed the 
impact of educational or counselling based interventions on functional, 
emotional and educational outcomes (164;166;167;189).   These studies have 
tended not to look at the physical outcomes of health education interventions 
(162;165), or have shown disappointing outcomes with respect to risk factor 
modification (190). 
The intervention in this randomised controlled trial appeared to be well 
tolerated, with drop out rates in the treatment group being very similar to the 
control group.  
Overall there was no significant difference between the groups in terms of the 
proportion of patients who had achieved 100% control of their risk factors.  
There was a very small and non-significant difference between the groups that 
favoured the intervention group.  The reason for the lack of a more significant 
result may reflect a type II statistical error, which would be most likely to be 
due to under-powering.   
The unexpected improvement in risk factor control in the control group is 
surprising when compared to previous studies which gave a more disappointing 
picture of risk factor control (191).   
It may be that part of the reason for improvement in the control group may be 
due to a smaller number of risk factors in the series than in the pilot survey.  It 
may be easier to gain 100% control of all of a patient’s risk factors if they only 
have one or two risk factors to control (compared to three or four).  In addition, 
hypercholesterolaemia was the most frequent risk factor in both groups.  It is 
ordinarily amenable to statin therapy in contrast to other drug therapy, lifestyle 
or dietary modification which were the mainstay of treatment in much of the 
comparable literature. 
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There was a non-significant trend to improvement in systolic blood pressure in 
the intervention group, when adjusted for baseline systolic blood pressure.  It 
might be postulated that a reduction as early as three months may reflect 
improved concordance in addition to lifestyle and dietary changes since it is well 
established that patients with chronic conditions (such as hypertension) may 
take as little as half of their prescribed medication (192).   
Studies show that many people with stroke are dissatisfied with the content and 
quality of information given to them (160).  Patients who feel inadequately 
informed seem to be less satisfied with the care they have received, less 
compliant with medical advice and suffer poorer outcomes (193;194).  Improving 
patient’s satisfaction with the level of information they have received and the 
level of health professional contact may be key to addressing these problems.  
Patients in the intervention group were statistically more likely to express 
satisfaction that they had been able to talk to someone about the problems they 
were having and that they knew who to contact should they have further 
problems relating to their stroke or TIA.  In terms of the information patients 
received, patients in the intervention group were more satisfied with the 
amount of information they had received about the causes and nature of their 
illness and about their risk factors.  These findings are not surprising given the 
nature of the intervention, and reflect other trial evidence (164;167). 
In conclusion, nurse specialist led education with tailored risk factor advice and 
patient held documentation was well tolerated.  This form of intervention did 
not result in significant improvements in risk factor control, and this may reflect 
under powering.  Patients in the intervention group were more satisfied with the 
amount of information they received, and expressed satisfaction that they felt 
they had someone that they could contact with regard to their stroke disease.  
Further research in this area is warranted since optimisation of risk factors is 
vital for long-term health outcomes. 
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Figure 2.1: Trial Profile 
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Table 2.1: Modifiable Risk Factor Targets 
Risk Factor Target Guideline 
Blood Pressure <140/85 National* 
Smoking Complete Cessation National† 
Cholesterol <5.0 Local 
Diabetes Random Glucose <8 
HbA1c <7.5 
Local 
*British Hypertension Society Guidelines 1999 (195) 
†Scottish Intercollegiate Guidelines Network 1997 (196) 
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Table 2.2: Summary of Baseline Characteristics 
 Experiment Control p Value 
% (n=100) % (n=105) 
Mean age 64 66 0.25 
Sex (Male) 54 (54) 49.5 (52) 0.68 
 
   
Diagnosis    
Transient Ischaemic Attack 29.0 (29) 25.7 (27) 0.18 
Stroke 61.0 (61) 64.8 (68) 0.18 
Cerebrovascular Disease 2.0 (2) 3.8 (4) 0.16 
Amaurosis Fugax 4.0 (4) 3.8 (4) 0.21 
Transient Global Amnesia 2.0 (2) 0.0 (0) 0.13 
Retinal Artery Occlusion (embolic) 2.0 (2) 1.9 (2) 0.36 
Modifiable Risk Factors    
Smoker 36.0 (36) 40.0 (42) 0.55 
Number of Cigarettes per day 13 13 0.99 
Hypertensive 66.0 (66) 73.3 (77) 0.26 
Systolic BP (mmHg) 156.2 151.1 0.19 
Diastolic BP (mmHg) 83.4 80.0 0.18 
Diabetic 25.0 (25) 24.8 (26) 0.97 
Random Blood Glucose (mmol/L) 10.73 9.94 0.57 
HbA1C (%) 7.54 7.89 0.58 
Hypercholesterolaemia 79.0 (79) 75.2 (79) 0.52 
Total Cholesterol (mmol/L) 5.8 5.7 0.66 
    
Other Risk Factors    
Previous TIA 18.0 (18) 10.5 (11) 0.12 
Previous stroke 12.0 (12) 21.9 (23) 0.06 
Atrial Fibrillation 2.0 (2) 3.8 (4) 0.45 
     
Number of Modifiable Risk 
Factors 
1 22.0 (22) 24.8 (26) 0.64 
 2 49.0 (49) 40.0 (42) 0.20 
 3 29.0 (29) 32.4 (34) 0.60 
 4 0.0 (0) 2.9 (3) 0.09 
For categorical variables, the Chi2 statistic has been used. 
For continuous variables the Student’s t-test has been used. 
 
 
 
 
52 
 
 
 
Table 2.3: Number of Controlled Risk Factors at Follow up 
 Experiment 
(n=94) 
Control 
(n=98) 
p Value 
% (n) % (n) 
None 28.7 (27) 31.6 (31) 0.79 
1 46.8 (44) 46.9 (46) 0.98 
2 20.2 (19) 20.4 (20) 0.97 
3 4.3 (4) 1.0 (1) 0.16 
4 0.0 (0) 0.0 (0)  
“All relevant risk 
factors controlled” 
46.4 
(95% CI 39.1 – 53.7) 
41.7 
(95% CI 34.7 – 48.7) 
0.34 
For categorical variables, the Chi2 statistic has been used. 
The number of risk factors controlled within the study population expressed as 
numbers of risk factors that fall within the guidelines laid out in Table 1.   
 
 
 
 
 
 
 
Table 2.4: Secondary Outcome Measures including Change in 
Individual Risk Factors 
Variable 
  
Experiment Control Student’s 
t-test 
    
Blood Pressure control    
Systolic BP (mmHg) -9.2 (SD 23.3, n=64) -1.0 (SD 22.4, n=72) P=0.04* 
Diastolic BP (mmHg) -2.1 (SD 15.1, n=64) -1.2 (SD 13.8, n=72) P=0.71 
     
Diabetic control     
RBG (mmol/L) 0.9 (SD 5.7, n=23) 0.9 (SD 7.4, n=24) P=0.99 
HbA1c (%) -0.3 (SD 0.7, n=17) -0.8 (SD 1.5, n=17) p=0.20 
     
Cholesterol (mmol/L) -1.0 (SD 1.1, n=75) -0.9 (SD 1.2, n=73) p=0.63 
     
Smoking No (cpd) -1.6 (SD 11.5, n=33) 1.1 (SD 8.1, n=37) P=0.56 
     
EuroQOL* (%) 3.5 (SD 20.9, n=94) 1.0 (SD 22.4, n=97) p=0.43 
     
*Bonferroni correction for multiple comparisons; p=0.28
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Table 2.5: Satisfaction with Stroke Services 
Question Experiment Control Pearson 
Chi-
Square Strongly Agree 
%(n=94) 
Strongly Agree 
%(n=98) 
I have been treated with kindness and 
respect by staff at the hospital. 84% (79) 78% (76) P=0.252 
The staff attended well to my needs when 
I was at the hospital. 78% (73) 75% (73) P=0.255 
I was able to talk to the staff about any 
problems I might have had. 75% (70) 57% (56) P=0.027 
I have received all the information I want 
about the causes and nature of my illness. 70% (66) 51% (50) P=0.022 
The doctors have done everything they 
can to make me well again. 76% (71) 66% (65) P=0.360 
I am satisfied with the outpatient services 
provided by the hospital. 75% (70) 65% (64) P=0.080 
I have received enough information about 
my risk factors for stroke. 71% (67) 54% (53) P=0.010 
Somebody has really listened and 
understood my needs and problems since I 
attended the hospital. 
 
68% (64) 60% (59) P=0.212 
I am satisfied with the amount of contact I 
have had with the hospital since I have 
attended. 
 
73% (69) 62% (61) P=0.166 
I have had enough emotional support 
since I attended the hospital. 60% (56) 48% (47) P=0.233 
I know whom to contact if I have problems 
relating to my TIA/stroke. 71% (67) 52% (51) P=0.034 
I am happy with the amount of recovery I 
have made. 
 
59% (55) 55% (54) P=0.928 
I was given all the information I needed 
about the allowances or services I might 
need. 
53% (50) 44% (43) P=0.436 
Satisfaction expressed as the percentage that strongly agree with the statements. 
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Chapter Three:  
3 Years On: Does Behaviour Modification Affect 
Post Stroke Risk Factor Control? 
 
Introduction 
Stroke recurrence is well documented and studies have suggested that rates are 
higher than was initially expected; a 5 year recurrence rate of up to 16% has 
been quoted (197).   As we have examined in Chapter Two, significant progress 
has been made in secondary prevention (198-201), however, evidence is lacking 
with regards to the best methods to promote medication adherence and modify 
health behaviour (202;203).  This is despite considerable evidence accumulating 
in cardiovascular disease regarding both behaviour modification (114;115;204-
208) and multiple simultaneous risk factor interventions (208).  In addition little 
is known about persistence with secondary prevention measures in stroke or TIA 
patients.  It is reasonable to assume that compliance in the “real world” might 
not reflect that recorded in randomised controlled trials (203). 
We describe a three year follow up study of a short term intervention (outlined 
in Chapter Two) to promote behaviour modification and encourage medication 
concordance. 
The original randomised controlled trial evaluated the impact of a three month 
nurse-led behaviour modification program that included counselling on lifestyle, 
risk factors and medication concordance post stroke or TIA (209).  Patients were 
randomised to the intervention for three months, or usual care.  Those in the 
intervention group were given counselling and written information regarding 
their individual risk factors, risk factor targets and medication. Despite not 
achieving a global improvement in risk factors, there was a statistically 
significant reduction seen in systolic blood pressure at follow up. Patients were 
significantly more satisfied with stroke services – specifically about information.  
We sought to establish if these benefits were maintained in the longer term. 
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Methods 
All contacts from the original study (n=205) were reviewed and cross checked 
with hospital records to exclude those who had died in the interim.  In addition, 
General Practitioners were contacted to confirm a patient’s status.  All living 
contacts were then sent a letter inviting them to participate in a follow up 
program.  General Practitioners were also informed of the study.  The letter to 
patients was followed two weeks later by a telephone call to invite them to 
participate, and making an appointment at the day hospital facility.  Where this 
was not practical, a home visit was arranged.  Where patients did not attend, 
they were contacted a second time by telephone to offer them one further 
appointment. 
We sought to contact, where possible, every member of the original cohort and 
to avoid loss to follow up.  Where patients did not respond to the letter and 
could not be contacted by telephone, General Practitioners were contacted to 
determine if the patient had died or moved and for details of forwarding 
addresses where available.  Residents of Nursing Homes were not contacted.  No 
residents of nursing homes were recruited to the original study. 
On attendance, the purpose of the study was explained and written consent was 
obtained.  Assessment reviews were conducted by three researchers blinded to 
the original patient allocation.  Details of patient randomisation from the 
original study were held on a database that was not accessed until all patient 
reviews had been completed.  
Details of the four main modifiable risk factors were documented. Blood 
pressure was recorded and smoking history documented. Blood was taken for 
cholesterol measurement and random blood glucose in all patients irrespective 
of their previous history of diabetes or hypercholesterolaemia.  Serum HbA1c 
was recorded in all previously established diabetics.  
Patients were asked to report whether they had further cerebrovascular or 
cardiovascular events in the interval period.  In addition admissions to hospital 
and their cause were recorded.  Patients were asked to fill in a EuroQOL 
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questionnaire to record perceived health status, a Geriatric Depression Scale and 
a follow-up questionnaire on satisfaction with stroke services.   
Medication concordance was documented.  This was assessed in several ways; 
1. Patients were asked to bring all of their current medication and 
comparison was made to the repeat prescription for inconsistencies. 
2. Medication packaging was also checked for any “out-of-date” medication. 
3. Patients were also asked whether they considered themselves to be 
compliant with therapy. 
Persistence with therapy was evaluated by comparing medication details at 
follow-up, with those documented at completion of the initial study.  
On completion of the study, General Practitioners were informed of the 
patient’s risk factor status and targets were once again reinforced.   
Data were analysed using SPSS version 13.  Dichotomous data were analysed 
using the χ2 statistic.  Continuous variables were analysed by an independent 
samples T-test.  Local ethics committee approval was obtained. 
 
Results 
The mean length of follow up was 3.6 years (SD 0.43).  Of the 205 patients 
enrolled in the initial study, 102 patients attended for follow-up (Figure 3.1). 
Reasons for non-attendance are documented (Table 3.2).  Twenty five patients 
had died since the completion of the initial study (11 intervention/14 control, 
p=0.39).  All intervention patients in the initial study were living within the 
community. At time of follow-up 5 patients from the control group were resident 
in a nursing home, though no patients from the intervention group had been 
admitted to a care facility. 
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Risk factor control 
The primary outcome was collective risk factor control. Risk factors were 
controlled if within local or national guidelines. Table 3.1 demonstrates that 
there was no significant difference in the percentage of controlled risk factors 
between groups. In addition there was no significant difference in control of the 
four main modifiable risk factors (diabetes, smoking status, cholesterol and 
blood pressure). 
There was no significant interval change in risk factor control between the initial 
and follow-up studies. Overall collective risk factor control was suboptimal in 
the initial study and disappointingly there was no significant improvement three 
years on. These results match others described in the literature at 2 years (210). 
The difference in systolic blood pressure documented in the initial study, 
appears not to have been maintained. 
Clinical outcomes 
Clinical events were self reported. There was no attempt to confirm evidence of 
self reported events or admissions. More than one cerebrovascular event was 
reported by several patients. The total number of strokes was similar between 
groups (Table 3.1); however the total number of reported TIA’s was higher in the 
intervention group. One patient in the intervention group reported 10 possible 
TIA’s in the interval between studies. No objective confirmation of these 
reported symptoms was possible in this study. The actual number of patients 
with recurrent events between groups was similar and therefore this does not 
reach statistical significance. Ischaemic heart disease episodes were more 
frequent in the control group but this was not statistically significant. 
Admission rates differ between groups, the number of admissions was higher in 
the control group, though this was largely due to non-vascular aetiology. 
Medication persistence 
Details of ongoing prescription of three secondary prevention medications were 
documented and compared with the initial study data (Table 3.3). Persistence 
was similar in both groups. Despite apparent differences in reported compliance 
and the presence of expired medication between groups, this does not reach 
statistical significance. 
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Perceived health status 
Overall there was no significant difference between perceived health status and 
Geriatric Depression Score between groups. The number of clinically depressed 
individuals determined by a cut off score of 5 or more on the short form of the 
GDS was greater in the control group (Table 3.1); however this did not reach 
statistical significance. 
Patient satisfaction with stroke services was evaluated using a series of 
questions on a Likert scale, as per the initial study. Overall satisfaction was high, 
however there was no significant difference in questionnaire scores as shown in 
Table 3.4. Also highlighted are the previously positive questions in the initial 
study. 
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Discussion 
It appears that brief intervention with respect to behaviour modification and risk 
factor control has no long-term benefit. This study may be one of few carried 
out showing long-term outcomes in post-stroke patients; however there are a 
number of important limitations. Firstly, in terms of study size, both the initial 
and follow-up studies were largely underpowered and therefore the results have 
to be cautiously interpreted. It is unlikely that anything other than major 
differences between groups would be detected and many results in this paper 
could represent a type II statistical error.  
Attrition is inevitable at long-term follow-up. Attrition bias, where one group of 
patients systematically drop out of follow-up is an important risk in behaviour 
modifications. Almost the entire cohort (94%) attended for follow-up during the 
initial study and had a clear understanding of what was involved. It could be 
assumed that patients who have been poorly compliant with education and 
therapy may not be willing to attend for follow-up, where their poor compliance 
since the initial study could be exposed. Follow-up rates between groups were 
comparable. 
The estimation of recurrent vascular events in this study was based on self-
reporting and no formal confirmation was possible. The apparent difference in 
reported TIAs in the intervention group may be due to increased awareness of 
symptoms following education, or a heightened level of anxiety.  
The gold standard assessment of medication concordance is by electronic or pill-
counting methods (211). We sought to use multiple methods in this study to 
assess adherence behaviour that were felt to be simple and objective. 
Medication persistence was reassuringly high in this study. Both groups had 
similar high levels of persistence with therapy at follow-up; this may explain the 
similarities in risk factor control. This may simply reflect the fact that patients 
who participate in studies are more motivated and our results may not be 
generalisable.  Persistence with secondary prevention therapies, in particular 
antithrombotic therapy, has been shown to be similarly high in other short-term 
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studies (212-214). However, in comparison to our study, other evidence suggests 
that persistence falls with time, in particular with antihypertensive therapy 
(215;216). 
A potential confounding factor for patients in the Glasgow area is the 
introduction of a chronic disease management programme since the initial study. 
Primary care teams aim to review all patients with a diagnosis of a stroke every 
six months, aiming to address secondary prevention, assess rehabilitation needs 
and provide education. This programme is independent of the study and it is 
likely that both the intervention and control group have undergone review.    
The difference between the two groups in terms of rates of institutionalisation 
raises interesting questions. These differences may be due to chance alone in a 
small study sample. However, it may be related to real clinical differences in 
stroke recurrence or cognitive decline. Nursing Home residents were not 
approached for inclusion in the follow-up study for ethical reasons; therefore we 
were unable to determine the reason for admission. A disabling stroke and 
cognitive impairment secondary to vascular disease are common causes of 
admission to a Nursing Home. In addition, cognition was not evaluated as a 
clinical outcome in this study. 
 Satisfaction with stroke services remained high within this study population; 
however the significant difference between groups has not been maintained 
long-term. In the initial study, patients in the intervention group felt more 
satisfied with the information provided to them about stroke disease, risk 
factors and who to contact in the event of problems. These results have also 
been replicated in a more recent study of short-term follow-up (217). Further 
work is required with regards to the most effective method in providing ongoing 
education over a longer time frame; it may be that that chronic disease 
management programmes have a role to play.   
It is clear that management of risk factors remains suboptimal. Overall 
collective risk factor control is poor and it is interesting that it remains very 
similar to results at completion of the initial study. It is disappointing that no 
significant improvements have been made in the interim despite recent 
developments. 
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Despite this study’s limitations it remains one of the few studies that describe 
the realities of risk factor control in a real world setting over a long time period 
(210). It is the intention of education and behaviour modifying interventions to 
improve longer term compliance and satisfaction and therefore further long-
term research is required. 
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Figure 3.1: Trial Flow 
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Dead 
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Table 3.1: Outcome data 
 Intervention 
   (n=49) 
Control 
(n=53) 
Significance 
 
Risk factor control    
 % of controlled risk factors 52% (SD 31.0) 56% (SD 35.4) p=0.53 
    
 Systolic BP (mean) 143 (SD 18.8) 139 (SD 21.6) p=0.38 
 Diastolic BP (mean) 74 (SD 10.3) 74 (SD 12.2) p=0.74 
 Cholesterol 4.3 (SD 1.2) 4.5 (SD 0.9) p=0.23 
 Diabetic control    
       Random Glucose (mean) 8.1 (SD 5.7) 7.1 (SD 3.5) p=0.31 
       HbA1c (mean) 8.0 (SD 1.9) 7.5 (SD 1.5) p=0.43 
 Cigarettes per day (mean) 13 (SD 7.7) 14 (SD 9.2) p=0.73 
    
Clinical events    
Recurrent Cerebrovascular events 25(n=7) 13(n=6) p=0.78 
(No. of patients)    
Total number of TIAs 23 10  
Total number of CVAs 2 3  
    
 Ischaemic heart disease events 2 6 p=0.27 
 (No. of patients)    
     
Total No. of admissions (all cause) 13 22 p=0.31 
Vascular admissions 7 11 p=0.69 
     
Perceived Health Status    
 EuroQOL (% score) 62% (SD 20.0) 60% (SD 20.5) p=0.73 
 Geriatric Depression Score(mean) 3.6 (SD 3.3) 4.3 (SD 4.2) p=0.36 
 Depressed (by cut-off) 11 16 p=0.49 
    
For categorical variables, the Chi2 statistic has been used. 
For continuous variables the Student’s t-test has been used. 
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Table 3.2: Reason for Non-attendance 
 Intervention 
(n) 
Control 
(n) 
Pearson Chi-
Square  
 
Death 11 14 p=0.39 
Institutionalisation 0 5 p=0.02 
(Death or institutionalisation) 11 19 p= 0.09 
    
Refused-Unwell 1 0 p=0.31 
Refused-No reason  19 11 p=0.09 
Not contactable 20 22 p=0.84 
 
 
 
 
 
 
Table 3.3: Persistence with Therapy 
 Intervention 
%,(n/N) 
Control 
%,(n/N) 
Significance 
 
Persistence with therapy       
   Antiplatelet 95% (44/46) 89% (44/50) p=0.28 
   Antihypertensive 97% (36/37) 95% (41/43) p=0.81 
   Statin 88% (32/36) 89% (39/44) p=0.92 
    
Expired medication (packaging)    
   “yes” 13% (4/32) 6% (2/34) p=0.42 
         
“Do you always take your 
medicines?” 
   
   “yes” 78% (29/37) 92% (36/39) p=0.10 
For categorical variables, the Chi2 statistic has been used. 
For continuous variables the Student’s t-test has been used. 
 
 
 
65 
 
Table 3.4: Satisfaction with Stroke Services 
Question          % Strongly Agree               
Intervention 
(49) 
Control 
(52) 
Pearson 
Chi-
Square 
I have been treated with kindness 
and respect by staff at the hospital. 
78% 
(38/49) 
 
75% 
(39/52) 
 
p=0.52 
 
The staff attended well to my needs 
when I was at the hospital. 
74% 
(36/49) 
 
75% 
(39/52) 
 
p=0.59 
 
I was able to talk to the staff about 
the problems I might have had.* 
68% 
(30/44) 
 
71% 
(35/49) 
 
p=0.78 
 
I have received all the information I 
want about the causes and nature of 
my illness.* 
53% 
(25/47) 
 
50% 
(26/52) 
 
p=0.54 
 
The doctors have done everything 
they can to make me well again. 
55% 
(26/47) 
 
67% 
(35/52) 
 
p=0.25 
 
I am satisfied with the outpatient 
services provided by the hospital. 
54% 
(26/48) 
 
62% 
(32/52) 
 
p=0.29 
 
I have received enough information 
about my risk factors for stroke.* 
47% 
(22/47) 
 
59% 
(30/51) 
 
p=0.17 
 
Somebody has really listened and 
understood my needs and problems 
since I attended the hospital. 
48% 
(19/40) 
 
 
58% 
(26/45) 
 
 
p=0.61 
 
 
I am satisfied with the amount of 
contact I have had with the hospital 
since I have attended. 
55% 
(26/47) 
 
 
50% 
(25/50) 
 
 
p=0.66 
 
 
I have had enough emotional 
support since I attended the 
hospital. 
52% 
(14/27) 
 
50% 
(17/34) 
 
p= 
0.97 
 
I know whom to contact if I have 
problems relating to my 
TIA/Stroke.* 
43% 
(21/49) 
 
42% 
(22/52) 
 
p=0.98 
 
I am happy with the amount of 
recovery I have made. 
57% 
(28/49) 
 
52% 
(27/52) 
 
p=0.68 
 
I was given all the information I 
needed about the allowances or 
services I might need. 
33%  
(8/24) 
42% 
(14/33) 
p=0.59 
Satisfaction expressed as the percentage that strongly agree with the statements. 
*Previously positive questions 
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Table 3.5: Change in Secondary Outcomes Over Study Period 
Variable Time  Experiment Control Significance 
    
Blood Pressure control    
Systolic BP 3 Months -9.2 (SD 23.3, n=64) -1.0 (SD 22.4, n=72) P=0.04 
(mmHg) 3 Year -8.5 (SD 24.9, n=33) -10.6 (SD 25.5, n=41) p=0.73 
 Interval  
(3 Years –  
3 Months) 
1.8 (SD 26.5, n=32) -8.3 (SD 25.1, n=43) p=0.10 
     
Diastolic BP 3 Months -2.1 (SD 15.1, n=64) -1.2 (SD 13.8, n=72) P=0.71 
(mmHg) 3 Year -2.5 (SD 16.0, n=33) -4.7(SD 15.9, n=41) p=0.55 
 Interval -3.8 (SD 11.0, n=32) -5.2 (SD 14.0, n=43) p=0.64 
     
Diabetic control     
RBG 3 Months 0.9 (SD 5.7, n=23) 0.9 (SD 7.4, n=24) P=0.99 
(mmol/L) 3 Year 0.8 (SD 13.8, n=8) -0.2 (SD 7.4, n=9) p=0.85 
 Interval -1.2 (SD 11.0, n=9) -0.9 (SD 7.1, n=10) p=0.95 
     
HbA1c 3 Months -0.3 (SD 0.7, n=17) -0.8 (SD 1.5, n=17) p=0.20 
(%) 3 Year -0.6 (SD 2.4,n=8) -0.5 (SD 1.8, n=8) p=0.93 
 Interval 0.0 (SD 2.0, n=9) 0.0 (SD 1.5, n=8) p=0.99 
     
Cholesterol 3 Months -1.0 (SD 1.1, n=75) -0.9 (SD 1.2, n=73) p=0.63 
(mmol/L) 3 Year -1.4 (SD 1.25, n=41) -1.3 (SD 1.1, n=40) p=0.51 
 Interval -0.4 (SD 1.0, n=40) -0.2 (SD 1.0, n=39) p=0.47 
     
Smoking No 3 Months -1.6 (SD 11.5, n=33) -0.4 (SD 8.1, n=37) P=0.61 
(cpd) 3 Year -1.6 (SD11.1, n=15) 1.08 (SD 9.5, n=12) p=0.51 
 Interval 0.8 (SD 9.3, n=15) 1.0 (SD 9.1, n=12) p=0.96 
     
EuroQOL* 3 Months 3.5 (SD 20.9, n=94) -1.0 (SD 22.4, n=97) p=0.43 
(%) 3 Year -4.0 (SD 22.9, n=49) -5.7 (SD 17.4, n=53) p=0.68 
 Interval -7.4 (SD 18.9, n=49) -5.3 (SD 18.8, n=51) p=0.56 
     
GDS† Interval -0.2 (SD 1.9, n=0.49) -0.6 (SD 3.8, n=51) p=0.57 
 (3 Years –  
3 Months) 
   
     
 Minus values indicate a reduction in the appropriate measure. 
*Higher scores indicate a higher quality of life score. 
†Higher (positive scores) indicate a greater likelihood of depression. 
For categorical variables, the Chi2 statistic has been used. 
For continuous variables the Student’s t-test has been used. 
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Chapter Four:  
Outpatient Rehabilitation Services After Stroke: A 
Descriptive Analysis of the Randomised Trials 
Introduction 
Complex interventions, defined as those made up of “various interconnecting 
parts”, encompass the majority of healthcare interventions especially in the 
context of rehabilitation (218). Ideally rehabilitation trials should follow the MRC 
framework for complex interventions, which recognises the challenge of 
developing, describing and researching complex interventions (219). It proposes 
that their development and testing should follow a series of phases (Figure 4.1).  
 
Figure 4.1: MRC Framework for Complex Interventions
Theory: explore relevant theory and 
best choice of hypotheses 
Modelling: identify components of an 
intervention and underlying 
mechanisms of effect 
Exploratory trial: develop a feasible 
protocol for a definitive trial 
Definitive randomised trial: 
adequately powered testing of 
defined intervention 
Long-term implementation: establish 
that intervention can be widely 
applied 
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The basic sciences underpinning rehabilitation are not well developed and the 
underlying pathophysiological rationale for, and intention of a rehabilitation 
intervention are often not clear.  Traditionally rehabilitation trials have been 
developed from an intuitive belief about what may be effective, and most trials 
of such interventions have not had sufficient statistical power to provide 
definitive conclusions.  Because individual trials are often small, conclusions 
about the effectiveness of rehabilitation interventions are often based on 
systematic reviews of all the randomised trials.  
In the area of outpatient stroke rehabilitation, the number of randomised 
controlled trials has increased considerably in recent years (220).   Classifying 
these separate interventions however presents some challenges.  Firstly, the 
nature of stroke rehabilitation is broad, ill-defined and multi-faceted (221). 
Secondly, a wide variety of outpatient rehabilitation services have been 
developed which address different aspects of stroke, including impairment, 
disability (activities), handicap (participation) and mood status.  Finally, 
rehabilitation services rarely operate in isolation and a variety of comparison 
treatments have been used as controls.   
In the absence of a framework for characterising rehabilitation interventions we 
wished to find a method of identifying and classifying trials of stroke 
rehabilitation in the community.  We therefore sought to develop a simple 
classification system which categorises interventions by simple descriptive 
characteristics to assist in the comparison of similar studies. 
Methods 
 
Identifying Trials 
We set out to identify all randomised controlled trials of outpatient 
rehabilitation interventions for stroke patients which had been compared with 
normal care. The definition of outpatient rehabilitation was derived from the 
World Health Organisation definition of rehabilitation (221); “a problem solving 
and educational process aimed at reducing the disability and handicap 
experienced by someone as a result of a disease”.  Rehabilitation was therefore 
considered to be any intervention delivered by a “rehabilitation worker” which 
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aimed to reduce disability or handicap after stroke.  This definition excluded 
drug and surgical interventions and trials of alternative systems of care (e.g. 
home versus hospital based rehabilitation).  Additionally we narrowed our search 
to exclude trials that treated only a specific impairment (e.g. treatments for 
upper limb spasticity) or a specific subgroup of patients (e.g. depressed post 
stroke patients only, or specific ethnic groups only (222)).  Thus the focus of this 
classification was at the outset to describe interventions delivered to the 
majority of stroke patients or carers in a community setting.  The classification 
of trials of systems of care or specific treatments for impairments has been 
attempted elsewhere [www.effectivestrokecare.org]. 
We searched the Cochrane Controlled Trials Register (8993 trials, search date 
September 2005).  In addition, we searched the reference lists of Cochrane 
reviews of outpatient interventions (25;131-133;223;224). Further (unpublished) 
trials were identified by communication with trialists (225-227). 
Selecting Trials:  
Trials for inclusion were identified using the following criteria: 
A randomised controlled trial, recruiting only stroke patients or carers, which 
evaluated an intervention provided by a rehabilitation worker (in comparison 
with no routinely provided intervention), which aimed to reduce some aspect of 
disability or handicap and was carried out in an outpatient setting (i.e. home, 
clinic, day hospital). 
Data collection:  
Trial characteristics were obtained from the available published and unpublished 
sources and recorded in a database.  The method of classifying interventions was 
derived from methods previously discussed at a collaborators’ meeting of the 
Outpatient Trialists Collaboration (228).  This used a simple Delphi process 
(229;230) to develop, collect and categorise data in an iterative process in 
collaboration with trialists from working in the area.  Each trial intervention was 
described using this classification including the following details: 
Trial identifiers (centre, publication year, contact trialists) 
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Who provided the intervention (profession or discipline) 
Domains of the intervention – these were categorised into one of four 
subcategories; 
1. Behavioural – interventions which focus on problem solving and 
adaptation through the active participation of both therapist and patient 
to bring about changes in task-orientated behaviour (e.g. walking, 
activities of daily living).  This could incorporate some adaptation of the 
physical environment. 
2. Psychological – interactions between rehabilitation worker and patient 
which focus on problem solving and adaptation through psychological 
interventions and changes in the patient’s thought or perspective.  This 
could address emotional needs or symptoms and include activities such as 
counselling. 
3. Informational – interventions which focus on problem-solving and 
adaptation though the provision of information (usually about the disease 
and its consequences). 
4. Social – interventions which focus on problem solving and adaptation by 
addressing social needs and influencing the social environment.  This 
frequently involves liaison with other staff or services. 
Delivery of the intervention – whether the intervention was provided on an 
individual or group basis and whether it was prescriptive in delivery or 
customised to the individual patient. 
1. Intensity of the intervention – expressed as the total number of treatment 
sessions per month and the duration of the intervention. 
2. Timing of the intervention; whether provided “early” (at hospital 
discharge or similar time after stroke) or at a later stage after stroke (6 
months or more). 
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3. Patients/Carers; whether the intervention was delivered to patients 
and/or carers, or simply to carers alone. 
4. Intention of the intervention – were the main and intermediate intentions 
of the intervention (e.g. to reduce disability by improving mobility).  This 
should be reflected in the primary outcome measure used in a trial. 
Where trials had more than one intervention arm, each independent 
intervention was classified separately. 
 
Numerical Taxonomy:  
Once standardised information from the original trials had been obtained, we 
carried out a simple numerical taxonomy cluster analysis (231).  Each individual 
trial intervention was examined for its similarity to each of the other trial 
interventions by calculating a similarity index (i.e. the proportion of 
characteristics which were shared by the two interventions under comparison).  
Five characteristics which the collaborative group (228) had previously judged to 
be important in determining the nature of an intervention were selected to 
calculate the similarity index: 
1. Staff providing the intervention – categorised as physiotherapy, 
occupational therapy, nursing, psychology or volunteer staff. 
2. Main domain of the intervention – categorised as behavioural, 
psychological, informational or social (see Data Collection above). 
3. Minor domain(s) of the intervention – i.e. other characteristics which 
were present in the intervention but not considered to be the main focus 
of the intervention. 
4. Method of delivery – categorised as individual or group, customised to the 
individual or prescriptive. 
5. Intention of the intervention – categorised as focussing on either 
disability or handicap. 
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A similarity index was calculated as the proportion of the above five 
characteristics which were shared by two interventions.  The maximum 
similarity index was 1.0. A numerical taxonomy dendrogram (231) was then 
developed by first grouping together interventions with a similarity index of 1.0, 
and then those of 0.8, then 0.6 etc. until all interventions were linked at some 
level. 
 
Results 
 
8993 titles were reviewed in the Cochrane Controlled Trials register.  In 
addition, 155 Cochrane reviews and protocols were searched. A total of 149 
trials were initially identified and assessed for inclusion; 76 were excluded 
because they were non-randomised, not targeted at stroke patients, were 
focussed on a subgroup of patients or a specific impairment, had an active 
intervention in the control group, or did not aim to reduce disability or 
handicap.  (See Figure 4.2) 
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Figure 4.2: Selection of Trials for Inclusion 
 
The process of trial identification and assessment for potential analysis.
8993 Titles in Cochrane 
Controlled Trials 
Register 
155 Cochrane Reviews 
and Protocols 
76 Excluded: 
• Non-randomised 
• Non-stroke 
population 
• Subgroup of Stroke 
patients only 
• Active control group 
• Not aiming to 
reduce disability or 
handicap 
73 Trials  
(82 Interventions) 
149 Trials assessed 
Contact with trialists 
2 Unpublished trials 
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73 trials were finally selected as relevant for inclusion, which studied 82 
different interventions (70;71;71;123;152;153;225-227;232-234;234-239;239-
241;241-245;245-254;254;255;255;256;256;257;257-274;274-300).  We obtained 
information for 72 trials and limited information regarding 1 trial (301). 
Data were complete for the majority of trials.  Tables 4.1-4.5 outline the basic 
characteristics of the identified randomised trials.  A wide range of approaches 
to delivering outpatient rehabilitation interventions have been or are currently 
being tested.  Most trials recruited a relatively mixed group of patients at the 
time of hospital discharge. 
The numerical taxonomy is displayed in Figure 4.3 and shows several clusters of 
trials which can be characterised under several themes: 
Multidisciplinary rehabilitation after stroke 
This title includes a broad range of studies that generally evaluated the 
intervention of a team of therapists providing multidimensional rehabilitation 
post stroke.  They were focused primarily on providing customised input in 
behavioural domains with the aim of reducing disability.  The group overall had a 
similarity index of >0.8, differing predominantly in the staff who provided the 
intervention.  This group had a moderate similarity (<0.6) with occupational 
therapy based rehabilitation programmes.  They differed from the occupational 
therapy group in the staff who provided the intervention and the intention of 
the intervention (disability Vs handicap).  They had a low similarity index with 
other groups (<0.4).  Within this broad group it is apparent that there are two 
further distinct groups that deliver multidisciplinary interventions but with 
differences that are not distinguished on the basis of this classification alone. 
a.) Early Supported Discharge; These trials evaluated a team of therapists 
providing a multidimensional rehabilitation programme immediately on 
discharge from hospital.  While broadly similar in the timing of the intervention, 
the co-ordination of these services is often more directly integrated with 
inpatient care and in some contexts begins there. 
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b.) Post Stroke Rehabilitation; These trials generally evaluated the impact of 
input in a behavioural domain early after stroke, providing customised 
interventions with the aim of reducing disability.  The trials had a similarity 
index of <0.8, differing only in the staff who provided input or whether 
interventions were customised or prescriptive. Whereas early supported 
discharge services had a greater degree of overlap or dovetailing with hospital 
services, post-stroke rehabilitation trials were distinct services. 
Occupational Therapy after Stroke;  
These were interventions provided by occupational therapists with the aim of 
reducing handicap and were delivered in a behavioural domain in a generally 
customised fashion.  They have a similarity index of 0.8 – 1.0.  Studies differed 
only in whether the intervention was customised or prescriptive and aimed to 
reduce disability or handicap.  This group of studies had a similarity index of 0.6 
to the Early Supported Discharge Trials and the Post Stroke Rehabilitation group 
as shown above. 
Physical Fitness after Stroke;  
This group of studies typically evaluated interventions provided by a 
physiotherapist late after stroke providing a prescriptive exercise intervention 
intended to improve physical performance or fitness.  The trials had similarity 
index of <0.8 to each other.  They differed significantly from the other groupings 
having a low similarity index of 0.2. 
Social and Psychological Support;   
This grouping covers a more diverse range of studies with a similarity index of 
<0.6.  Typically they evaluate services provided by a nurse, volunteer or social 
worker who provides social support, information and liaison with other services 
aiming to reduce aspects of handicap, especially improving quality of life or 
reducing depression.  Differences between studies existed in the healthcare 
worker who delivered the intervention, the domain of the intervention (e.g. 
psychological or social) and whether the intervention was prescriptive or 
customised.  This group showed only moderate similarity to other groups (0.4).   
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Information Provision;  
This disparate group of trials generally evaluated information delivered by 
differing team members at different stages post stroke with different intentions 
(e.g. improving knowledge, mood or subjective health status).  Overall they 
have a similarity index of 0.6. 
Discussion 
 
The main aim of this was to identify and classify the characteristics of 
outpatient rehabilitation services for stroke patients after discharge from 
hospital.  We therefore focussed on those randomised trials which have tested 
the null hypotheses that the routine intervention by a “rehabilitation worker” 
for stroke patients outwith hospital is no more effective than no routine 
intervention.  We did not include trials examining alternative services to hospital 
care (e.g. “hospital at home”) although we did include services designed to 
accelerate discharge from hospital. 
Before discussing the implication of this analysis, it is important to acknowledge 
some of the methodological limitations.  Because the basic sciences 
underpinning rehabilitation are not well established, we have sought to develop 
a classification based on superficial characteristics.  For example who was doing 
what to whom, where, how often and with what intent?  This descriptive method 
may not take into account important components of the intervention. 
Secondly, the analysis described here was developed initially by the Outpatient 
Trialists Collaboration through an iterative process, drawing on their collective 
experience.  As such it might be said to be in part data-driven.  The choice of 
different characteristics might well have produced a different clustering.   
The grouping of trials in this taxonomy may not exactly match the choice of 
trials for the Cochrane reviews previously mentioned, but bears a great 
resemblance.  This similarity is unlikely to be coincidental as these methods of 
classification were initially employed by the Outpatient Trialists Collaboration in 
order to identify areas for the development of Cochrane reviews and has 
informed that process.  Similarly, trials that are clustered in the taxonomy may 
not be included in the Cochrane reviews.  This may occur where based on 
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additional information not included in this analysis the reviewers have concluded 
that the trial does not meet the review inclusion criteria.  It is hoped that 
despite these limitations, this methodology for classifying outpatient 
interventions may prove useful in informing future reviews. 
The current classification does suggest that three major themes emerge from 
these trials.  Firstly there are the “physical rehabilitation” services which are 
typically delivered by either physiotherapists, occupational therapists or a multi-
disciplinary team.  These tend to focus on the physical aspects of disability and 
handicap, and as a whole provide intensive therapy. 
The second of the themes concerns what might simply be termed the 
“psychological impact” of stroke.  This more diverse grouping is unified by its 
intention to impact some aspect of the social, psychological or informational 
needs of stroke patients and improve their quality of life or mood. They include 
the use of education, counselling, liaison and social support and are generally 
less intense than physical rehabilitation interventions. 
A separate category is beginning to emerge in stroke rehabilitation trials and it is 
those trials that seek specifically or exclusively to impact on carers after stroke.  
Because of the broad inclusion criteria of this analysis, they have not been 
excluded where they did not intervene with stroke patients, but have been 
marked with an asterisk in the dendrogram to indicate where they sit within this 
analysis.  These trials represent a growing area of stroke rehabilitation research 
and may represent the next generation of both primary and secondary research. 
In conclusion, we have identified a heterogeneous group of outpatient stroke 
rehabilitation services which have been tested within randomised controlled 
trials and provided a simple taxonomy of their content.  Most of these 
interventions can be fitted into one of three descriptive themes.  We believe 
that this can form the basis for future discussion and research, informing the 
gaps in primary and secondary research. 
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Figure 4.3: Dendrogram of Outpatient Therapy Interventions 
*Interventions targeted at carers only
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Table 4.1: Therapy Based Rehabilitation and Family Support Trials 
 
Intervention 
Ref 
Staffing Domain Delivery Timing Intention 
Physio OT Nursing SW Other Major Minor Customised Prescriptive Early Late (Target) 
Therapy Based Rehab  
             
Copenhagen (272) ●     B S,I ●  ●  Disability, ADL 
Hong Kong 95 (273) ●     B,S I ●  ●  Disability, Mood 
Kansas (274) ●     B   ● ●  ADL, Mobility 
London (intens) 81 (275) ● ●    B  ●  ●  ADL 
London (convent) 81 (302) ● ●    B  ●  ●  ADL 
Vancouver 91 (278)  ●    B, S  ●   ● Leisure 
London 00 (277) ● ●   Med and 
SLT 
B, I S ●  ●  Disability, ADL 
              
Family Support/Carers               
Toronto 92 (71)  ●    S   ●  ● Social Support 
Groningen (258)   ●   I, S Psy  ● ●  Carer strain 
Alabama (75)   ●   S, Psy   ● ●  Caregiver strain, 
Social functioning,  
Mood 
London 04 (21) ● ● ●   B I  ● ●  Carer strain, 
Patient ADL,  
Dependence 
B – Behavioural, I – Information, Psy – Psychological, S - Social 
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Table 4.2: Physical Fitness Training Trials 
Intervention 
Ref 
Staffing Domain Delivery Timing Intention 
Physio OT Nursing SW Other Major Minor Customised Prescriptive Early Late (Target) 
Physical Fitness 
Training 
 
             
Duncan 98 (274) ● ●    B  ●  ●  ADL, Mobility 
Cuviello-Palmer 88 (282) ●     B   ● ●  Mobility, Fitness 
Dean 00 (284) ●     B   ● ●  Mobility, Fitness 
Glasser 86 (285) ●     B   ● ●  Mobility 
Inaba 73 (286) ●     B   ● ●  Strength 
Kim 01 (287) ●     B   ●  ● Strength, Mobility 
Pohl  02 (treadmill) (288) ●     B   ●  ● Mobility 
Potempa 95 (289) ●     B   ●  ● Fitness 
Tiexeira 99 (291) ●     B   ●  ● Fitness, Strength 
Pohl  02 (physio) (288) ●     B  ●   ● Mobility 
Young 92 (303) ●     B,I  ●  ●  Disability, ADL 
Werner 96 (304) ● ●    B S ●   ● Disability, ADL 
Yokokawa 91 (301) ●     B, I  ●   ● Fitness, Mood 
Wade 92 (221) ●     B I ●   ● Mobility, ADL 
B – Behavioural, I – Information, Psy – Psychological, S - Social 
82 
Table 4.3: Information Provision and Early Supported Discharge Trials 
Intervention Ref Staffing Domain Delivery Timing Intention 
Physio OT Nursing SW Other Major Minor Customised Prescriptive Early Late (Target) 
Information Provision  
             
Birmingham 93 (248)   ●   I  ●  ●  Knowledge, Mood 
Seattle (73)  ●  ●  I S,B  ● ●  Knowledge, Family function 
Minneapolis (153) ● ● ●   I S,B  ●  ● Depression / Mood 
Newcastle 99 (152)  ● ● ●  I S, B  ● ●  Subjective Health status 
Knowledge 
Birmingham 92 (251)     ● i   ● ●  Knowledge 
Bradford 03 (155) ● ● ●   I S,B  ● ●  Knowledge, Handicap 
  
            
Early Supported 
Discharge 
 
             
Stockholm (269) ● ●  ● ● B S ●  ●  ADL / Disability 
Newcastle (267) ● ●  ● ● B  ●  ●  ADL / Disability 
Adelaide (259;261) ● ●  ● ● B I ●  ●  Disability 
Belfast (264) ● ●   ● B  ●  ●  Disability 
London (305) ● ●   ● B  ●  ●  Disability / ADL 
Manchester (265) ● ● ●  ● B  ●  ●  Disability 
Montreal (266) ● ● ●  ● B  ●  ●  Disability 
Oslo (268;306) ● ● ●   B  ●  ●  Disability 
Trondheim (270) ● ●    B I,S ●  ●  Disability / ADL 
Akershus (262) ●    ● B  ●  ●  Disability / Length of Stay 
Bangkok (263)   ●  ● B  ●  ●  Disability 
B – Behavioural, I – Information, Psy – Psychological, S - Social 
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Table 4.4: Occupational Therapy Trials 
Intervention Ref Staffing Domain Delivery Timing Intention 
Physio OT Nursing SW Other Major Minor Customised Prescriptive Early Late (Timing) 
OT               
Cardiff 95 (233)  ●    B,S I ●  ●  ADL 
Glasgow 00 (234)  ●    B,S  ●  ●  ADL, Disability 
Netherlands 01 (237)  ●    B  ●  ●  ADL 
Nottingham 95 (Leisure) (276)  ●    S, B  ●  ●  Leisure, Disability 
Nottingham 95 (ADL) (276)  ●    B,S  ●  ●  Disability, Leisure 
Nottingham 96 (239)  ●    B,S  ●  ●  ADL 
Nottingham 97 (307)  ●    B,S  ●  ●  ADL 
Nottingham 99 (241)  ●    B,S  ●  ●  ADL 
Total 01 (LEI) (245)  ●    B,S  ●  ●  Disability, Handicap 
Total 01 (ADL) (245)  ●    B,S  ●  ●  Disability, Handicap 
Vancouver 89 (246)  ●    B  ●  ●  ADL, Satisfaction 
Nottingham 01 (232)  ●    B,S,I  ●   ● Dependence, ADL 
Ontario 83 (A) (244)  ●    B  ●  ●  ADL 
Ontario 83 (B) (244)  ●    B   ● ●  ADL 
Ontario 83 (C) (244)  ●    B   ● ●  Disability 
Hong Kong 01 (308)  ●    B   ● ●  ADL 
Hong Kong 04 (236)  ●    B   ● ●  ADL 
Nottingham 00 (242)  ●    B,S   ● ●  Disability, Handicap 
Mount 00 (309)  ●    B   ● ●  ADL 
B – Behavioural, I – Information, Psy – Psychological, S - Social 
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Intervention Ref Staffing Domain Delivery Timing Intention 
Physio OT Nursing SW Other Major Minor Customised Prescriptive Early Late (Target) 
SLW               
Adelaide (300)   ●   S,I  ●  ●  QOL / EADL 
Glasgow 04 (298)   ●   I,B  ●  ●  Risk Factor Control / QOL 
Melbourne (SHIPS) (299)   ●   S,I B ●  ●  ADL / QOL 
Chicago  (310)   ●   S,I P ●  ●  Mood / Strain 
Utrecht (297)   ●   I B  ● ●  Satisfaction / QOL / Mood 
Bradford 96 (70)   ●   S,I B  ● ●  EADL 
Preston (295)   ●   S,i   ● ●  EADL 
Indianapolis (311)   ●   B P  ● ●  ADL 
Rhode Island (226)    ●  P,I S  ● ●  QOL/EADL 
Edinburgh 97 (255)    ●  S,I P ●  ●  EADL 
Melbourne 84 (254)    ●  S P,I ●   ● Institutionalisation/ Disability 
Boston (293)     ● p I,s ●  ●  ADL 
Mansfield (123)     ● P,I S ●  ●  Mood / EADL 
Liverpool (Psych) (227)     ● P,I S ●  ●  QOL / Mood 
Leeds House 00 (Psych) (279)     ● P I ●  ●  EADL 
Oxford (32)     ● S,I  ●  ●  QOL / EADL 
Liverpool (FSO) (227)     ● S,I P ●  ●  QOL / Mood 
London (296)     ● S,I P ●  ●  EADL 
Philadelphia (257)     ● S,P I ●  ●  EADL/ QOL/ Participation 
Leeds House 00 
(Volunteer) 
 
(279) 
    ● S,I  ●  ●  EADL 
Table 4.5: Stroke Liaison Worker Trials 
B – Behavioural, I – Information, Psy – Psychological, S - Social 
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Chapter Five:  
Meta-analysis of Stroke Liaison Workers for 
Patients and Carers. 
 
Introduction 
 
As we have seen in Chapter One, for many patients stroke is associated with 
significant psychosocial problems for both patients and carers.  These 
include depression anxiety, reduced social networks, information needs and 
dissatisfaction with the diversity in service provision.  These might be 
considered the psychosocial complications of stroke that affect not only the 
patient but also their social network and carers.  As we have seen in 
Chapter One a potential result of these psychosocial problems is an 
association with increasing social isolation, depression, poor health and 
increased mortality (22;23;45-47;89-91;94;96;97).   
 
Support following discharge from hospital, information about stroke and 
available resources, and practical help have been identified by patients and 
carers as services that they would value (312).   In Chapters Two and Three 
we evaluated an intervention with a predominantly educational component 
that attempted to target the informational needs associated with poor 
compliance and its associated problems.    This appeared to result in 
improved satisfaction with components of information provision and liaison.  
However, these results did not appear to be maintained at three years post 
intervention (Chapter Three). 
 
As we have seen in Chapter Four, a number of similar studies exist in the 
context of outpatient services for stroke and TIA.  These interventions as 
yet have not been evaluated in a systematic review of their effectiveness.  
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The nurse secondary prevention study in Chapter Two appears to fit into this 
group of fairly diverse interventions.  What unites these interventions is that 
they are intended for a broad group of stroke patients and the aim of the 
intervention is to improve some aspect of rehabilitation in its broadest 
form.  Where they differ is primarily in the profession that provides the 
intervention, or in the primary recipient of the intervention (patient or 
carer). 
 
While some studies did report positive effects of these interventions (32), 
none were found to have a significant impact on psychological outcomes or 
quality of life.  This may have been due to small sample size and type II 
statistical error.  Meta-analysis of similar studies offers the potential to 
overcome type II statistical errors that have resulted from underpowered 
individual studies (313). 
 
Whilst it is well recognised that there are associations between the 
psychosocial problems post stroke and worsened clinical outcomes 
(89;91;94;97), developing an intervention for these problems becomes 
problematic.  It is dangerous to assume that association is the same as 
causation.  The absence of a clear underlying pathophysiology for many 
rehabilitation interventions means that we remain uncertain as to the 
mechanisms of some problems post stroke (such as depression) and 
therefore uncertain as to the mechanisms of an intervention (such as social 
support or counselling).  As a result there has been the testing of a number 
of “black-box” interventions in randomised controlled trials, which it has 
been hoped might “happen upon” a mechanism for effective interventions 
into real problems.  Many of these trials are underpowered to detect a real 
clinical benefit and therefore in combining these studies in meta-analysis we 
are most likely to see if they are truly effective.  For many areas of stroke 
care it is this process of secondary research that has provided coherent and 
conclusive evidence where individual trials have been disappointing or 
conflicting (131;223;314).   
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Criticism of meta-analysis often centres around its combining of trials and 
the perceived risk that it combines differing studies (313).  The risk of 
combining irreconcilably different trials is best addressed by careful 
attention to the methods of the review.  In addition it is important that the 
participant group included in the review are carefully described in advance.  
These safeguards can be achieved through the pre-planned classification of 
trials for inclusion, careful attention to the types of intervention, careful 
description of the comparisons (i.e. what are the control group to receive) 
and perhaps more fundamentally to the methods of the trial (e.g. 
randomised controlled trial versus controlled trial or interrupted time 
series) (313).    This assessment must also include a method of trial quality 
assessment to determine the potential risks of bias within a trial or a review 
process (313;315).  These quality features include the methods of 
randomisation, the efforts to provide allocation concealment, and the 
attention to other factors such as blinding and intention to treat analysis 
(313). 
 
 
Before attempting a review of these trials we need to consider which are 
combinable and what descriptives we would give to the intervention.  On 
reviewing the group of studies in more detail, it becomes apparent that 
there are additional similarities not described by our taxonomy process 
(Chapter Four).   
 
1. The intervention evaluated in these trials is a multifaceted 
intervention.  That is the intervention has several distinct areas of 
focus that differentiate them from the trials of (for example) 
information provision alone.  Specifically, the trials appear to provide 
aspects of information provision, liaison, and social support in 
combination.  The degree to which they provide all three may vary, 
however it becomes apparent that they provide a comprehensive 
intervention.  The overall intention of these interventions might be 
described as aiming to return patients and carers to normal roles. 
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2. The participants in each of these trials can be broadly divided into 
four groups: 
 
a. Those interventions that solely address patients and evaluate 
patient outcomes. 
b. Those that address and evaluate patient and carer outcomes 
together. 
c. Those that address only caregivers and evaluate caregiver 
outcomes. 
d. Those that evaluate an intervention for a subset of stroke 
patients only (e.g. depressed patients).  
 
It is easy to see that combining trials that evaluate patients and those 
that evaluate only caregivers raises problems of incompatible 
populations and outcomes.  Additionally trials that evaluate a sub-
population of patients (such as depressed patients post stroke) cannot 
provide generalisation to a general stroke population or permit 
combination with trials that attempt to address that entire 
population.  The two remaining groups that offer some hope for 
combination in a review process therefore are those that evaluate 
patient outcomes alone or those that evaluate patients in 
combination with caregivers.  This could offer some potential 
additional information about the interventions effects on caregivers.   
 
3. The methods of studies considered for this review process has been 
implied in our previous chapter on a taxonomy of trials.  Randomised 
controlled trials provide the best available method for evaluating an 
intervention without the introduction of systematic bias.  Combining 
randomised controlled trials provides the least risk of bias within a 
meta-analysis. 
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In summary a stroke liaison worker can be defined as a healthcare worker 
whose aim is to help return patients and their carers to normal roles. 
Typically they provide emotional and social support and information to 
stroke patients and their families and liaise with services with the aim of 
improving aspects of participation and quality of life for patients with stroke 
and/or their carers (316). This multi-faceted role distinguishes stroke liaison 
workers from interventions whose aim is to treat a single problem such as 
improving activities or knowledge (e.g. trials of information provision). A 
stroke liaison worker may be a health or social care professional, or be from 
the voluntary sector. Such services have been evaluated under a range of 
different names, such as 'social work' (254;281), 'specialist nurse support' 
(70), 'stroke family care worker' (76), and 'stroke family support organiser' 
(32). For the purposes of this review, such services have been grouped under 
the generic title of 'stroke liaison worker'. There has been one descriptive 
review of published trials of 'support workers' within the context of a 
broader review of non-drug strategies aimed at reducing psycho-social 
problems after stroke (317). No meta-analysis of these studies has yet been 
attempted.  
 
Objectives 
 
To determine the effects of intervention from a stroke liaison worker for 
patients with stroke and their carers in returning to normal roles, (as 
measured by improving social activities, participation, and mental health).  
 
 
Methods 
 
Criteria for considering studies for this review 
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Types of studies 
We wanted to review only randomised controlled trials comparing allocation 
to intervention from a stroke liaison worker with no intervention or normal 
care. 
 
Types of participants 
We included trials of survivors of acute stroke with or without their closest 
informal carer. A clinical definition of stroke was used: rapidly developing 
clinical symptoms and/or signs of focal, and at times global loss of cerebral 
function (318). Studies that included TIA patients were not excluded since 
TIA is part of the same disease spectrum and patients with TIAs, while 
seldom having reduced activities, may have reduced participation and a high 
level of anxiety regarding stroke recurrence (138). Participants had to be 
adult (aged 16 or over). Trials that address carer needs alone (and did not 
include patients) were not considered. 
 
Types of interventions 
We considered only trials that evaluated referral to a stroke liaison worker. 
Such a worker would typically provide a multi-faceted service including 
more than one of the following: education and information provision; social 
support; and liaison with other services (228). Often this intervention is 
provided from the point of patient discharge from hospital.  Trials assessing 
workers of any professional background were considered relevant, and might 
include health or social care professionals or volunteers.  Studies where the 
intervention was judged to be single faceted were excluded.  This 
distinction is to separate the stroke liaison worker interventions from trials 
of (for example) information provision alone (133).  Similarly, trials of 
therapist-delivered physical rehabilitation or psychological interventions on 
their own were excluded.  The control group had to receive no intervention 
or usual care. 
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Types of outcome measures 
Outcomes for Patients  
Primary: Subjective Health Status (e.g. GHQ12 (319), SF36 (320), EuroQOL 
(184)); extended activities of daily living (including social activities e.g. 
Nottingham EADL (321), Frenchay Activities Index (322)).  
Secondary: death; place of residence (institutionalisation); activities of 
daily living (e.g. Barthel (323), FIM (324)); dependency (e.g. Functional 
Ambulatory Categories (325), Modified Rankin (326)); mental health -
including anxiety and depression (e.g. GDS (327), GHQ (319), HADS (328)); 
knowledge about stroke; use of services; satisfaction with services; 
participation (e.g. Reintegration to Normal Living Scale (329)).  
 
Outcomes for Carers  
Primary: Subjective Health Status (including measures of carer strain e.g. 
Carer Strain Index (330), GHQ, SF36).  
Secondary: Extended activities of daily living (e.g. Frenchay Activities 
Index,); mental health (e.g. GHQ, HADS etc.); knowledge about stroke, 
satisfaction with services. 
 
Search strategy for identification of studies 
Relevant trials were identified in the Cochrane Stroke Group's trials register. 
The register was searched for trials that relate to psychological therapy, 
counselling, social support, therapists, service provision, support workers, 
carer training, or information giving. 
 
In addition we searched the following bibliographic databases: Cochrane 
Central Register of Controlled Trials (latest issue); MEDLINE (from 1966); 
EMBASE (from 1980); CINAHL (from 1982); ASSIA (Applied Social Science 
Index and Abstracts, from 1987); PsychINFO (from 1967); and Social Science 
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Citation Index (from 1956). The search strategy for MEDLINE is shown below. 
This was adapted for the other databases. 
 
1. stress, psychological/ 
2. psychosocial$.tw. 
3. social adjustment/ 
4. adaptation, psychological/ 
5. activities of daily living/ 
6. exp interpersonal relations/ 
7. morale/ 
8. (cope or coping).tw. 
9. patient satisfaction/ 
10. exp emotions/ 
11. ((psychological or social) and (problem$ or difficult$)).tw. 
12. exp social isolation/ 
13. emotion$.tw. 
14. stress/ 
15. knowledge, attitudes, practice/ 
16. exp motivation/ 
17. quality of life/ 
18. anxiety/ 
19. caregivers/ 
20. life change events/ 
21. depression/ 
22. life style/ 
23. social behavior/ 
24. mental health/ 
25. knowledge/ 
26. psychomotor performance/ 
27. exp family relations/ 
28. or/1-27 
29. patient care management/ 
30. continuity of patient care/ 
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31. needs assessment/ 
32. rehabilitation nursing/ 
33. home nursing/ 
34. "referral and consultation"/ 
35. social support/ 
36. exp professional-patient relations/ 
37. ((patient$ or carer or caregiver$ or famil$) adj10 support$).tw. 
38. patient education/ 
39. exp social work/ 
40. community health services/ 
41. (home or in-home or home-based).tw. 
42. health services for the aged/ 
43. ((patient$ or carer or caregiver$ or famil$) adj10 information$).tw. 
44. family health/ 
45. family care$.tw. 
46. outreach.tw. 
47. advice.tw. 
48. counseling/ 
49. counsel?ing.tw. 
50. nursing assessment/ 
51. aftercare/ 
52. volunteer$.tw. 
53. exp rehabilitation/ 
54. communit$.tw. 
55. empathy/ 
56. visitor$.tw. 
57. patient-centered care/ 
58. health education/ 
59. interview, psychological/ 
60. exp patient care planning/ 
61. domiciliary.tw. 
62. (liaison or link or contact).tw. 
63. Home care services/ 
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64. ambulatory care/ 
65. or/29-64 
66. exp cerebrovascular disorders/ 
67. (stroke$ or cva$ or cerebrovascular or cerebral vascular or post-stroke 
or transient isch$ or TIA).tw. 
68. (cerebral or cerebellar or brain$ or vertebrobasilar).tw. 
69. (infarct$ or isch?emi$ or thrombo$ or emboli$ or apoplexy).tw. 
70. 68 and 69 
71. (cerebral or brain or subarachnoid).tw. 
72. (haemorrhage or hemorrhage or haematoma or hematoma or bleed$ or 
aneurysm).tw. 
73. 71 and 72 
74. hemiplegia/ or exp aphasia/ or hemianopsia/ 
75. (aphasi$ or dysphasi$ or hemianop$ or hemipleg$ or hemipar$).tw. 
76. 66 or 67 or 70 or 73 or 74 or 75 
77. 28 and 65 and 76 
78. limit 77 to human 
 
In order to identify further published and unpublished studies, a citation 
search was carried out using the Web of Science Citation Indices, the 
reference lists of identified relevant trials were checked, and authors of 
relevant papers were contacted. Relevant conference proceedings were 
reviewed, trials registers were searched, and contact was made with 
investigators in this area of stroke services trials.  Finally, a poster 
presentation was made at a major international conference to invite 
interest from trialists (European Stroke Congress 2005). 
 
Methods of the review: Selection of studies 
Obviously irrelevant articles were first excluded by me (GE).  Two 
independent reviewers (GE & Peter Langhorne (PL)) then reviewed the 
retrieved abstracts of papers identified.  Papers that clearly did not meet 
the inclusion criteria were excluded at this stage, and the reason recorded. 
95 
A full text copy of all possibly relevant papers was obtained, and two 
independent reviewers (GE & PL) also assessed these according to pre-
defined inclusion criteria. Where there was disagreement, the intention was 
that Simon Winner and Martin Dennis would moderate.  This was not 
required.  
 
Contact with trialists and data collection 
The contact author or lead investigator was contacted and invited to join a 
collaborative review process.  Individual patient data were requested and 
authors were invited to meet in Glasgow to discuss the development of the 
review.  (The members of this collaborative group are listed at the end of 
this chapter.) 
Authors were asked prior to the meeting for additional information including 
information on design characteristics, the study population, the 
intervention, outcome measures used, and length of follow up, as well as 
additional information regarding the intervention that may not have been 
apparent in the published papers.  Where authors could not be contacted, 
these trial grids were completed by the author and supervising reviewer (PL) 
independently.  Details on the intervention were then used to construct 
subgroups according to the apparent emphasis of the intervention (liaison; 
education and information provision; social support). 
The trial grid is attached in Appendix G. 
 
At the trialists meeting (04/03/05), the intentions of the review process and 
methods were discussed.  Trialists were invited to comment on the 
classification system developed for grouping trials.  The trialists felt that 
the initial system developed (analysis by primary emphasis, Table 5.2) did 
not adequately describe the similar and differing studies.  This discussion 
led to the development of a subsequent classification (Table 5.1) which was 
used for the primary analysis. 
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Figure 5.1: Definitions of Intervention Subgroups 
 
 
Additional subgroup analyses were suggested by the group and are noted in 
the minutes of the meeting (Appendix H).  These included analysis of the 
intervention by the profession of the individual providing the intervention.  
The results were also to be presented stratified by timing of referral to 
stroke liaison worker (less than six months after stroke; more than six 
months after stroke).  
 
Analysis by patient characteristics included subgroups defined by sex, age 
(<65 and ≥65), the presence or absence of a main carer and patient 
functional status at baseline.  This last subgroup was considered because 
one trial in particular had suggested that patients with mild-to-moderate 
functional dependence had the most to gain from the intervention (70).  For 
this reason the same definitions of dependence were used as in the original; 
trial (Severe dependence = Barthel <15; Mild to moderate dependence = 
Barthel 15-19; Independent = Barthel 20).  All subgroup definitions were 
made prior to data analysis and blind to review data. 
Following discussion with the trialists, interventions were characterised in 
three ways: 
 
Proactive and Structured.   
These interventions of a consistent intensity sought to contact all patients 
proactively, and provided input for a defined period of follow up only.  They 
often covered a range of predefined topics against for example a checklist, 
irrespective of a patients stated needs. 
 
Reactive and Flexible.   
These trials typically provided a flexible intervention that met needs as they 
presented or as requested for a more open-ended time period and variable 
intensity. 
 
Proactive and Focused.   
These trials sought to contact all patients consistently and offer a similar 
intensity of intervention, but often focussing on a specific issue (such as 
mental health or risk factor control). 
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Assessment of quality 
Eligible trials were not given a quality score (331). Nevertheless, the trials 
were coded with regard to quality of randomisation procedure, method of 
consent, concealment of treatment allocation, blinding of patients and 
carers, blinding of outcome assessor, and handling of withdrawals and drop-
outs (313).  
 
Analysis 
Outcome measures were classified according to which domain they were 
assessing (activities of daily living; extended activities of daily living; 
participation; dependency; mental health; subjective health status; 
knowledge about stroke; use of services; satisfaction with services).  Most of 
the scales used were ordinal.  If the same measure had been used in 
different studies, then a weighted mean difference was calculated across 
trials using the Cochrane statistical package RevMan 4.2 (Update Software).  
No meta-analysis was performed where grossly differing outcome measures 
preclude combination.  Where it was possible to dichotomise the data, then 
odds ratios and 95% confidence intervals were calculated for each study. 
Where it was not possible to dichotomise the data, the effects on outcome 
were summarised in terms of direction of effect (in favour of intervention or 
control), and the size of the effect (in terms of standardised mean 
differences).  Results are presented separately for patients and carers for 
each domain of outcome.  
 
Prior to data analysis, an analysis plan was constructed which included the 
apriori selection of outcome measures that would be used in the review 
process.  This pre-planned method was used where trialists had evaluated 
an outcome with more than one outcome measure.  Where one measure 
(e.g. Frenchay Activities Index) was used by several trials, the most 
commonly used measure was selected.  There was the potential risk of the 
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reviewer selecting an outcome measure that had achieved more positive 
results, thus influencing the results and it was hoped that the prior planning 
of analysis would reduce that risk.   
In the analysis of satisfaction, due to differences between trials in the 
questions that were asked, it became necessary to select questions for 
comparison.  An analysis table of satisfaction questions was constructed  
(Table 5.29).  Questions were selected for analysis only if they appeared in 
two or more studies.  All satisfaction questions involved a likert scale with 
four separate categories of satisfaction (highly satisfied, satisfied, 
dissatisfied and highly dissatisfied).  Results were contracted into a 
dichotomised outcome (satisfied or dissatisfied) and data were entered into 
analysis to produce an odds ratio for reporting being satisfied. 
 
Individual patient data was cross checked for completeness on receipt.  In 
addition they were cross checked with published data.  For subgroup 
analysis, data were split into separate databases and analysed separately.  
Double data entry was used for data entry into RevMan to ensure the 
avoidance of simple errors.  The direction of effect for each outcome 
measure in each trial was checked and all tables were cross checked on 
completion for errors and completeness. 
99 
Figure 5.2: Trial Selection
10,848 Titles reviewed 
45 Abstracts or Papers Reviewed 
31 Not suitable 
5 not RCTs  
6 interventions for caregivers only  
5 education interventions alone  
7 rehabilitation interventions  
5 single faceted intervention only  
2 defined sub-population only 
 
16 Included RCTs 
Data 
 12 Individual patient data 
3 Additional data available from authors  
1 Published data only 
 
Contact with trialists 
2 Unpublished studies 
10,803 excluded by title alone 
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Results 
 
Review process results 
The search strategy revealed 10,848 titles to be reviewed (search date 
August 2004).  From these titles 45 studies were selected as being of 
possible relevance to the review.  Where possible the full text of these 
studies was sought or the abstract where a full paper was not available.  Of 
these studies, 31 were considered unsuitable for the systematic review.  
Five were not randomised controlled trials, six evaluated interventions for 
caregivers only.  A further five studies evaluated education interventions 
only.  Seven studies evaluated some form of physical rehabilitation and a 
further five evaluated a single faceted intervention only such as social 
support alone (71).  Two additional studies were identified that evaluated 
only a sub-population (such as post surgical subarachnoid haemorrhages 
only).  Trial selection is illustrated in Figure 5.2.   
 
Selected Trials 
The search strategy identified 14 published randomised trials.  Two 
additional unpublished trials were identified following contact with trialists.  
One (Leeds) evaluated two interventions in separate arms; the input of a 
volunteer or a psychologist for problem solving therapy compared to usual 
care.  One study (Liverpool – the “Life after Stroke” study) evaluated three 
separate interventions, alone or combined.  These included a stroke family 
support worker (social), a psychology intervention (psychology) and an 
occupational therapy intervention (physical).  Only the stroke family support 
worker and the psychology arms of the study were considered relevant for 
inclusion and where these elements were combined, the data were also 
excluded. 
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Individual patient data were obtained for 12 studies, with additional 
tabulated data obtained for two additional trials (Philadelphia STAIR study 
and Adelaide).  Limited information from one unpublished trial was 
available from correspondence with the author (Melbourne SHIPS trial).  
Published data only were available for one additional trial (Melbourne). 
The 16 trials came from 4 countries (Australia, Holland, UK and USA).  Most 
were based in city hospitals and evaluated services in urban populations.  13 
studies described adequate allocation concealment. (Tables 5.10–5.25)  11 
studies performed blinding of the final outcome assessor and two studies 
performed additional patient blinding by a means of delayed or modified 
consent (Edinburgh, Utrecht) (159).   
The intervention characteristics are shown in Tables 5.10-5.25.  Subgroup 
allocations for the primary analysis are shown in table 5.1.  Four 
interventions were classified as employing a proactive and structured 
approach to the intervention.  Eight interventions were reactive and 
flexible, whilst six interventions employed a proactive but focussed 
approach.  Subgroup analysis by intervention emphasis is also illustrated in 
table 5.2.   
Publication bias is recognised as potential risk for meta-analysis.  Negative 
studies are less likely to be published or cited and therefore are at risk of 
not being included in a meta-analysis (313).  As a result the review is likely 
to bias towards a more positive treatment result.  Similarly, studies of 
poorer methodological quality are more likely to show a positive result and 
give rise to a biased result due to methodological bias.  To evaluate the risk 
of publication bias in this review, we prepared a funnel plot of all included 
studies for the primary outcome (subjective health status) shown in Figure 
5.3. 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 01 Subjective Health Status                                                                                   
 -1  -0.5  0  0.5  1
0.0
0.1
0.2
0.3
0.4
SE(SMD)
SMD (fixed)
 
Figure 5.3:  Funnel Plot of Included Trials 
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The analysis plan for each trial and outcome measure is shown in Tables 
5.26-28.  The satisfaction questions selected for comparison are shown in 
Table 5.29. 
 
Available data for some outcomes was very limited and not combinable.  For 
instance knowledge was only apparently evaluated in two studies 
(Oxford/Mansfield).  Neither study used validated methods to test that 
knowledge and data were only available for one study (Oxford).  For this 
reason, no attempt has been made to perform a meta-analysis of knowledge 
as an outcome.  Similarly, data on caregiver knowledge were only available 
for one study (Oxford).  Resource or service usage was reported in several 
studies (Edinburgh, Liverpool, Melbourne SHIPS, Oxford, Philadelphia and 
Utrecht).  Data were only available for two of these studies (Oxford, 
Utrecht).  Due to variations in service provision, and differences in the 
available data it was felt to be too difficult to combine and dichotomise 
these data.  For this reason, no meta-analysis of service usage has been 
performed.   
 
After receipt of data it became apparent that analysis of mental health 
under one single heading was potentially inaccurate where some general 
measures of mental health (such as GHQ28) were being combined with more 
specific measures of depression (such as the HADS-Depression scale) or 
anxiety (HADS-Anxiety scale).  In addition, since it was apparent that some 
studies had used the Anxiety scale of the HADS, it was felt to be of potential 
additional value to split mental health outcomes into depression and anxiety 
in addition to analysis under a generic mental health domain.  It was 
considered plausible that the intervention might reduce anxiety without 
necessarily reducing depression.  This decision was made post-hoc, and 
therefore the results are presented with that caution alongside generic 
mental health results as originally planned. 
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Review results 
These data are presented in two stages for simplicity.  Overall data have 
been presented here with subgroups as pre-planned by the collaborative 
group according to intervention characteristic (Table 5.1, Figures 5.4-5.50).   
Primary Patient outcomes 
 
1. Subjective health status: Analysis of data for 3349 participants (13 
interventions) did not show a significant overall difference between 
the intervention and control groups for this outcome, although the 
direction of effect was in favour of the intervention (SMD -0.05, 95% 
CI -0.11 to 0.02, p=0.18).  Tests for heterogeneity were borderline 
(Chi2 heterogeneity p=0.08), however no single subgroup showed a 
significant effect.   Considerable heterogeneity (Chi2 heterogeneity 
p=0.007) was present in the Proactive and Structured subgroup, 
largely due to the positive results of one study (Preston). 
 
2. Extended activities of daily living: Analysis of data for 3258 patients 
(15 interventions) did not show any benefit of Stroke Liaison Workers 
over control group for an improvement in extended activities of daily 
living (SMD 0.04, 95% CI -0.03 to 0.11, p=0.22).  In addition there 
were no positive subgroups.  No significant subgroup interaction was 
present (Chi2 heterogeneity p>0.05). 
 
Secondary Patient Outcomes 
 
1. Death:  There was no significant effect of the Stroke Liaison Worker 
intervention on the outcome of death.  (4181 participants, 16 
interventions, OR 0.87, 95% CI 0.72 to 1.06, p=0.17).  There was no 
single subgroup effect and no subgroup interaction (Chi2 p>0.05). 
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2. Place of residence (Institutionalisation):  Data was more limited for 
analysis of institutionalisation (1146 participants, 6 interventions), 
however there was no overall effect (OR 0.83, 95% CI 0.51 to 1.36, 
p=0.46) and no significant subgroup effect (Chi2 p>0.05). 
 
3. Activities of daily living:  No significant benefit was seen on activities 
of daily living for the intervention group compared to the control 
group (3457 participants, 15 interventions, SMD -0.02, 95% CI -0.09 to 
0.05, p=0.55).  No subgroup interaction existed (Chi2 p>0.05). 
 
4.  Dependency:  Data on dependency was more limited (1494 
participants, 4 trials) and were not available for one subgroup 
(Proactive and Focused).  No overall benefit was seen for the Stroke 
Liaison Worker intervention, with the direction of benefit favouring 
the control group (SMD 0.03, 95% CI -0.07 to 0.14, p=0.53).  There 
was no significant heterogeneity seen between the two remaining 
subgroups (Chi2 p >0.05).  Few outcome measures for dependency 
were used, providing only limited outcome data for dependency (four 
trials, 1,494 participants).  In contrast a larger number of studies (12 
interventions, 2,906 participants), used the Barthel measure.  We 
therefore decided to dichotomise the Barthel measure as an outcome 
for dependency.  The potential “cut-point” for dependency was 
discussed with trialists and set at 19/20 (i.e. dependent in one or 
more activities of daily living).  This decision was made prior to 
analysis of the data without prior knowledge of the results.  Analysis 
using this outcome for dependency yielded greater participant 
involvement across a greater range of studies.  In addition it allowed 
the use of odds ratios for an identical outcome measure allowing 
more accurate combination of results.  For this reason, subsequent 
analyses for the outcome of dependency were conducted using this 
definition of dependency.  Overall, there was no significant 
difference between the treatment and control groups for a reduction 
in dependence (OR 0.90, 95% CI 0.76 to 1.06, p=0.20).  There was a 
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trend to a reduction in dependence in the Proactive and Structured 
group (OR 0.72, 95% CI 0.52 to 1.01, p=0.06), although this was not 
statistically significant and there was no subgroup interaction (Chi2 
p>0.05). 
 
5. Mental Health (Generic): Data were available for 3314 participants 
from 15 interventions.  Overall results did not suggest any beneficial 
effect of Stroke Liaison Workers compared to control for an 
improvement in mental health score (SMD -0.02, 95% CI -0.09 to 0.05, 
p=0.56).  One subgroup (the Proactive and Focused subgroup) showed 
a trend toward benefit from the Stroke Liaison Workers versus control 
(p=0.09).  This might not be surprising given that many of the 
interventions in this group had a psychological focus, however there 
was no subgroup interaction (Chi2 p>0.05) to support this effect. 
 
6. Mental Health (Depression): Analysis of data from 15 interventions 
(2949 participants) did not show any evidence of a beneficial effect 
from the input of a Stroke Liaison Worker when compared to the 
control group, despite the direction of effect favouring the treatment 
group (SMD -0.05, 95% CI -0.12 to 0.02, p=0.17).  Again one group 
(Proactive and Structured) demonstrated a trend towards a benefit 
from the Stroke Liaison Workers  (p=0.08), however again there was 
no subgroup interaction to support this effect (Chi2 p>0.05). 
 
7. Mental Health (Anxiety):  Data were available for two subgroups 
(Proactive and Structured, Reactive and Flexible) involving 5 
interventions (1222 participants).  No significant benefit was seen for 
the intervention group (WMD -0.20, 95% CI -0.66 to 0.26, p=0.39).  
Tests for heterogeneity were borderline overall (p>0.05), 
predominantly because of one study (Adelaide) that showed a positive 
treatment effect (-1.7, 95% CI -2.89 to -0.51), however this study 
reported differences in the groups at baseline that may have 
accounted for the effect. 
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8. Participation: Results for participation were more limited in the 
number of participants (n=886) and only available for one subgroup 
(Reactive and Flexible).  Overall there were no significant differences 
between the groups (SMD -0.04, 95% CI -0.17 to 0.10, p=0.59) and 
there was no heterogeneity within the available subgroup (p>0.05). 
 
Primary Caregiver Outcome: 
 
1. Caregiver Subjective Health Status: Data for 1921 caregivers was 
available from 15 interventions.  The predominant measure used was 
the Carer strain index (9/13 trials).  For this reason, this measure was 
used in the Oxford study, rather than the more positive published 
Carer SF36. Although the direction of effect was in favour of the 
control group, there was no overall significant effect (SMD 0.04, 95% 
CI -0.05 to 0.13, p=0.33) and no significant subgroup or subgroup 
interaction (Chi2 p>0.05). 
 
Secondary Caregiver Outcomes: 
 
1. Caregiver extended activities of daily living: Only two subgroups 
(Proactive and Structured, Reactive and Flexible) had adequate data 
from 5 trials (776 participants).  There was a trend to an 
improvement in extended activities of living in the control group (SMD 
-0.13, 95% CI -0.28 to 0.01, p=0.07).  No significant subgroup 
interaction existed (Chi2 p>0.05). 
 
2. Caregiver mental health: Data for 1777 caregivers was analysed 
across 13 intervention arms.  No significant overall effect or subgroup 
effect existed. (SMD -0.02, 95% CI -0.12 to 0.07, p=0.62,  
heterogeneity p>0.05). 
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Patient Satisfaction Data 
Satisfaction data are presented in Figures 5.18-5.34 
 
In summary, only one domain of patient satisfaction reached a statistically 
significant result with data from three trials (915 participants).  Patients in 
the intervention group were significantly more satisfied that “Someone has 
really listened” (OR 1.58, 95% CI 1.14 to 2.19, p=0.006).  Subgroup results 
suggested borderline heterogeneity (Chi2 p=0.07), with one subgroup 
(Reactive and Flexible) strongly positive (two trials, n=439, p=0.0005) and 
one (Proactive and Structured) being neutral (one trial, n=470, p=0.61). 
 
Carer Satisfaction Data 
Carer Satisfaction data are presented in Figures 5.35-5.50 
 
 
Four questions for carers yielded statistically significant results. 
1. “I received all the information I needed about the nature and causes 
of the patient’s illness” was included in three trials (459 caregivers) 
from one subgroup (Reactive and Flexible).  The question was positive 
in favour of the Stroke Liaison Worker arm of the trial (OR 1.72, 95% 
CI 1.04 to 2.85, p=0.03). 
 
2. “I have received enough information about recovery and 
rehabilitation” was answered favourably by the treatment group in 
three trials (457 caregivers, OR 1.98, 95% CI 1.25 to 3.14, p=0.004). 
 
3. “Someone has really listened” was answered in two trials (Edinburgh 
and London), both in the same subgroup, with a smaller number of 
caregivers (n=300, OR 2.56, 95% CI 1.52 to 4.31, p=0.0004). 
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4. Caregivers in the Stroke Liaison Workers group were more likely to 
report that they felt that they were not neglected (OR 2.62, 95% CI 
1.44 to 4.77, p= 0.002) than in the control group. 
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Table 5.1: Subgroup Analysis: Intervention Characteristics 
 N in 
analysis 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results 
 
   
 Proactive and 
Structured 
Reactive and Flexible Proactive and Focused 
Primary Outcomes for Patients 
       
Subjective Health Status 3349 SMD -0.05 (-0.11, 0.02), p=0.18 >0.05 -0.05 (-0.17, 0.07), 
p=0.43 
0.01 (-0.10, 0.13), 
p=0.83† 
-0.10 (-0.22, 0.01), 
p=0.08 
Extended Activities of Daily Living 3260 SMD  0.04 (-0.03, 0.11), p=0.23 >0.05  0.09 (-0.03, 0.21), 
p=0.15 
0.07 (-0.04, 0.18), 
p=0.22 
-0.05 (-0.18, 0.08), 
p=0.49† 
        
Secondary Outcomes for Patients 
       
Death 4183 OR  0.87 (0.72, 1.06),  p=0.17 >0.05 1.14 (0.66, 1.95), 
p=0.64† 
0.83 (0.65, 1.06), p=0.14 0.86 (0.59, 1.27), p=0.46 
Place of Residence (Institutionalisation) 1146 OR  0.83 (0.51, 1.36),  p=0.46 >0.05 1.00 (0.34, 2.94), p=1.00 1.00 (0.42, 2.38), p=1.00 0.67 (0.32, 1.39), p=0.28 
Activities of Daily Living 3463 SMD -0.02 (-0.09, 0.05), p=0.55 >0.05 0.07 (-0.06, 0.20), 
p=0.32 
-0.03 [-0.14, 0.07], 
p=0.51† 
-0.08 [-0.20, 0.05], 
p=0.22† 
Dependence* 2908 OR  0.90 (0.76, 1.06),  p=0.20 >0.05 0.72 (0.52, 1.01), p=0.06 0.95 (0.74, 1.21), p=0.67 0.99 (0.73, 1.33), p=0.94 
Depression 2949 SMD -0.05 (-0.12, 0.02), p=0.17 >0.05 -0.13 (-0.28, 0.02), 
p=0.08 
0.03 (-0.08, 0.15), 
p=0.56† 
-0.09 (-0.21, 0.03), 
p=0.14 
Anxiety 1222 SMD -0.20 (-0.66, 0.26), p=0.39 >0.05 -0.38 (-0.18, 0.42), 
p=0.35 
-0.11 (-0.67, 0.45), 
p=0.70 
NA 
Participation 886 SMD -0.04 (-0.17, 0.10), p=0.59 NA NA -0.04 (-0.17, 0.10), 
p=0.59 
NA 
        
Primary Outcome for Carers 
       
Subjective Health Status 1915 SMD  0.04 (-0.05, 0.13), p=0.33† >0.05 0.06 (-0.10, 0.21), 
p=0.46† 
0.02 (-0.12, 0.16), 
p=0.76† 
0.06 (-0.12, 0.25), 
p=0.49† 
        
Secondary Outcome for Carers 
       
Extended Activities of Daily Living 752 SMD -0.13 (-0.28, 0.01), p=0.07† >0.05 -0.10 (-0.35, 0.15), 
p=0.42† 
-0.15 (-0.32, 0.03), 
p=0.10† 
NA 
Caregiver Mental Health 1777 SMD -0.02 (-0.12, 0.07), p=0.62 >0.05 0.02 (-0.15, 0.20), 
p=0.80† 
-0.08 (-0.22, 0.06), 
p=0.27 
0.02 (-0.16, 0.21), 
p=0.81† 
        
Subgroup analysis was stratified by intervention characteristic 
*Defined as Barthel score ≤19 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
SMD = Standardised Mean Difference, OR = Odds Ratio 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 01 Subjective Health Status                                                                                   
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford               120    123.25(115.02)       120    108.80(95.14)      7.23      0.14 [-0.12, 0.39]       
Preston                 87    158.36(113.82)        89    218.94(127.37)     5.15     -0.50 [-0.80, -0.20]      
Utrecht                227    -60.28(20.88)        246    -59.39(20.99)     14.25     -0.04 [-0.22, 0.14]       
Rhode Island            62    -54.33(23.28)         82    -57.97(22.71)      4.25      0.16 [-0.17, 0.49]       
Subtotal (95% CI)    496                         537  30.88     -0.05 [-0.17, 0.07]
Test for heterogeneity: Chi² = 12.20, df = 3 (P = 0.007), I² = 75.4%
Test for overall effect: Z = 0.79 (P = 0.43)
02 Reactive and Flexible
Liverpool               85      3.66(4.10)          77      4.74(4.13)       4.84     -0.26 [-0.57, 0.05]       
Edinburgh              156      8.22(7.05)         154      7.57(7.13)       9.35      0.09 [-0.13, 0.31]       
Oxford                 156      4.39(0.91)         167      4.36(1.00)       9.74      0.03 [-0.19, 0.25]       
Adelaide                39    -39.70(6.40)          40    -40.90(7.60)       2.38      0.17 [-0.27, 0.61]       
Mansfield              126     16.55(7.62)         124     16.41(7.39)       7.55      0.02 [-0.23, 0.27]       
Subtotal (95% CI)    562                         562  33.84      0.01 [-0.10, 0.13]
Test for heterogeneity: Chi² = 4.00, df = 4 (P = 0.41), I² = 0%
Test for overall effect: Z = 0.22 (P = 0.83)
03 Proactive and Focused
Leeds (Psychology)     151      4.50(5.26)         150      5.77(5.31)       9.02     -0.24 [-0.47, -0.01]      
Leeds (Volunteers)     149      5.52(5.40)         150      5.77(5.31)       9.02     -0.05 [-0.27, 0.18]       
Liverpool (Psych)       39      3.90(4.33)          77      4.74(4.13)       3.11     -0.20 [-0.58, 0.19]       
Boston (FIRST)         129      2.77(1.05)         134      2.80(1.05)       7.94     -0.03 [-0.27, 0.21]       
Glasgow                100    -63.06(21.41)        105    -62.58(22.82)      6.18     -0.02 [-0.30, 0.25]       
Subtotal (95% CI)    568                         616  35.28     -0.10 [-0.22, 0.01]
Test for heterogeneity: Chi² = 2.57, df = 4 (P = 0.63), I² = 0%
Test for overall effect: Z = 1.73 (P = 0.08)
Total (95% CI)   1626                        1715 100.00     -0.05 [-0.11, 0.02]
Test for heterogeneity: Chi² = 20.63, df = 13 (P = 0.08), I² = 37.0%
Test for overall effect: Z = 1.34 (P = 0.18)
 -1  -0.5  0  0.5  1
 Favours treatment  Favours control
 
Figure 5.4: Patients’ Subjective Health Status 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 02 Extended Activities of Daily Living                                                                        
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford               120     13.37(8.73)         120     12.19(9.39)       7.42      0.13 [-0.12, 0.38]       
Preston                 87     16.02(10.25)         89     14.81(10.64)      5.44      0.12 [-0.18, 0.41]       
Utrecht                236     19.34(2.20)         252     19.31(1.75)      15.10      0.02 [-0.16, 0.19]       
Rhode Island            63     23.51(10.27)         81     20.75(12.26)      4.36      0.24 [-0.09, 0.57]       
Subtotal (95% CI)    506                         542  32.32      0.09 [-0.03, 0.21]
Test for heterogeneity: Chi² = 1.60, df = 3 (P = 0.66), I² = 0%
Test for overall effect: Z = 1.43 (P = 0.15)
02 Reactive and Flexible
Liverpool               84     12.70(7.49)          77     12.03(7.45)       4.97      0.09 [-0.22, 0.40]       
Edinburgh              164     21.66(9.66)         164     21.24(11.55)     10.16      0.04 [-0.18, 0.26]       
Oxford                 156     16.23(11.48)        167     15.98(10.56)      9.99      0.02 [-0.20, 0.24]       
Adelaide                32     21.60(5.50)          30     18.30(5.10)       1.83      0.61 [0.10, 1.12]        
Mansfield              126     23.64(16.48)        124     25.73(16.26)      7.73     -0.13 [-0.38, 0.12]       
London                  83    -15.06(3.05)          86    -16.00(3.22)       5.18      0.30 [-0.01, 0.60]       
Subtotal (95% CI)    645                         648  39.86      0.07 [-0.04, 0.18]
Test for heterogeneity: Chi² = 9.23, df = 5 (P = 0.10), I² = 45.8%
Test for overall effect: Z = 1.24 (P = 0.22)
03 Proactive and Focused
Leeds (Psychology)     116     12.74(10.79)        124     15.37(11.97)      7.38     -0.23 [-0.48, 0.02]       
Leeds (Volunteers)     124     14.37(11.23)        124     15.37(11.97)      7.68     -0.09 [-0.33, 0.16]       
Liverpool (Psych)       39     13.64(7.84)          77     12.03(7.45)       3.19      0.21 [-0.18, 0.60]       
Philadelphia (STAIR)     21     31.00(8.30)          21     31.10(10.70)      1.30     -0.01 [-0.62, 0.59]       
Boston (FIRST)         133     10.83(3.15)         134     10.68(2.98)       8.27      0.05 [-0.19, 0.29]       
Subtotal (95% CI)    433                         480  27.82     -0.05 [-0.18, 0.08]
Test for heterogeneity: Chi² = 4.42, df = 4 (P = 0.35), I² = 9.5%
Test for overall effect: Z = 0.70 (P = 0.49)
Total (95% CI)   1584                        1670 100.00      0.04 [-0.03, 0.11]
Test for heterogeneity: Chi² = 17.81, df = 14 (P = 0.22), I² = 21.4%
Test for overall effect: Z = 1.23 (P = 0.22)
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Figure 5.5: Patients’ Extended Activities of Daily Living 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 03 Death                                                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                  17/120             15/120         5.86      1.16 [0.55, 2.44]        
 Preston                    7/87               8/89          3.31      0.89 [0.31, 2.56]        
 Utrecht                    7/263              5/273         2.17      1.47 [0.46, 4.68]        
Subtotal (95% CI) 470                482  11.33      1.14 [0.66, 1.95]
Total events: 31 (Treatment), 28 (Control)
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.47 (P = 0.64)
02 Reactive and Flexible
 Liverpool                 12/137             20/139         8.24      0.57 [0.27, 1.22]        
 Melbourne                 11/110             20/103         8.46      0.46 [0.21, 1.02]        
 Edinburgh                 19/210             22/207         9.17      0.84 [0.44, 1.60]        
 Oxford                    65/156             67/167        17.17      1.07 [0.68, 1.66]        
 Adelaide                   1/35               1/33          0.45      0.94 [0.06, 15.69]       
 Mansfield                 17/126             24/126         9.44      0.66 [0.34, 1.31]        
 London                    30/170             28/170        10.49      1.09 [0.62, 1.91]        
Subtotal (95% CI) 944                945  63.41      0.83 [0.65, 1.06]
Total events: 155 (Treatment), 182 (Control)
Test for heterogeneity: Chi² = 5.58, df = 6 (P = 0.47), I² = 0%
Test for overall effect: Z = 1.48 (P = 0.14)
03 Proactive and Focused
 Leeds (Psychology)        21/150             22/149         8.63      0.94 [0.49, 1.79]        
 Leeds (Volunteers)        22/147             22/149         8.45      1.02 [0.54, 1.93]        
 Liverpool (Psych)          4/67              20/139         5.56      0.38 [0.12, 1.15]        
 Philadelphia (STAIR)        0/21               0/20                Not estimable         
 Boston (FIRST)             7/146              6/145         2.61      1.17 [0.38, 3.56]        
 Glasgow                    0/100              0/105               Not estimable         
Subtotal (95% CI) 631                707  25.25      0.86 [0.59, 1.27]
Total events: 54 (Treatment), 70 (Control)
Test for heterogeneity: Chi² = 2.70, df = 3 (P = 0.44), I² = 0%
Test for overall effect: Z = 0.74 (P = 0.46)
Total (95% CI) 2045               2134 100.00      0.87 [0.72, 1.06]
Total events: 240 (Treatment), 280 (Control)
Test for heterogeneity: Chi² = 9.71, df = 13 (P = 0.72), I² = 0%
Test for overall effect: Z = 1.37 (P = 0.17)
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Figure 5.6: Death 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 04 Place of Residence                                                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                   7/120              7/120        18.92      1.00 [0.34, 2.94]        
Subtotal (95% CI) 120                120  18.92      1.00 [0.34, 2.94]
Total events: 7 (Treatment), 7 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.00 (P = 1.00)
02 Reactive and Flexible
 Liverpool                  9/137              9/139        23.96      1.02 [0.39, 2.64]        
 Adelaide                   2/35               2/33          5.57      0.94 [0.12, 7.08]        
Subtotal (95% CI) 172                172  29.54      1.00 [0.42, 2.38]
Total events: 11 (Treatment), 11 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.95), I² = 0%
Test for overall effect: Z = 0.00 (P = 1.00)
03 Proactive and Focused
 Liverpool (Psych)          3/67               9/139        16.05      0.68 [0.18, 2.59]        
 Philadelphia (STAIR)        2/21               2/20          5.32      0.95 [0.12, 7.46]        
 Boston (FIRST)             7/146             11/145        30.17      0.61 [0.23, 1.63]        
Subtotal (95% CI) 234                304  51.54      0.67 [0.32, 1.39]
Total events: 12 (Treatment), 22 (Control)
Test for heterogeneity: Chi² = 0.14, df = 2 (P = 0.93), I² = 0%
Test for overall effect: Z = 1.08 (P = 0.28)
Total (95% CI) 526                596 100.00      0.83 [0.51, 1.36]
Total events: 30 (Treatment), 40 (Control)
Test for heterogeneity: Chi² = 0.77, df = 5 (P = 0.98), I² = 0%
Test for overall effect: Z = 0.74 (P = 0.46)
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Figure 5.7: Institutionalisation 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 05 Activities of Daily Living                                                                                 
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford               120     15.94(4.67)         120     15.57(4.86)       7.17      0.08 [-0.18, 0.33]       
Preston                 87     14.44(5.66)          89     13.44(4.79)       5.24      0.19 [-0.11, 0.49]       
Utrecht                236     19.34(2.20)         252     19.31(1.75)      14.57      0.02 [-0.16, 0.19]       
Subtotal (95% CI)    443                         461  26.98      0.07 [-0.06, 0.20]
Test for heterogeneity: Chi² = 1.00, df = 2 (P = 0.61), I² = 0%
Test for overall effect: Z = 0.99 (P = 0.32)
02 Reactive and Flexible
Liverpool               92     15.27(5.75)          86     14.34(6.41)       5.30      0.15 [-0.14, 0.45]       
Melbourne (SHIPS)       42     20.00(0.00)          45     20.00(0.70)             Not estimable         
Edinburgh              210     16.76(11.91)        207     16.81(12.24)     12.46      0.00 [-0.20, 0.19]       
Oxford                 156     15.09(5.36)         167     16.07(4.98)       9.60     -0.19 [-0.41, 0.03]       
Adelaide                39     18.70(2.00)          40     17.40(3.90)       2.31      0.41 [-0.03, 0.86]       
Mansfield              126     13.74(4.95)         124     14.63(4.23)       7.44     -0.19 [-0.44, 0.06]       
London                  94     14.13(5.83)          89     14.06(5.84)       5.47      0.01 [-0.28, 0.30]       
Subtotal (95% CI)    759                         758  42.58     -0.03 [-0.14, 0.07]
Test for heterogeneity: Chi² = 9.10, df = 5 (P = 0.11), I² = 45.1%
Test for overall effect: Z = 0.65 (P = 0.51)
03 Proactive and Focused
Leeds (Psychology)     151     15.40(4.78)         150     16.52(4.29)       8.93     -0.25 [-0.47, -0.02]      
Leeds (Volunteers)     149     15.76(4.84)         150     16.52(4.29)       8.91     -0.17 [-0.39, 0.06]       
Liverpool (Psych)       45     14.02(7.05)          86     14.34(6.41)       3.53     -0.05 [-0.41, 0.31]       
Philadelphia (STAIR)     20    103.60(25.10)         20    102.50(27.10)      1.20      0.04 [-0.58, 0.66]       
Boston (FIRST)         131     89.50(14.10)        134     86.50(18.20)      7.89      0.18 [-0.06, 0.42]       
Subtotal (95% CI)    496                         540  30.45     -0.08 [-0.20, 0.05]
Test for heterogeneity: Chi² = 7.36, df = 4 (P = 0.12), I² = 45.6%
Test for overall effect: Z = 1.23 (P = 0.22)
Total (95% CI)   1698                        1759 100.00     -0.02 [-0.09, 0.05]
Test for heterogeneity: Chi² = 20.02, df = 13 (P = 0.09), I² = 35.1%
Test for overall effect: Z = 0.59 (P = 0.55)
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Figure 5.8: Patients’ Activities of Daily Living 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 06 Dependency                                                                                                 
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford               120     -3.80(1.63)         120     -3.84(1.58)      16.37      0.02 [-0.23, 0.28]       
Utrecht                237      1.43(0.99)         251      1.45(1.04)      33.25     -0.02 [-0.20, 0.16]       
Subtotal (95% CI)    357                         371  49.61      0.00 [-0.15, 0.14]
Test for heterogeneity: Chi² = 0.08, df = 1 (P = 0.78), I² = 0%
Test for overall effect: Z = 0.07 (P = 0.95)
02 Reactive and Flexible
Edinburgh              210      4.60(13.28)        207      3.34(6.87)      28.38      0.12 [-0.07, 0.31]       
Oxford                 156    -15.41(5.42)         167    -15.45(5.04)      22.00      0.01 [-0.21, 0.23]       
Subtotal (95% CI)    366                         374  50.39      0.07 [-0.07, 0.21]
Test for heterogeneity: Chi² = 0.56, df = 1 (P = 0.45), I² = 0%
Test for overall effect: Z = 0.95 (P = 0.34)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    723                         745 100.00      0.03 [-0.07, 0.14]
Test for heterogeneity: Chi² = 1.16, df = 3 (P = 0.76), I² = 0%
Test for overall effect: Z = 0.63 (P = 0.53)
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Figure 5.9: Patient Dependency 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 10 Dependence (Defined as a Barthel </= 19)                                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Bradford                  81/102             82/105         5.56      1.08 [0.56, 2.11]        
 Preston                   45/63              54/62          5.20      0.37 [0.15, 0.93]        
 Utrecht                   47/236             65/252        16.84      0.72 [0.47, 1.10]        
Subtotal (95% CI) 401                419  27.60      0.72 [0.52, 1.01]
Total events: 173 (Treatment), 201 (Control)
Test for heterogeneity: Chi² = 3.43, df = 2 (P = 0.18), I² = 41.7%
Test for overall effect: Z = 1.91 (P = 0.06)
02 Reactive and Flexible
 Liverpool                 65/92              67/86          6.80      0.68 [0.35, 1.35]        
 Edinburgh                116/210            118/207        17.79      0.93 [0.63, 1.37]        
 Oxford                   110/146            105/148         8.60      1.25 [0.75, 2.10]        
 Adelaide                  19/32              18/30          2.52      0.97 [0.35, 2.69]        
 Mansfield                 84/95              86/92          3.38      0.53 [0.19, 1.51]        
 London                    78/94              72/89          4.21      1.15 [0.54, 2.45]        
Subtotal (95% CI) 669                652  43.31      0.95 [0.74, 1.21]
Total events: 472 (Treatment), 466 (Control)
Test for heterogeneity: Chi² = 3.45, df = 5 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.42 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)        83/116             81/124         7.45      1.34 [0.77, 2.31]        
 Leeds (Volunteers)        82/124             81/124         9.17      1.04 [0.61, 1.75]        
 Boston (FIRST)            75/134             85/135        12.47      0.75 [0.46, 1.22]        
Subtotal (95% CI) 374                383  29.09      0.99 [0.73, 1.33]
Total events: 240 (Treatment), 247 (Control)
Test for heterogeneity: Chi² = 2.45, df = 2 (P = 0.29), I² = 18.2%
Test for overall effect: Z = 0.07 (P = 0.94)
Total (95% CI) 1444               1454 100.00      0.90 [0.76, 1.06]
Total events: 885 (Treatment), 914 (Control)
Test for heterogeneity: Chi² = 11.43, df = 11 (P = 0.41), I² = 3.8%
Test for overall effect: Z = 1.28 (P = 0.20)
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Figure 5.10: Patient Dependence (Defined as Barthel ≤19) 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 07 Mental Health - Generic                                                                                    
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Preston                 87      9.26(6.04)          89     10.41(6.30)       5.34     -0.19 [-0.48, 0.11]       
Utrecht                263     35.33(2.90)         273     35.13(3.21)      16.32      0.07 [-0.10, 0.23]       
Rhode Island            62      4.21(4.12)          82      3.90(3.86)       4.30      0.08 [-0.25, 0.41]       
Subtotal (95% CI)    412                         444  25.96      0.02 [-0.12, 0.15]
Test for heterogeneity: Chi² = 2.24, df = 2 (P = 0.33), I² = 10.6%
Test for overall effect: Z = 0.23 (P = 0.82)
02 Reactive and Flexible
Liverpool               85      3.66(4.10)          77      4.74(4.13)       4.88     -0.26 [-0.57, 0.05]       
Edinburgh              128     11.10(8.03)         124      9.82(7.57)       7.65      0.16 [-0.08, 0.41]       
Oxford                 156     45.53(170.15)       167     34.16(107.41)     9.82      0.08 [-0.14, 0.30]       
Adelaide                39      4.50(2.10)          40      4.80(1.00)       2.40     -0.18 [-0.62, 0.26]       
Mansfield              126     16.55(7.62)         124     16.41(7.39)       7.62      0.02 [-0.23, 0.27]       
London                  88     15.58(9.11)          85     14.46(8.63)       5.26      0.13 [-0.17, 0.42]       
Subtotal (95% CI)    622                         617  37.63      0.03 [-0.08, 0.14]
Test for heterogeneity: Chi² = 6.00, df = 5 (P = 0.31), I² = 16.7%
Test for overall effect: Z = 0.53 (P = 0.60)
03 Proactive and Focused
Leeds (Psychology)     151      4.50(5.26)         150      5.77(5.31)       9.10     -0.24 [-0.47, -0.01]      
Leeds (Volunteers)     149      5.52(5.40)         150      5.77(5.31)       9.11     -0.05 [-0.27, 0.18]       
Liverpool (Psych)       39      3.90(4.33)          77      4.74(4.13)       3.14     -0.20 [-0.58, 0.19]       
Philadelphia (STAIR)     19     18.90(8.60)          19     20.20(9.80)       1.15     -0.14 [-0.77, 0.50]       
Boston (FIRST)         126     11.68(9.97)         128     10.20(7.70)       7.71      0.17 [-0.08, 0.41]       
Glasgow                100      4.26(3.17)         105      5.06(3.61)       6.20     -0.23 [-0.51, 0.04]       
Subtotal (95% CI)    584                         629  36.42     -0.10 [-0.21, 0.02]
Test for heterogeneity: Chi² = 7.32, df = 5 (P = 0.20), I² = 31.7%
Test for overall effect: Z = 1.69 (P = 0.09)
Total (95% CI)   1618                        1690 100.00     -0.02 [-0.09, 0.05]
Test for heterogeneity: Chi² = 18.42, df = 14 (P = 0.19), I² = 24.0%
Test for overall effect: Z = 0.58 (P = 0.56)
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Figure 5.11: Patients’ Mental Health (Generic Measures) 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 51 Mental Health: Depression                                                                                  
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Preston                 61      9.26(6.04)          56     10.41(6.30)       3.99     -0.19 [-0.55, 0.18]       
Utrecht                215      4.59(4.45)         240      5.43(4.73)      15.50     -0.18 [-0.37, 0.00]       
Rhode Island            62      4.21(4.12)          82      3.90(3.86)       4.84      0.08 [-0.25, 0.41]       
Subtotal (95% CI)    338                         378  24.33     -0.13 [-0.28, 0.02]
Test for heterogeneity: Chi² = 1.92, df = 2 (P = 0.38), I² = 0%
Test for overall effect: Z = 1.75 (P = 0.08)
02 Reactive and Flexible
Liverpool               85      3.66(4.10)          77      4.74(4.13)       5.50     -0.26 [-0.57, 0.05]       
Edinburgh              128      5.40(4.12)         124      4.60(3.97)       8.60      0.20 [-0.05, 0.44]       
Oxford                 115      5.57(3.20)         109      5.41(3.51)       7.68      0.05 [-0.21, 0.31]       
Adelaide                39      4.50(2.10)          40      4.80(1.00)       2.70     -0.18 [-0.62, 0.26]       
Mansfield              126     16.55(7.62)         124     16.41(7.39)       8.58      0.02 [-0.23, 0.27]       
London                  89      8.17(4.93)          86      7.29(4.93)       5.98      0.18 [-0.12, 0.47]       
Subtotal (95% CI)    582                         560  39.03      0.03 [-0.08, 0.15]
Test for heterogeneity: Chi² = 7.00, df = 5 (P = 0.22), I² = 28.5%
Test for overall effect: Z = 0.59 (P = 0.56)
03 Proactive and Focused
Leeds (Psychology)     116      4.50(5.26)         123      5.77(5.31)       8.13     -0.24 [-0.49, 0.02]       
Leeds (Volunteers)     124      5.52(5.40)         123      5.77(5.31)       8.47     -0.05 [-0.30, 0.20]       
Liverpool (Psych)       39      3.90(4.33)          77      4.74(4.13)       3.54     -0.20 [-0.58, 0.19]       
Philadelphia (STAIR)     19     18.90(8.60)          19     20.20(9.80)       1.30     -0.14 [-0.77, 0.50]       
Boston (FIRST)         126     11.68(9.97)         128     10.20(7.70)       8.68      0.17 [-0.08, 0.41]       
Glasgow                 93      4.26(3.17)          98      5.06(3.61)       6.50     -0.23 [-0.52, 0.05]       
Subtotal (95% CI)    517                         568  36.63     -0.09 [-0.21, 0.03]
Test for heterogeneity: Chi² = 6.89, df = 5 (P = 0.23), I² = 27.5%
Test for overall effect: Z = 1.48 (P = 0.14)
Total (95% CI)   1437                        1506 100.00     -0.05 [-0.12, 0.02]
Test for heterogeneity: Chi² = 19.45, df = 14 (P = 0.15), I² = 28.0%
Test for overall effect: Z = 1.39 (P = 0.17)
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Figure 5.12: Patient Depression (Specific Measures) 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 52 Mental Health: Anxiety                                                                                     
Study  Treatment  Control  WMD (fixed)  Weight  WMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Utrecht                215      5.17(4.51)         244      5.55(4.22)      32.97     -0.38 [-1.18, 0.42]       
Subtotal (95% CI)    215                         244  32.97     -0.38 [-1.18, 0.42]
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
02 Reactive and Flexible
Edinburgh              128      5.70(4.58)         124      5.22(4.30)      17.65      0.48 [-0.62, 1.58]       
Oxford                 119      4.85(3.88)         118      4.53(3.56)      23.62      0.32 [-0.63, 1.27]       
Adelaide                39      4.50(2.70)          40      6.20(2.70)      14.97     -1.70 [-2.89, -0.51]      
London                  88      7.40(5.21)          85      7.22(4.16)      10.79      0.18 [-1.22, 1.58]       
Subtotal (95% CI)    374                         367  67.03     -0.11 [-0.67, 0.45]
Test for heterogeneity: Chi² = 8.91, df = 3 (P = 0.03), I² = 66.3%
Test for overall effect: Z = 0.39 (P = 0.70)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    589                         611 100.00     -0.20 [-0.66, 0.26]
Test for heterogeneity: Chi² = 9.20, df = 4 (P = 0.06), I² = 56.5%
Test for overall effect: Z = 0.85 (P = 0.39)
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Figure 5.13: Patient Anxiety (Specific Measures) 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 11 Participation                                                                                              
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
Edinburgh              156     34.40(3.57)         150     34.20(3.18)      35.63     0.06 [-0.17, 0.28]       
Oxford                 156     15.41(5.42)         167     15.45(5.04)      37.60    -0.01 [-0.23, 0.21]       
Adelaide                32     22.10(4.40)          30     22.90(3.40)       7.18    -0.20 [-0.70, 0.30]       
London                  83      6.51(3.45)          86      7.19(3.16)      19.59    -0.20 [-0.51, 0.10]       
Subtotal (95% CI)    427                         433 100.00    -0.04 [-0.17, 0.10]
Test for heterogeneity: Chi² = 2.37, df = 3 (P = 0.50), I² = 0%
Test for overall effect: Z = 0.53 (P = 0.59)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    427                         433 100.00    -0.04 [-0.17, 0.10]
Test for heterogeneity: Chi² = 2.37, df = 3 (P = 0.50), I² = 0%
Test for overall effect: Z = 0.53 (P = 0.59)
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Figure 5.14: Patients’ Participation 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 12 Caregiver Subjective Health Status                                                                         
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                56      4.04(5.07)          55      4.24(5.62)       5.88     -0.04 [-0.41, 0.33]       
Preston                 37      4.08(2.63)          36      5.11(2.28)       3.78     -0.41 [-0.88, 0.05]       
Utrecht                145     22.99(3.14)         179     22.43(3.35)      16.91      0.17 [-0.05, 0.39]       
Rhode Island            58      4.00(3.49)          79      3.57(3.63)       7.07      0.12 [-0.22, 0.46]       
Subtotal (95% CI)    296                         349  33.65      0.06 [-0.10, 0.21]
Test for heterogeneity: Chi² = 5.38, df = 3 (P = 0.15), I² = 44.2%
Test for overall effect: Z = 0.74 (P = 0.46)
02 Reactive and Flexible
Liverpool               61      3.93(4.02)          52      4.23(3.43)       5.94     -0.08 [-0.45, 0.29]       
Melbourne (SHIPS)       20      3.50(2.80)          28      3.00(4.20)       2.47      0.13 [-0.44, 0.71]       
Edinburgh               68     10.44(17.18)         69     13.38(15.93)      7.23     -0.18 [-0.51, 0.16]       
Oxford                 107      3.86(2.98)         100      3.51(3.01)      10.93      0.12 [-0.16, 0.39]       
Adelaide                32    -48.20(12.10)         30    -49.40(13.70)      3.28      0.09 [-0.41, 0.59]       
Mansfield               74      5.55(3.64)          69      5.25(3.41)       7.56      0.08 [-0.24, 0.41]       
London                  43     21.58(3.93)          49     21.49(3.58)       4.85      0.02 [-0.39, 0.43]       
Subtotal (95% CI)    405                         397  42.26      0.02 [-0.12, 0.16]
Test for heterogeneity: Chi² = 2.45, df = 6 (P = 0.87), I² = 0%
Test for overall effect: Z = 0.30 (P = 0.76)
03 Proactive and Focused
Leeds (Psychology)      87      4.52(3.16)          88      4.43(3.59)       9.27      0.03 [-0.27, 0.32]       
Leeds (Volunteers)      90      5.08(3.72)          88      4.43(3.59)       9.39      0.18 [-0.12, 0.47]       
Liverpool (Psych)       22      4.41(3.39)          52      4.23(3.43)       3.27      0.05 [-0.45, 0.55]       
Philadelphia (STAIR)     21     42.70(8.00)          20     44.70(8.40)       2.15     -0.24 [-0.85, 0.38]       
Subtotal (95% CI)    220                         248  24.09      0.06 [-0.12, 0.25]
Test for heterogeneity: Chi² = 1.56, df = 3 (P = 0.67), I² = 0%
Test for overall effect: Z = 0.69 (P = 0.49)
Total (95% CI)    921                         994 100.00      0.04 [-0.05, 0.13]
Test for heterogeneity: Chi² = 9.57, df = 14 (P = 0.79), I² = 0%
Test for overall effect: Z = 0.96 (P = 0.33)
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Figure 5.15: Carer Subjective Health 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 13 Caregiver Extended Activities of Daily Living                                                              
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                56     27.39(7.39)          61     27.64(5.57)      15.68     -0.04 [-0.40, 0.32]       
Rhode Island            56     29.63(7.96)          78     30.92(7.92)      17.45     -0.16 [-0.51, 0.18]       
Subtotal (95% CI)    112                         139  33.13     -0.10 [-0.35, 0.15]
Test for heterogeneity: Chi² = 0.23, df = 1 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.81 (P = 0.42)
02 Reactive and Flexible
Edinburgh               87     47.00(3.57)          84     48.00(2.14)      22.63     -0.34 [-0.64, -0.03]      
Oxford                 103     31.03(6.69)          96     31.07(7.12)      26.69     -0.01 [-0.28, 0.27]       
Mansfield               67     51.42(18.96)         64     53.34(14.72)     17.55     -0.11 [-0.45, 0.23]       
Subtotal (95% CI)    257                         244  66.87     -0.15 [-0.32, 0.03]
Test for heterogeneity: Chi² = 2.55, df = 2 (P = 0.28), I² = 21.5%
Test for overall effect: Z = 1.63 (P = 0.10)
03 Proactive and Focused
Subtotal (95% CI)      0                           0         Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI)    369                         383 100.00     -0.13 [-0.28, 0.01]
Test for heterogeneity: Chi² = 2.86, df = 4 (P = 0.58), I² = 0%
Test for overall effect: Z = 1.80 (P = 0.07)
 -1  -0.5  0  0.5  1
 Favours control  Favours treatment
 
 
 
 
 
 
Figure 5.16: Carers’ Extended Activities of Daily Living 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 14 Caregiver Mental Health                                                                                    
Study  Treatment  Control  SMD (fixed)  Weight  SMD (fixed)
or sub-category N Mean (SD) N Mean (SD)  95% CI  %  95% CI
01 Proactive and Structured
Bradford                56     19.80(11.34)         55     20.64(12.84)      6.39     -0.07 [-0.44, 0.30]       
Utrecht                126     84.48(9.85)         163     84.22(8.72)      16.36      0.03 [-0.20, 0.26]       
Rhode Island            47      9.28(6.70)          74      8.68(5.62)       6.61      0.10 [-0.27, 0.46]       
Subtotal (95% CI)    229                         292  29.36      0.02 [-0.15, 0.20]
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.26 (P = 0.80)
02 Reactive and Flexible
Liverpool               64      2.69(3.78)          53      3.11(3.03)       6.66     -0.12 [-0.48, 0.24]       
Edinburgh               94      7.22(8.32)          92      8.36(7.62)      10.68     -0.14 [-0.43, 0.15]       
Oxford                  93      3.66(4.29)          90      4.00(4.68)      10.52     -0.08 [-0.37, 0.21]       
Adelaide                32    -46.40(6.80)          30    -48.40(6.20)       3.52      0.30 [-0.20, 0.80]       
Mansfield               75     14.08(5.70)          70     14.77(7.47)       8.33     -0.10 [-0.43, 0.22]       
London                  45     12.67(8.77)          55     13.71(8.35)       5.69     -0.12 [-0.52, 0.27]       
Subtotal (95% CI)    403                         390  45.40     -0.08 [-0.22, 0.06]
Test for heterogeneity: Chi² = 2.53, df = 5 (P = 0.77), I² = 0%
Test for overall effect: Z = 1.11 (P = 0.27)
03 Proactive and Focused
Leeds (Psychology)      82      5.02(5.25)          85      5.33(6.18)       9.61     -0.05 [-0.36, 0.25]       
Leeds (Volunteers)      88      5.58(6.55)          85      5.33(6.18)       9.95      0.04 [-0.26, 0.34]       
Liverpool (Psych)       22      2.73(3.10)          53      3.11(3.03)       3.57     -0.12 [-0.62, 0.37]       
Philadelphia (STAIR)     19     21.40(10.40)         19     16.60(6.60)       2.10      0.54 [-0.11, 1.19]       
Subtotal (95% CI)    211                         242  25.24      0.02 [-0.16, 0.21]
Test for heterogeneity: Chi² = 3.02, df = 3 (P = 0.39), I² = 0.8%
Test for overall effect: Z = 0.23 (P = 0.81)
Total (95% CI)    843                         924 100.00     -0.02 [-0.12, 0.07]
Test for heterogeneity: Chi² = 7.08, df = 12 (P = 0.85), I² = 0%
Test for overall effect: Z = 0.49 (P = 0.62)
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Figure 5.17: Carers’ Mental Health 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 34 "I have been treated with kindness and respect" - patient                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  221/230            250/253        31.86      0.29 [0.08, 1.10]        
Subtotal (95% CI) 230                253  31.86      0.29 [0.08, 1.10]
Total events: 221 (Treatment), 250 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.07)
02 Reactive and Flexible
 Edinburgh                135/136            139/142         3.42      2.91 [0.30, 28.36]       
 Oxford                   114/128            123/130        45.65      0.46 [0.18, 1.19]        
Subtotal (95% CI) 264                272  49.07      0.63 [0.28, 1.45]
Total events: 249 (Treatment), 262 (Control)
Test for heterogeneity: Chi² = 2.15, df = 1 (P = 0.14), I² = 53.5%
Test for overall effect: Z = 1.08 (P = 0.28)
03 Proactive and Focused
 Leeds (Psychology)       110/111            119/121         3.51      1.85 [0.17, 20.67]       
 Leeds (Volunteers)       112/115            119/121        10.35      0.63 [0.10, 3.83]        
 Glasgow                   93/94              98/98          5.21      0.32 [0.01, 7.86]        
Subtotal (95% CI) 320                340  19.06      0.77 [0.22, 2.70]
Total events: 315 (Treatment), 336 (Control)
Test for heterogeneity: Chi² = 0.85, df = 2 (P = 0.65), I² = 0%
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 814                865 100.00      0.55 [0.30, 1.01]
Total events: 785 (Treatment), 848 (Control)
Test for heterogeneity: Chi² = 4.15, df = 5 (P = 0.53), I² = 0%
Test for overall effect: Z = 1.93 (P = 0.05)
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Figure 5.18: Patient Satisfaction; “I have been treated with kindness and respect” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 35 "The staff attended well to my personal needs" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  219/230            249/253        28.26      0.32 [0.10, 1.02]        
Subtotal (95% CI) 230                253  28.26      0.32 [0.10, 1.02]
Total events: 219 (Treatment), 249 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.05)
02 Reactive and Flexible
 Edinburgh                134/136            135/140         4.88      2.48 [0.47, 13.01]       
 Oxford                   112/128            117/129        36.30      0.72 [0.33, 1.59]        
Subtotal (95% CI) 264                269  41.18      0.93 [0.46, 1.86]
Total events: 246 (Treatment), 252 (Control)
Test for heterogeneity: Chi² = 1.76, df = 1 (P = 0.19), I² = 43.1%
Test for overall effect: Z = 0.21 (P = 0.83)
03 Proactive and Focused
 Leeds (Psychology)       107/111            114/121         9.80      1.64 [0.47, 5.77]        
 Leeds (Volunteers)       109/115            114/121        14.44      1.12 [0.36, 3.42]        
 Glasgow                   92/94              98/98          6.33      0.19 [0.01, 3.96]        
Subtotal (95% CI) 320                340  30.56      1.09 [0.50, 2.37]
Total events: 308 (Treatment), 326 (Control)
Test for heterogeneity: Chi² = 1.69, df = 2 (P = 0.43), I² = 0%
Test for overall effect: Z = 0.22 (P = 0.82)
Total (95% CI) 814                862 100.00      0.81 [0.51, 1.28]
Total events: 773 (Treatment), 827 (Control)
Test for heterogeneity: Chi² = 6.73, df = 5 (P = 0.24), I² = 25.7%
Test for overall effect: Z = 0.92 (P = 0.36)
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Figure 5.19: Patient Satisfaction; “The staff have attended well to my personal needs” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 36 "I was able to talk to the staff about any problems" - patient                                             
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  199/228            230/250        33.17      0.60 [0.33, 1.09]        
Subtotal (95% CI) 228                250  33.17      0.60 [0.33, 1.09]
Total events: 199 (Treatment), 230 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.69 (P = 0.09)
02 Reactive and Flexible
 Edinburgh                124/136            132/142        13.55      0.78 [0.33, 1.88]        
 Oxford                   102/125            111/127        24.08      0.64 [0.32, 1.28]        
Subtotal (95% CI) 261                269  37.63      0.69 [0.40, 1.19]
Total events: 226 (Treatment), 243 (Control)
Test for heterogeneity: Chi² = 0.13, df = 1 (P = 0.72), I² = 0%
Test for overall effect: Z = 1.34 (P = 0.18)
03 Proactive and Focused
 Leeds (Psychology)       102/111            110/121        10.14      1.13 [0.45, 2.85]        
 Leeds (Volunteers)       103/115            110/121        13.30      0.86 [0.36, 2.03]        
 Glasgow                   89/94              93/98          5.76      0.96 [0.27, 3.42]        
Subtotal (95% CI) 320                340  29.20      0.97 [0.55, 1.71]
Total events: 294 (Treatment), 313 (Control)
Test for heterogeneity: Chi² = 0.19, df = 2 (P = 0.91), I² = 0%
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% CI) 809                859 100.00      0.74 [0.54, 1.03]
Total events: 719 (Treatment), 786 (Control)
Test for heterogeneity: Chi² = 1.77, df = 5 (P = 0.88), I² = 0%
Test for overall effect: Z = 1.79 (P = 0.07)
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Figure 5.20: Patient Satisfaction; “I was able to talk to the staff about any problems” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 37 "I received all the information I want about the causes and nature of my disease" - patient                
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  184/230            213/252        28.08      0.73 [0.46, 1.17]        
Subtotal (95% CI) 230                252  28.08      0.73 [0.46, 1.17]
Total events: 184 (Treatment), 213 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
02 Reactive and Flexible
 Edinburgh                114/137            115/140        13.19      1.08 [0.58, 2.01]        
 Oxford                    96/124            101/128        15.50      0.92 [0.50, 1.67]        
 Mansfield                 83/95              70/90          6.27      1.98 [0.90, 4.32]        
 London                    70/92              61/87         10.36      1.36 [0.70, 2.63]        
Subtotal (95% CI) 448                445  45.33      1.21 [0.87, 1.68]
Total events: 363 (Treatment), 347 (Control)
Test for heterogeneity: Chi² = 2.58, df = 3 (P = 0.46), I² = 0%
Test for overall effect: Z = 1.15 (P = 0.25)
03 Proactive and Focused
 Leeds (Psychology)        98/111            101/121         7.82      1.49 [0.70, 3.17]        
 Leeds (Volunteers)        91/115            101/121        14.19      0.75 [0.39, 1.45]        
 Glasgow                   87/94              91/98          4.58      0.96 [0.32, 2.84]        
Subtotal (95% CI) 320                340  26.59      1.00 [0.64, 1.57]
Total events: 276 (Treatment), 293 (Control)
Test for heterogeneity: Chi² = 1.83, df = 2 (P = 0.40), I² = 0%
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 998                1037 100.00      1.02 [0.81, 1.28]
Total events: 823 (Treatment), 853 (Control)
Test for heterogeneity: Chi² = 7.34, df = 7 (P = 0.39), I² = 4.7%
Test for overall effect: Z = 0.18 (P = 0.86)
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Figure 5.21: Patient Satisfaction; “I received all the information about the causes and nature of my disease” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 38 "The staff have done everything to make me well" - patient                                                 
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  217/229            246/254        32.58      0.59 [0.24, 1.47]        
Subtotal (95% CI) 229                254  32.58      0.59 [0.24, 1.47]
Total events: 217 (Treatment), 246 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
02 Reactive and Flexible
 Edinburgh                134/137            137/141         7.88      1.30 [0.29, 5.94]        
 Oxford                   112/122            122/131        25.71      0.83 [0.32, 2.11]        
Subtotal (95% CI) 259                272  33.59      0.94 [0.42, 2.07]
Total events: 246 (Treatment), 259 (Control)
Test for heterogeneity: Chi² = 0.25, df = 1 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.16 (P = 0.88)
03 Proactive and Focused
 Leeds (Psychology)       107/111            114/121        10.48      1.64 [0.47, 5.77]        
 Leeds (Volunteers)       106/114            114/121        20.69      0.81 [0.29, 2.32]        
 Glasgow                   93/94              96/98          2.67      1.94 [0.17, 21.73]       
Subtotal (95% CI) 319                340  33.83      1.16 [0.55, 2.46]
Total events: 306 (Treatment), 324 (Control)
Test for heterogeneity: Chi² = 0.91, df = 2 (P = 0.64), I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI) 807                866 100.00      0.90 [0.56, 1.43]
Total events: 769 (Treatment), 829 (Control)
Test for heterogeneity: Chi² = 2.40, df = 5 (P = 0.79), I² = 0%
Test for overall effect: Z = 0.45 (P = 0.65)
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Figure 5.22: Patient Satisfaction; “The staff have done everything to make me well” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 39 "I am happy with my recovery" - patient                                                                    
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  206/229            228/254        18.68      1.02 [0.57, 1.85]        
Subtotal (95% CI) 229                254  18.68      1.02 [0.57, 1.85]
Total events: 206 (Treatment), 228 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.94)
02 Reactive and Flexible
 Edinburgh                114/137            127/144        17.89      0.66 [0.34, 1.30]        
 Oxford                    92/125            107/130        23.83      0.60 [0.33, 1.09]        
Subtotal (95% CI) 262                274  41.72      0.63 [0.40, 0.98]
Total events: 206 (Treatment), 234 (Control)
Test for heterogeneity: Chi² = 0.05, df = 1 (P = 0.83), I² = 0%
Test for overall effect: Z = 2.04 (P = 0.04)
03 Proactive and Focused
 Leeds (Psychology)        91/111             92/120        13.71      1.38 [0.73, 2.63]        
 Leeds (Volunteers)        89/115             92/120        17.52      1.04 [0.57, 1.91]        
 Glasgow                   83/94              85/98          8.38      1.15 [0.49, 2.72]        
Subtotal (95% CI) 320                338  39.60      1.18 [0.80, 1.75]
Total events: 263 (Treatment), 269 (Control)
Test for heterogeneity: Chi² = 0.40, df = 2 (P = 0.82), I² = 0%
Test for overall effect: Z = 0.85 (P = 0.40)
Total (95% CI) 811                866 100.00      0.92 [0.71, 1.20]
Total events: 675 (Treatment), 731 (Control)
Test for heterogeneity: Chi² = 4.96, df = 5 (P = 0.42), I² = 0%
Test for overall effect: Z = 0.61 (P = 0.54)
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Figure 5.23: Patient Satisfaction; “I am happy with my recovery” 
131 
 
Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 40 "I am satisfied with the type of treatment I have received" - patient                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  164/187            195/221        35.59      0.95 [0.52, 1.73]        
Subtotal (95% CI) 187                221  35.59      0.95 [0.52, 1.73]
Total events: 164 (Treatment), 195 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
02 Reactive and Flexible
 Edinburgh                118/128            119/133        14.76      1.39 [0.59, 3.25]        
 Oxford                    92/103            100/108        16.88      0.67 [0.26, 1.74]        
Subtotal (95% CI) 231                241  31.64      1.00 [0.54, 1.88]
Total events: 210 (Treatment), 219 (Control)
Test for heterogeneity: Chi² = 1.25, df = 1 (P = 0.26), I² = 20.2%
Test for overall effect: Z = 0.01 (P = 0.99)
03 Proactive and Focused
 Leeds (Psychology)        98/111            107/120        19.50      0.92 [0.40, 2.07]        
 Leeds (Volunteers)       106/115            107/120        13.27      1.43 [0.59, 3.49]        
Subtotal (95% CI) 226                240  32.77      1.12 [0.62, 2.05]
Total events: 204 (Treatment), 214 (Control)
Test for heterogeneity: Chi² = 0.52, df = 1 (P = 0.47), I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)
Total (95% CI) 644                702 100.00      1.02 [0.72, 1.46]
Total events: 578 (Treatment), 628 (Control)
Test for heterogeneity: Chi² = 1.93, df = 4 (P = 0.75), I² = 0%
Test for overall effect: Z = 0.14 (P = 0.89)
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Figure 5.24: Patient Satisfaction; “I am satisfied with the type of treatment I have received” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 41 "I was given all the information I needed about allowances" - patient                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  130/210            139/225        34.42      1.01 [0.68, 1.48]        
Subtotal (95% CI) 210                225  34.42      1.01 [0.68, 1.48]
Total events: 130 (Treatment), 139 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
02 Reactive and Flexible
 Edinburgh                104/125            106/133        11.62      1.26 [0.67, 2.37]        
 Oxford                    96/120             98/127        12.82      1.18 [0.64, 2.18]        
 Mansfield                 64/68              47/52          2.11      1.70 [0.43, 6.68]        
 London                    50/74              48/67         11.00      0.82 [0.40, 1.70]        
Subtotal (95% CI) 387                379  37.55      1.13 [0.79, 1.62]
Total events: 314 (Treatment), 299 (Control)
Test for heterogeneity: Chi² = 1.22, df = 3 (P = 0.75), I² = 0%
Test for overall effect: Z = 0.67 (P = 0.50)
03 Proactive and Focused
 Leeds (Psychology)        95/107            102/119         7.29      1.32 [0.60, 2.91]        
 Leeds (Volunteers)        91/112            102/119        12.49      0.72 [0.36, 1.45]        
 Glasgow                   77/91              81/94          8.25      0.88 [0.39, 2.00]        
Subtotal (95% CI) 310                332  28.03      0.92 [0.60, 1.43]
Total events: 263 (Treatment), 285 (Control)
Test for heterogeneity: Chi² = 1.27, df = 2 (P = 0.53), I² = 0%
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 907                936 100.00      1.03 [0.82, 1.29]
Total events: 707 (Treatment), 723 (Control)
Test for heterogeneity: Chi² = 3.00, df = 7 (P = 0.89), I² = 0%
Test for overall effect: Z = 0.26 (P = 0.80)
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Figure 5.25: Patient Satisfaction; “I was given all the information I needed about allowances” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 42 "Things were well prepared for my return home" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  125/183            145/204        46.03      0.88 [0.57, 1.35]        
Subtotal (95% CI) 183                204  46.03      0.88 [0.57, 1.35]
Total events: 125 (Treatment), 145 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.55)
02 Reactive and Flexible
 Edinburgh                102/120            106/128        16.30      1.18 [0.60, 2.32]        
 Oxford                   111/123            122/129        12.30      0.53 [0.20, 1.40]        
Subtotal (95% CI) 243                257  28.60      0.90 [0.52, 1.55]
Total events: 213 (Treatment), 228 (Control)
Test for heterogeneity: Chi² = 1.74, df = 1 (P = 0.19), I² = 42.6%
Test for overall effect: Z = 0.38 (P = 0.70)
03 Proactive and Focused
 Leeds (Psychology)        98/107            101/118         8.56      1.83 [0.78, 4.31]        
 Leeds (Volunteers)        93/111            101/118        16.81      0.87 [0.42, 1.79]        
Subtotal (95% CI) 218                236  25.37      1.19 [0.69, 2.06]
Total events: 191 (Treatment), 202 (Control)
Test for heterogeneity: Chi² = 1.71, df = 1 (P = 0.19), I² = 41.5%
Test for overall effect: Z = 0.64 (P = 0.52)
Total (95% CI) 644                697 100.00      0.96 [0.72, 1.29]
Total events: 529 (Treatment), 575 (Control)
Test for heterogeneity: Chi² = 4.23, df = 4 (P = 0.38), I² = 5.3%
Test for overall effect: Z = 0.25 (P = 0.80)
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Figure 5.26: Patient Satisfaction; “Things were well prepared for my return home” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 43 "I get all the services I need" - patient                                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                   92/157            111/177        45.97      0.84 [0.54, 1.31]        
Subtotal (95% CI) 157                177  45.97      0.84 [0.54, 1.31]
Total events: 92 (Treatment), 111 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
02 Reactive and Flexible
 Edinburgh                104/120            100/120        14.19      1.30 [0.64, 2.65]        
 Oxford                   115/122            118/130         6.98      1.67 [0.64, 4.39]        
 London                    39/52              35/47          9.78      1.03 [0.41, 2.55]        
Subtotal (95% CI) 294                297  30.94      1.30 [0.80, 2.10]
Total events: 258 (Treatment), 253 (Control)
Test for heterogeneity: Chi² = 0.51, df = 2 (P = 0.77), I² = 0%
Test for overall effect: Z = 1.06 (P = 0.29)
03 Proactive and Focused
 Leeds (Psychology)       100/106            106/118         6.04      1.89 [0.68, 5.22]        
 Leeds (Volunteers)        90/107            106/118        17.04      0.60 [0.27, 1.32]        
Subtotal (95% CI) 213                236  23.09      0.94 [0.51, 1.71]
Total events: 190 (Treatment), 212 (Control)
Test for heterogeneity: Chi² = 3.05, df = 1 (P = 0.08), I² = 67.2%
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 664                710 100.00      1.00 [0.76, 1.34]
Total events: 540 (Treatment), 576 (Control)
Test for heterogeneity: Chi² = 5.30, df = 5 (P = 0.38), I² = 5.7%
Test for overall effect: Z = 0.03 (P = 0.97)
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Figure 5.27: Patient Satisfaction; “I get all the services I need” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 44 "I am satisfied with outpatient services" - patient                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  185/220            217/243        46.00      0.63 [0.37, 1.09]        
Subtotal (95% CI) 220                243  46.00      0.63 [0.37, 1.09]
Total events: 185 (Treatment), 217 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.10)
02 Reactive and Flexible
 Edinburgh                119/127            116/127        10.25      1.41 [0.55, 3.63]        
Subtotal (95% CI) 127                127  10.25      1.41 [0.55, 3.63]
Total events: 119 (Treatment), 116 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
03 Proactive and Focused
 Leeds (Psychology)        98/107            106/118        11.89      1.23 [0.50, 3.05]        
 Leeds (Volunteers)        91/110            106/118        24.77      0.54 [0.25, 1.18]        
 Glasgow                   89/94              97/98          7.08      0.18 [0.02, 1.60]        
Subtotal (95% CI) 311                334  43.75      0.67 [0.39, 1.16]
Total events: 278 (Treatment), 309 (Control)
Test for heterogeneity: Chi² = 3.39, df = 2 (P = 0.18), I² = 41.1%
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 658                704 100.00      0.73 [0.51, 1.04]
Total events: 582 (Treatment), 642 (Control)
Test for heterogeneity: Chi² = 5.53, df = 4 (P = 0.24), I² = 27.7%
Test for overall effect: Z = 1.74 (P = 0.08)
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Figure 5.28: Patient Satisfaction; “I am satisfied with the outpatient services” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 45 "I am satisfied with the practical help I have received" - patient                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  133/190            162/213        84.00      0.73 [0.47, 1.14]        
Subtotal (95% CI) 190                213  84.00      0.73 [0.47, 1.14]
Total events: 133 (Treatment), 162 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.37 (P = 0.17)
02 Reactive and Flexible
 Edinburgh                114/124            110/128        16.00      1.87 [0.82, 4.22]        
Subtotal (95% CI) 124                128  16.00      1.87 [0.82, 4.22]
Total events: 114 (Treatment), 110 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 314                341 100.00      0.92 [0.62, 1.34]
Total events: 247 (Treatment), 272 (Control)
Test for heterogeneity: Chi² = 3.88, df = 1 (P = 0.05), I² = 74.2%
Test for overall effect: Z = 0.45 (P = 0.65)
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Figure 5.29: Patient Satisfaction; “I am satisfied with the practical help I have received” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 46 "I have had enough information about recovery" - patient                                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  161/226            180/250        51.24      0.96 [0.65, 1.44]        
Subtotal (95% CI) 226                250  51.24      0.96 [0.65, 1.44]
Total events: 161 (Treatment), 180 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.85)
02 Reactive and Flexible
 Edinburgh                112/128            101/125        13.31      1.66 [0.84, 3.31]        
 Mansfield                 67/94              62/90         18.96      1.12 [0.60, 2.11]        
 London                    62/91              48/85         16.49      1.65 [0.89, 3.05]        
Subtotal (95% CI) 313                300  48.76      1.45 [1.00, 2.09]
Total events: 241 (Treatment), 211 (Control)
Test for heterogeneity: Chi² = 0.96, df = 2 (P = 0.62), I² = 0%
Test for overall effect: Z = 1.96 (P = 0.05)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 539                550 100.00      1.20 [0.91, 1.57]
Total events: 402 (Treatment), 391 (Control)
Test for heterogeneity: Chi² = 3.10, df = 3 (P = 0.38), I² = 3.2%
Test for overall effect: Z = 1.32 (P = 0.19)
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Figure 5.30: Patient Satisfaction; “I have had enough information about recovery and rehabilitation” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 47 "Someone has really listened" - patient                                                                    
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  177/222            193/248        62.77      1.12 [0.72, 1.75]        
Subtotal (95% CI) 222                248  62.77      1.12 [0.72, 1.75]
Total events: 177 (Treatment), 193 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.61)
02 Reactive and Flexible
 Edinburgh                114/125            103/132        14.98      2.92 [1.39, 6.14]        
 London                    70/92              53/86         22.25      1.98 [1.04, 3.78]        
Subtotal (95% CI) 217                218  37.23      2.36 [1.45, 3.83]
Total events: 184 (Treatment), 156 (Control)
Test for heterogeneity: Chi² = 0.59, df = 1 (P = 0.44), I² = 0%
Test for overall effect: Z = 3.46 (P = 0.0005)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 439                466 100.00      1.58 [1.14, 2.19]
Total events: 361 (Treatment), 349 (Control)
Test for heterogeneity: Chi² = 5.39, df = 2 (P = 0.07), I² = 62.9%
Test for overall effect: Z = 2.77 (P = 0.006)
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Figure 5.31: Patient Satisfaction; “Someone has really listened” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 50 "I have not felt neglected" - patient                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  177/223            205/250        59.79      0.84 [0.53, 1.33]        
Subtotal (95% CI) 223                250  59.79      0.84 [0.53, 1.33]
Total events: 177 (Treatment), 205 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
02 Reactive and Flexible
 Edinburgh                130/136            123/136         8.14      2.29 [0.84, 6.21]        
 London                    64/92              68/86         32.08      0.61 [0.31, 1.20]        
Subtotal (95% CI) 228                222  40.21      0.95 [0.55, 1.63]
Total events: 194 (Treatment), 191 (Control)
Test for heterogeneity: Chi² = 4.66, df = 1 (P = 0.03), I² = 78.5%
Test for overall effect: Z = 0.20 (P = 0.84)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 451                472 100.00      0.89 [0.62, 1.26]
Total events: 371 (Treatment), 396 (Control)
Test for heterogeneity: Chi² = 4.71, df = 2 (P = 0.09), I² = 57.6%
Test for overall effect: Z = 0.68 (P = 0.50)
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Figure 5.32: Patient Satisfaction; “I have not felt neglected” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 48 "I have had enough emotional support" - patient                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  167/224            194/247        53.69      0.80 [0.52, 1.23]        
Subtotal (95% CI) 224                247  53.69      0.80 [0.52, 1.23]
Total events: 167 (Treatment), 194 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.02 (P = 0.31)
02 Reactive and Flexible
 Edinburgh                127/136            118/134         9.00      1.91 [0.81, 4.50]        
 Mansfield                 55/58              31/35          2.29      2.37 [0.50, 11.26]       
Subtotal (95% CI) 194                169  11.28      2.01 [0.95, 4.25]
Total events: 182 (Treatment), 149 (Control)
Test for heterogeneity: Chi² = 0.05, df = 1 (P = 0.82), I² = 0%
Test for overall effect: Z = 1.82 (P = 0.07)
03 Proactive and Focused
 Leeds (Psychology)        94/108             99/118        14.03      1.29 [0.61, 2.72]        
 Leeds (Volunteers)        94/111             99/118        16.81      1.06 [0.52, 2.16]        
 Glasgow                   90/94              88/98          4.19      2.56 [0.77, 8.46]        
Subtotal (95% CI) 313                334  35.03      1.33 [0.83, 2.13]
Total events: 278 (Treatment), 286 (Control)
Test for heterogeneity: Chi² = 1.54, df = 2 (P = 0.46), I² = 0%
Test for overall effect: Z = 1.20 (P = 0.23)
Total (95% CI) 731                750 100.00      1.12 [0.84, 1.50]
Total events: 627 (Treatment), 629 (Control)
Test for heterogeneity: Chi² = 6.75, df = 5 (P = 0.24), I² = 26.0%
Test for overall effect: Z = 0.78 (P = 0.43)
 0.1  0.2  0.5  1  2  5  10
 Favours control  Favours treatment
 
 
Figure 5.33: Patient Satisfaction; “I have had enough emotional support” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 49 "I know who to contact" - patient                                                                          
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
 Utrecht                  167/222            198/247        67.71      0.75 [0.49, 1.16]        
Subtotal (95% CI) 222                247  67.71      0.75 [0.49, 1.16]
Total events: 167 (Treatment), 198 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.28 (P = 0.20)
02 Reactive and Flexible
 Edinburgh                129/135            122/138         7.82      2.82 [1.07, 7.44]        
 London                    71/92              63/86         21.67      1.23 [0.62, 2.44]        
Subtotal (95% CI) 227                224  29.49      1.65 [0.96, 2.86]
Total events: 200 (Treatment), 185 (Control)
Test for heterogeneity: Chi² = 1.87, df = 1 (P = 0.17), I² = 46.5%
Test for overall effect: Z = 1.80 (P = 0.07)
03 Proactive and Focused
 Glasgow                   92/94              92/98          2.79      3.00 [0.59, 15.25]       
Subtotal (95% CI) 94                 98   2.79      3.00 [0.59, 15.25]
Total events: 92 (Treatment), 92 (Control)
Test for heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
Total (95% CI) 543                569 100.00      1.08 [0.78, 1.50]
Total events: 459 (Treatment), 475 (Control)
Test for heterogeneity: Chi² = 8.07, df = 3 (P = 0.04), I² = 62.8%
Test for overall effect: Z = 0.46 (P = 0.64)
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Figure 5.34: Patient Satisfaction; “I know who to contact” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 53 "The patient has been treated with kindness and respect" - carer                                           
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                100/100            104/106         2.48      4.81 [0.23, 101.40]      
 Oxford                   109/123            117/131        63.61      0.93 [0.42, 2.04]        
Subtotal (95% CI) 223                237  66.09      1.08 [0.51, 2.27]
Total events: 209 (Treatment), 221 (Control)
Test for heterogeneity: Chi² = 1.06, df = 1 (P = 0.30), I² = 5.3%
Test for overall effect: Z = 0.20 (P = 0.85)
03 Proactive and Focused
 Leeds (Psychology)        85/87              87/88          9.81      0.49 [0.04, 5.49]        
 Leeds (Volunteers)        85/90              87/88         24.11      0.20 [0.02, 1.71]        
Subtotal (95% CI) 177                176  33.91      0.28 [0.06, 1.37]
Total events: 170 (Treatment), 174 (Control)
Test for heterogeneity: Chi² = 0.31, df = 1 (P = 0.58), I² = 0%
Test for overall effect: Z = 1.57 (P = 0.12)
Total (95% CI) 400                413 100.00      0.81 [0.42, 1.55]
Total events: 379 (Treatment), 395 (Control)
Test for heterogeneity: Chi² = 3.25, df = 3 (P = 0.35), I² = 7.8%
Test for overall effect: Z = 0.65 (P = 0.52)
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Figure 5.35: Carer Satisfaction; “The patient has been treated with kindness and respect” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 54 "The staff have attended to my needs" - carer                                                              
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 94/99              92/106        11.12      2.86 [0.99, 8.26]        
 Oxford                   105/123            111/131        39.00      1.05 [0.53, 2.10]        
Subtotal (95% CI) 222                237  50.12      1.45 [0.82, 2.56]
Total events: 199 (Treatment), 203 (Control)
Test for heterogeneity: Chi² = 2.41, df = 1 (P = 0.12), I² = 58.5%
Test for overall effect: Z = 1.29 (P = 0.20)
03 Proactive and Focused
 Leeds (Psychology)        78/87              79/84         20.61      0.55 [0.18, 1.71]        
 Leeds (Volunteers)        77/90              79/84         29.26      0.37 [0.13, 1.10]        
Subtotal (95% CI) 177                168  49.88      0.45 [0.20, 0.97]
Total events: 155 (Treatment), 158 (Control)
Test for heterogeneity: Chi² = 0.23, df = 1 (P = 0.63), I² = 0%
Test for overall effect: Z = 2.03 (P = 0.04)
Total (95% CI) 399                405 100.00      0.95 [0.61, 1.48]
Total events: 354 (Treatment), 361 (Control)
Test for heterogeneity: Chi² = 7.99, df = 3 (P = 0.05), I² = 62.4%
Test for overall effect: Z = 0.22 (P = 0.82)
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Figure 5.36: Carer Satisfaction; “The staff have attended to my needs” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 55 "I received all the information I needed about the nature and causes of the patients illness" - carer      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 84/99              81/107        50.11      1.80 [0.89, 3.64]        
 Mansfield                 73/76              62/70         10.82      3.14 [0.80, 12.35]       
 London                    38/50              41/57         39.07      1.24 [0.52, 2.95]        
Subtotal (95% CI) 225                234 100.00      1.72 [1.04, 2.85]
Total events: 195 (Treatment), 184 (Control)
Test for heterogeneity: Chi² = 1.31, df = 2 (P = 0.52), I² = 0%
Test for overall effect: Z = 2.12 (P = 0.03)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 225                234 100.00      1.72 [1.04, 2.85]
Total events: 195 (Treatment), 184 (Control)
Test for heterogeneity: Chi² = 1.31, df = 2 (P = 0.52), I² = 0%
Test for overall effect: Z = 2.12 (P = 0.03)
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Figure 5.37: Carer Satisfaction; “I received all the information I needed about the nature and causes of the patient’s illness” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 56 "The staff have done everything to make the patient well" - carer                                          
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 94/99             100/106        19.90      1.13 [0.33, 3.82]        
 Oxford                   112/122            115/128        37.54      1.27 [0.53, 3.01]        
Subtotal (95% CI) 221                234  57.44      1.22 [0.60, 2.47]
Total events: 206 (Treatment), 215 (Control)
Test for heterogeneity: Chi² = 0.02, df = 1 (P = 0.88), I² = 0%
Test for overall effect: Z = 0.55 (P = 0.58)
03 Proactive and Focused
 Leeds (Psychology)        84/87              84/88         11.75      1.33 [0.29, 6.14]        
 Leeds (Volunteers)        82/90              84/88         30.81      0.49 [0.14, 1.68]        
Subtotal (95% CI) 177                176  42.56      0.72 [0.28, 1.84]
Total events: 166 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.00, df = 1 (P = 0.32), I² = 0.4%
Test for overall effect: Z = 0.68 (P = 0.49)
Total (95% CI) 398                410 100.00      1.01 [0.58, 1.76]
Total events: 372 (Treatment), 383 (Control)
Test for heterogeneity: Chi² = 1.75, df = 3 (P = 0.63), I² = 0%
Test for overall effect: Z = 0.02 (P = 0.98)
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Figure 5.38: Carer Satisfaction; “The staff have done everything to make the patient well” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 57 "I am satisfied with the type of treatment the patient received" - carer                                   
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 82/94              88/105        40.34      1.32 [0.59, 2.93]        
 Oxford                    93/112             95/118        59.66      1.19 [0.61, 2.32]        
Subtotal (95% CI) 206                223 100.00      1.24 [0.74, 2.07]
Total events: 175 (Treatment), 183 (Control)
Test for heterogeneity: Chi² = 0.04, df = 1 (P = 0.84), I² = 0%
Test for overall effect: Z = 0.82 (P = 0.41)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 206                223 100.00      1.24 [0.74, 2.07]
Total events: 175 (Treatment), 183 (Control)
Test for heterogeneity: Chi² = 0.04, df = 1 (P = 0.84), I² = 0%
Test for overall effect: Z = 0.82 (P = 0.41)
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Figure 5.39: Carer Satisfaction; “I am satisfied with the type of treatment the patient received” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 58 "They have had enough therapy" - carer                                                                     
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 66/94              60/104        38.06      1.73 [0.96, 3.11]        
 Oxford                    71/115             75/124        61.94      1.05 [0.63, 1.77]        
Subtotal (95% CI) 209                228 100.00      1.31 [0.89, 1.93]
Total events: 137 (Treatment), 135 (Control)
Test for heterogeneity: Chi² = 1.52, df = 1 (P = 0.22), I² = 34.2%
Test for overall effect: Z = 1.37 (P = 0.17)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 209                228 100.00      1.31 [0.89, 1.93]
Total events: 137 (Treatment), 135 (Control)
Test for heterogeneity: Chi² = 1.52, df = 1 (P = 0.22), I² = 34.2%
Test for overall effect: Z = 1.37 (P = 0.17)
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Figure 5.40: Carer Satisfaction; “The patient has had enough therapy” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 59 "I was given enough information about allowances available" - carer                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 75/97              69/100        18.04      1.53 [0.81, 2.90]        
 Oxford                    90/115             85/126        20.64      1.74 [0.97, 3.10]        
 Mansfield                 53/54              42/50          0.95     10.10 [1.21, 83.93]       
 London                    23/40              34/46         15.74      0.48 [0.19, 1.18]        
Subtotal (95% CI) 306                322  55.37      1.45 [1.01, 2.10]
Total events: 241 (Treatment), 230 (Control)
Test for heterogeneity: Chi² = 9.37, df = 3 (P = 0.02), I² = 68.0%
Test for overall effect: Z = 1.99 (P = 0.05)
03 Proactive and Focused
 Leeds (Psychology)        65/87              63/87         18.65      1.13 [0.57, 2.21]        
 Leeds (Volunteers)        58/89              63/87         25.98      0.71 [0.38, 1.35]        
Subtotal (95% CI) 176                174  44.63      0.89 [0.56, 1.41]
Total events: 123 (Treatment), 126 (Control)
Test for heterogeneity: Chi² = 0.93, df = 1 (P = 0.34), I² = 0%
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 482                496 100.00      1.20 [0.90, 1.60]
Total events: 364 (Treatment), 356 (Control)
Test for heterogeneity: Chi² = 12.53, df = 5 (P = 0.03), I² = 60.1%
Test for overall effect: Z = 1.25 (P = 0.21)
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Figure 5.41: Carer Satisfaction; “I was given enough information about allowances available” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 60 "Things were well prepared for their return home" - carer                                                  
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 74/93              72/96         22.49      1.30 [0.66, 2.57]        
 Oxford                    91/113             99/122        28.80      0.96 [0.50, 1.84]        
Subtotal (95% CI) 206                218  51.30      1.11 [0.69, 1.77]
Total events: 165 (Treatment), 171 (Control)
Test for heterogeneity: Chi² = 0.39, df = 1 (P = 0.53), I² = 0%
Test for overall effect: Z = 0.43 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)        69/87              67/84         21.92      0.97 [0.46, 2.05]        
 Leeds (Volunteers)        65/87              67/84         26.79      0.75 [0.37, 1.54]        
Subtotal (95% CI) 174                168  48.70      0.85 [0.51, 1.42]
Total events: 134 (Treatment), 134 (Control)
Test for heterogeneity: Chi² = 0.24, df = 1 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.62 (P = 0.54)
Total (95% CI) 380                386 100.00      0.98 [0.69, 1.39]
Total events: 299 (Treatment), 305 (Control)
Test for heterogeneity: Chi² = 1.19, df = 3 (P = 0.76), I² = 0%
Test for overall effect: Z = 0.10 (P = 0.92)
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Figure 5.42: Carer Satisfaction; “Things were well prepared for their return home” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 61 "I get all the support I need from services" - carer                                                       
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 69/89              66/94         19.85      1.46 [0.75, 2.85]        
 Oxford                    90/111             97/121        24.16      1.06 [0.55, 2.04]        
 London                    14/22              23/29          9.93      0.46 [0.13, 1.59]        
Subtotal (95% CI) 222                244  53.94      1.10 [0.71, 1.69]
Total events: 173 (Treatment), 186 (Control)
Test for heterogeneity: Chi² = 2.62, df = 2 (P = 0.27), I² = 23.7%
Test for overall effect: Z = 0.42 (P = 0.67)
03 Proactive and Focused
 Leeds (Psychology)        68/84              65/83         17.14      1.18 [0.55, 2.50]        
 Leeds (Volunteers)        57/84              65/83         28.92      0.58 [0.29, 1.17]        
Subtotal (95% CI) 168                166  46.06      0.81 [0.49, 1.34]
Total events: 125 (Treatment), 130 (Control)
Test for heterogeneity: Chi² = 1.79, df = 1 (P = 0.18), I² = 44.1%
Test for overall effect: Z = 0.84 (P = 0.40)
Total (95% CI) 390                410 100.00      0.96 [0.69, 1.34]
Total events: 298 (Treatment), 316 (Control)
Test for heterogeneity: Chi² = 5.23, df = 4 (P = 0.26), I² = 23.5%
Test for overall effect: Z = 0.23 (P = 0.82)
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Figure 5.43: Carer Satisfaction; “I get all the support I need from services” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 62 "I have received enough practical help" - carer                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 85/98              79/98         69.39      1.57 [0.73, 3.39]        
 Mansfield                 55/61              42/48         30.61      1.31 [0.39, 4.35]        
Subtotal (95% CI) 159                146 100.00      1.49 [0.78, 2.85]
Total events: 140 (Treatment), 121 (Control)
Test for heterogeneity: Chi² = 0.06, df = 1 (P = 0.80), I² = 0%
Test for overall effect: Z = 1.21 (P = 0.23)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 159                146 100.00      1.49 [0.78, 2.85]
Total events: 140 (Treatment), 121 (Control)
Test for heterogeneity: Chi² = 0.06, df = 1 (P = 0.80), I² = 0%
Test for overall effect: Z = 1.21 (P = 0.23)
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Figure 5.44: Carer Satisfaction; “I have received enough practical help” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 63 "I have received enough information about recovery and rehabilitation" - carer                             
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 84/99              72/105        40.47      2.57 [1.29, 5.10]        
 Mansfield                 67/76              59/70         27.80      1.39 [0.54, 3.58]        
 London                    37/49              37/58         31.72      1.75 [0.75, 4.07]        
Subtotal (95% CI) 224                233 100.00      1.98 [1.25, 3.14]
Total events: 188 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.17, df = 2 (P = 0.56), I² = 0%
Test for overall effect: Z = 2.90 (P = 0.004)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 224                233 100.00      1.98 [1.25, 3.14]
Total events: 188 (Treatment), 168 (Control)
Test for heterogeneity: Chi² = 1.17, df = 2 (P = 0.56), I² = 0%
Test for overall effect: Z = 2.90 (P = 0.004)
 0.1  0.2  0.5  1  2  5  10
 Favours control  Favours treatment
Figure 5.45: Carer Satisfaction; “I have received enough information about recovery and rehabilitation” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 64 "Someone has really listened" - carer                                                                      
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 82/97              64/99         53.94      2.99 [1.50, 5.95]        
 London                    32/47              29/57         46.06      2.06 [0.92, 4.60]        
Subtotal (95% CI) 144                156 100.00      2.56 [1.52, 4.31]
Total events: 114 (Treatment), 93 (Control)
Test for heterogeneity: Chi² = 0.48, df = 1 (P = 0.49), I² = 0%
Test for overall effect: Z = 3.54 (P = 0.0004)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 144                156 100.00      2.56 [1.52, 4.31]
Total events: 114 (Treatment), 93 (Control)
Test for heterogeneity: Chi² = 0.48, df = 1 (P = 0.49), I² = 0%
Test for overall effect: Z = 3.54 (P = 0.0004)
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Figure 5.46: Carer Satisfaction; “Someone has really listened” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 65 "I have not felt neglected" - carer                                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 91/99              78/103        44.11      3.65 [1.56, 8.54]        
 London                    35/46              37/58         55.89      1.81 [0.76, 4.28]        
Subtotal (95% CI) 145                161 100.00      2.62 [1.44, 4.77]
Total events: 126 (Treatment), 115 (Control)
Test for heterogeneity: Chi² = 1.29, df = 1 (P = 0.26), I² = 22.6%
Test for overall effect: Z = 3.14 (P = 0.002)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 145                161 100.00      2.62 [1.44, 4.77]
Total events: 126 (Treatment), 115 (Control)
Test for heterogeneity: Chi² = 1.29, df = 1 (P = 0.26), I² = 22.6%
Test for overall effect: Z = 3.14 (P = 0.002)
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Figure 5.47: Carer Satisfaction; “I have not felt neglected” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 66 "I have received enough emotional support" - carer                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 81/97              72/98         21.95      1.83 [0.91, 3.68]        
 Mansfield                 45/46              16/18          0.93      5.63 [0.48, 66.32]       
Subtotal (95% CI) 143                116  22.88      1.98 [1.01, 3.88]
Total events: 126 (Treatment), 88 (Control)
Test for heterogeneity: Chi² = 0.74, df = 1 (P = 0.39), I² = 0%
Test for overall effect: Z = 2.00 (P = 0.05)
03 Proactive and Focused
 Leeds (Psychology)        60/87              57/86         33.05      1.13 [0.60, 2.14]        
 Leeds (Volunteers)        51/87              57/86         44.07      0.72 [0.39, 1.34]        
Subtotal (95% CI) 174                172  77.12      0.90 [0.58, 1.39]
Total events: 111 (Treatment), 114 (Control)
Test for heterogeneity: Chi² = 0.99, df = 1 (P = 0.32), I² = 0%
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 317                288 100.00      1.14 [0.79, 1.65]
Total events: 237 (Treatment), 202 (Control)
Test for heterogeneity: Chi² = 5.48, df = 3 (P = 0.14), I² = 45.2%
Test for overall effect: Z = 0.73 (P = 0.47)
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Figure 5.48: Carer Satisfaction; “I have received enough emotional support” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 67 "I have received enough special equipment" - carer                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 76/88              69/89         77.00      1.84 [0.84, 4.03]        
 London                    30/33              34/40         23.00      1.76 [0.41, 7.68]        
Subtotal (95% CI) 121                129 100.00      1.82 [0.91, 3.64]
Total events: 106 (Treatment), 103 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.96), I² = 0%
Test for overall effect: Z = 1.69 (P = 0.09)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 121                129 100.00      1.82 [0.91, 3.64]
Total events: 106 (Treatment), 103 (Control)
Test for heterogeneity: Chi² = 0.00, df = 1 (P = 0.96), I² = 0%
Test for overall effect: Z = 1.69 (P = 0.09)
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Figure 5.49: Carer Satisfaction; “I have received enough special equipment” 
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Review: Stroke liaison workers for stroke patients and carers
Comparison: 01 Stroke Liaison Workers Versus Usual Care - Intervention Type                                               
Outcome: 68 "I know who to contact" - carer                                                                            
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Proactive and Structured
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
02 Reactive and Flexible
 Edinburgh                 91/100             80/100        34.43      2.53 [1.09, 5.87]        
 London                    31/47              45/58         65.57      0.56 [0.24, 1.33]        
Subtotal (95% CI) 147                158 100.00      1.24 [0.69, 2.20]
Total events: 122 (Treatment), 125 (Control)
Test for heterogeneity: Chi² = 6.01, df = 1 (P = 0.01), I² = 83.4%
Test for overall effect: Z = 0.72 (P = 0.47)
03 Proactive and Focused
Subtotal (95% CI) 0                  0         Not estimable
Total events: 0 (Treatment), 0 (Control)
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 147                158 100.00      1.24 [0.69, 2.20]
Total events: 122 (Treatment), 125 (Control)
Test for heterogeneity: Chi² = 6.01, df = 1 (P = 0.01), I² = 83.4%
Test for overall effect: Z = 0.72 (P = 0.47)
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Figure 5.50: Carer Satisfaction; “I know who to contact” 
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Subgroup analyses 
 
Within a systematic review, sub-grouping of trials offers a potentially useful 
method of trying to establish which aspects of an intervention are most 
effective or which patient group are likely to benefit most.  This last 
grouping according to patient characteristics is only largely possible with 
individual patient data. 
 
In order to find out which aspects of the Stroke Liaison Worker intervention 
might be effective, and which might not, an attempt was made to form 
meaningful intervention subgroups.  This sub-grouping was based on 
external or pragmatic factors rather than on a known mechanism of effect 
for the intervention.  Because individual trials were conflicting, it could not 
be clearly established which aspects of the intervention might be resulting 
in a positive benefit (170) and which might result in harm (76).  These 
subgroups were agreed by the trialists at the meeting.  They are presented 
here with their rationale and results.  Satisfaction data are presented for 
sub-grouping according to intervention type rather than for patient 
characteristics. 
 
Prior to the meeting of trialists, an attempt was made to form a 
classification based on the dominant emphasis of an intervention (education 
and information provision; social support; liaison).  In order to acquire more 
detailed information about the types of intervention, trialists were asked to 
complete a “grid” detailing different aspects of the Stroke Liaison Workers 
role and function (Appendix G).  Trials were then allocated to a subgroup 
(education and information provision; social support; liaison) according to 
the dominant emphasis of a particular trial.  Where trialists could not be 
contacted, PL and GE completed trial grids independently. 
 
The results of the trial grids is illustrated in Table 5.2 
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Results are presented in Table 5.3.  Results are discussed here where there 
was a significant subgroup or subgroup interaction. 
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Table 5.2:  Subgrouping of Trials by Primary Intervention Emphasis 
 *Both intervention arms reported by the trialist as the same 
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Glasgow ●   ● ● ●  ●  ●    ●   ●     
Preston ●    ● ● ● ●  ●   ●  ●  ● ● ● ●  
Edinburgh  ●   ●  ●  ● ● ●  ● ● ●  ● ● ● ●  
Bradford ● ● ● ●   ● ●  ●   ● ● ●  ● ●    
Adelaide ● ●  ● ● ● ●   ●  ● ● ● ●  ●     
Oxford  ●  ● ●  ●   ●     ●  ● ●    
London  ●  ● ●  ●   ●       ● ●    
Liverpool*  ●  ●   ●   ● ●      ● ● ● ●  
Leeds (Volunteer)  ●        ●       ●     
Boston (FIRST)  ●    ● ●     ● ●    ● ●    
Mansfield  ●  ● ● ● ● ●  ● ●  ●  ●  ● ●    
Utrecht  ●  ● ● ● ● ●  ● ●  ● ●   ●     
Rhode Island  ●  ● ● ● ● ●  ● ●  ● ● ●  ●     
Philadelphia (STAIR)  ●  ●      ●   ●    ● ● ● ●  
Melbourne   ●    ●   ● ●      ● ● ●  ● 
Leeds (Psychiatry Nurse)   ●       ●  ●  ●   ●     
Melbourne(SHIPS)   ●              ● ● ●   
161 
 
Primary Patient outcomes 
1. Subjective health status: Analysis of data for 3341 participants (14 
interventions) did not suggest an overall benefit from Stroke Liaison 
Worker (as before).  The subgroup providing education and 
information provision (two interventions) as the dominant emphasis 
of the service showed a positive subgroup result (SMD -0.24, 95% CI -
0.44 to -0.04, p=0.02).  Similarly the group providing liaison as the 
dominant emphasis (one intervention) suggested a benefit in the 
treatment group (SMD -0.24, 95% CI -0.47 to -0.01, p=0.04).  There 
was no benefit seen for the larger subgroup (11 interventions) whose 
dominant emphasis was on social support (SMD 0.00, 95% CI -0.07 to 
0.08, p=0.94).  Overall there was significant subgroup heterogeneity 
(p<0.05) suggesting that the contrast between social support and the 
other aspects of the Stroke Liaison role reflected a real difference in 
the intervention.   
 
Patient Satisfaction Data 
1. “Someone has really listened”: Data were available for 915 
participants from three interventions, but only one subgroup (social 
support).  Results suggest a benefit from the Stroke Liaison Worker 
intervention (OR 1.58 in favour of treatment, 95% CI 1.14 to 2.19, 
p=0.006). 
 
Carer Satisfaction Data 
1. “I received all the information I needed about the nature and causes 
of the patient’s illness”: Results for this question were available from 
459 carers in three interventions but only one subgroup (social 
support).  Results favoured the treatment group (OR 1.72, 95% CI 1.04 
to 2.85, p=0.03). 
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2. “Someone has really listened”: Data were available from 300 carers 
in two interventions, but again only one subgroup (social support). 
Results favoured the intervention group (OR 2.56, 95% CI 1.52 to 4.31, 
p=0.0004). 
 
3. “I have not felt neglected”: Results were available from two 
interventions (306 carers) in one subgroup (social support).  These 
suggested a significant benefit in favour of the intervention group (OR 
2.62, 95% CI 1.44 to 4.77, p=0.002). 
 
4. “I have received enough information about recovery and 
rehabilitation”: Results were only available for one subgroup (social 
support), three trials with 457 carers. Results demonstrate 
significantly improved satisfaction in favour of the treatment group 
(OR 1.98, 95% CI 1.25 to 3.14, p=0.004). 
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Table 5.3: Subgroup Analysis : Emphasis of Stroke Liaison Worker Intervention 
 N in 
analysis 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results   
 
   
 Education and 
Information Provision 
Social Support Liaison 
Primary Outcomes for Patients 
       
Subjective Health Status 3345 SMD -0.05 (-0.11, 0.02), p=0.18 <0.05 -0.24 (-0.44, -0.04), p=0.02# 0.00 (-0.07, 0.08), 
p=0.94† 
-0.24 (-0.47, -0.01), 
p=0.04 
Extended Activities of Daily Living 3254 SMD  0.04 (-0.03, 0.11), p=0.22 >0.05  0.12 (-0.18, 0.41), p=0.44 0.06 (-0.01, 0.14), 
p=0.10 
-0.23 (-0.48, 0.02), 
p=0.08† 
        
Secondary Outcomes for Patients 
       
Death 4183 OR  0.87 (0.72, 1.06),  p=0.17 >0.05 0.89 (0.31, 2.56), p=0.82 0.91 (0.73, 1.13), p=0.39 0.70 (0.43, 1.15), p=0.16 
Place of Residence 
(Institutionalisation) 
1146 OR  0.83 (0.51, 1.36),  p=0.46 >0.05 NA 0.80 (0.51, 1.36), p=0.46 NA 
Activities of Daily Living 3457 SMD -0.02 (-0.09, 0.05), p=0.55 >0.05 0.19 (-0.11, 0.49), p=0.21 -0.01 (-0.08, 0.06), 
p=0.79 
-0.25 (-0.47, -0.02), 
p=0.03† 
Dependence (Barthel score ≤19) 2898 OR  0.90 (0.76, 1.06),  p=0.20 >0.05 0.37 (0.15, 0.93), p=0.03 0.89 (0.75, 1.06), p=0.21 1.34 (0.77, 2.31), p=0.30† 
Depression 2945 SMD -0.05 (-0.12, 0.02), p=0.17 >0.05 -0.22 (-0.44, 0.01), p=0.06 -0.01 (-0.09, 0.07), 
p=0.78 
-0.24 (-0.49, 0.02), 
p=0.07 
Anxiety 1200 SMD -0.20 (-0.66, 0.26), p=0.39 NA NA -0.20 (-0.66, 0.26), 
p=0.39 
NA 
Participation 860 SMD -0.04 (-0.17, 0.10), p=0.59 NA NA -0.04 (-0.17, 0.10), 
p=0.59 
NA 
        
Primary Outcome for Carers 
       
Subjective Health Status 1915 SMD  0.04 (-0.05, 0.13), p=0.33† >0.05 -0.41 (-0.88, 0.05), p=0.08 0.06 (-0.03, 0.16), 
p=0.20† 
0.05 (-0.21, 0.31), 
p=0.72† 
        
Secondary Outcome for Carers 
       
Extended Activities of Daily Living 752 SMD -0.13 (-0.28, 0.01), p=0.07† NA NA -0.13 (-0.28, 0.01), 
p=0.07† 
NA 
Caregiver Mental Health 1767 SMD -0.02 (-0.12, 0.07), p=0.62 >0.05 NA -0.02 (-0.12, 0.08), 
p=0.69 
-0.05 (-0.36, 0.25), 
p=0.73 
Subgroup analysis stratified by the emphasis of the Stroke Liaison Worker intervention  
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group.) 
#Intra-group heterogeneity present, SMD = Standardised Mean Difference, OR = Odds Ratio 
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Profession of Stroke Liaison Worker 
 
The term “Stroke Liaison Worker” describes a role that spans different 
professions including Nursing, Psychology, Social Work, other Allied health 
professions or the voluntary sector.  It could be argued that differing levels 
of knowledge and skill rather than attitude alone may differentiate between 
otherwise, externally comparable roles.  This knowledge or skills may 
influence patient education and information provision, or provide more 
focused patient and carer counselling.  For this reason dividing the results 
by professional grouping seems a legitimate method of analysing the overall 
results. 
 
Trialists were asked to provide information on the professional background 
of the Stroke Liaison Worker evaluated in each trial where this was not clear 
from published data.  The professions were grouped into four distinct 
subgroups: Nurse, Psychologist, Social Worker and a final grouping of 
Generic Health Care Worker or Volunteer.  This last subgroup included trials 
where the SLW was from an Allied Health Profession, the voluntary sector or 
(in the case of some trials with more than one worker) no specific 
background but had been trained in the SLW role. 
 
Results are presented in Table 5.4.  Results are discussed here where there 
was a significant subgroup or subgroup interaction. 
 
Secondary Patient Outcomes 
1. Mental Health (Depression): Overall analysis from 15 interventions 
(2949 participants) as we have seen suggests a non-significant trend 
towards the Stroke Liaison Worker intervention being beneficial.  In 
one subgroup (nurse) this effect becomes significant (SMD -0.20, 95% 
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CI -0.34 to -0.05, p=0.007).  Subgroup heterogeneity was present with 
the Chi2 heterogeneity p<0.05 suggesting a real subgroup interaction.  
 
Patient Satisfaction Data 
The most relevant satisfaction results are listed here. 
 
1. “The staff attended well to my personal needs”: Data were available 
for 1668 participants across 6 interventions in all four subgroups.  
Overall, the results for this question did not show any significant 
results, however the nurse subgroup showed a significant effect 
suggesting less satisfaction in the Stroke Liaison Worker group (OR 
controls 0.30, 95% CI 0.10 to 0.87, p=0.03).  There was significant 
subgroup heterogeneity (p<0.05) suggesting a significant subgroup 
interaction. 
 
Carer Satisfaction Data 
1. “I know who to contact”: 305 Carers in two subgroups (Social Worker 
and Generic Health Care Worker or Volunteer) did not demonstrate 
any overall significant improvement in satisfaction for this question 
(OR 1.24, 95% CI 0.69 to 2.20, p=0.01) however one subgroup (Social 
Worker) did report a significant improvement in satisfaction (OR 2.53, 
95% CI 1.09 to 5.87, p=0.03) in the intervention group.  The other 
subgroup (Generic Health Care Worker or Volunteer) suggested a 
trend in favour of an improvement in control group satisfaction (OR 
0.56, 95% CI 0.69 to 2.20, p=0.19).  As a result there was a significant 
subgroup effect (test for heterogeneity p<0.05). 
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Table 5.4: Subgroup Analysis: Profession of Stroke Liaison Worker 
 N in 
analysis 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results    
 
   
 Nurse Psychologist Social Worker Generic Health Care 
Worker or Volunteer 
Primary Outcomes for 
Patients 
        
Subjective Health Status 3343 SMD -0.05 (-0.11, 0.02), p=0.18 >0.05 -0.07 (-0.19, 0.05), p=0.24 -0.10 (-0.23, 0.03), p=0.12  0.11 (-0.09, 0.31), 
p=0.29† 
-0.03 (-0.15, 0.10), p=0.70 
Extended Activities of 
Daily Living 
3254 SMD  0.04 (-0.03, 0.11), p=0.22 >0.05  0.07 (-0.07, 0.20), p=0.33 -0.06 (-0.19, 0.07), 
p=0.38† 
 0.13 (-0.07, 0.33), p=0.21  0.08 (-0.04, 0.20), p=0.20 
         
Secondary Outcomes 
for Patients 
        
Death 4179 OR  0.87 (0.72, 1.06),  p=0.17 >0.05  1.14 (0.66, 1.95), p=0.64†  0.74 (0.50, 1.10), p=0.14  0.66 (0.41, 1.08), p=0.10  0.97 (0.73, 1.29), p=0.83† 
Place of Residence 
(Institutionalisation) 
1122 OR  0.83 (0.51, 1.36),  p=0.46 >0.05  1.00 (0.34, 2.94), p=1.00  0.64 (0.29, 1.40), p=0.26  0.94 (0.12, 7.08), p=0.95  1.00 (0.42, 2.39), p=0.99 
Activities of Daily Living 3457 SMD -0.02 (-0.09, 0.05), p=0.55 >0.05  0.07 (-0.06, 0.20), p=0.32 -0.08 (-0.21, 0.04), 
p=0.20† 
 0.06 (-0.12, 0.24), p=0.50 -0.08 (-0.20, 0.04), 
p=0.21† 
Dependence (Barthel ≤19) 2898 OR  0.90 (0.76, 1.06),  p=0.20 >0.05  0.72 (0.52, 1.01), p=0.06  0.90 (0.64, 1.27), p=0.56  0.94 (0.65, 1.34), p=0.72  1.03 (0.77, 1.39), p=0.83† 
Depression 2943 SMD -0.05 (-0.12, 0.02), p=0.17 >0.05 -0.20 (-0.34, -0.05), 
p=0.007 
-0.04 (-0.17, 0.10), p=0.60  0.11 (-0.11, 0.32), 
p=0.33† 
-0.01 (-0.13, 0.12), p=0.92 
Anxiety 1200 SMD -0.20 (-0.66, 0.26), p=0.39 >0.05 -0.38 (-1.18, 0.42), p=0.35 NA -0.52 (-1.33, 0.29), p=0.21  0.28 (-0.51, 1.06), 
p=0.49† 
Participation 860 SMD -0.04 (-0.17, 0.10), p=0.59 >0.05 NA NA  0.02 (-0.19, 0.22), p=0.88 -0.08 (-0.25, 0.10), 
p=0.41† 
         
Primary Outcome for 
Carers 
        
Subjective Health Status 1915 SMD  0.04 (-0.05, 0.13), p=0.33† >0.05  0.05 (-0.12, .22), p=0.56†  0.05 (-0.15, 0.25), 
p=0.61† 
-0.09 (-0.37, 0.19), p=0.51  0.07 (-0.07, 0.21), 
p=0.32† 
         
Secondary Outcome for 
Carers 
        
Extended Activities of 
Daily Living 
752 SMD -0.13 (-0.28, 0.01), p=0.07† >0.05 -0.04 (-0.40, 0.32), 
p=0.84† 
-0.11 (-0.45, 0.23), p=0.52 -0.34 (-0.64, -0.03), 
p=0.03† 
-0.07 (-0.28, 0.15), p=0.54 
Caregiver Mental Health 1767 SMD -0.02 (-0.12, 0.07), p=0.62 >0.05  0.00 (-0.20, 0.20), p=0.99 -0.08 (-0.29, 0.12), p=0.41 -0.03 (-0.28, 0.22), p=0.80  0.00 (-0.15, 0.14), p=0.97 
Subgroup analysis stratified by the profession of the Stroke Liaison Worker  
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) SMD = Standardised Mean Difference, OR = Odds Ratio 
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Patient Characteristics - Subgroup analysis 
 
Patient Age 
 
Patient data were dichotomised where possible into two subgroups - under 
65s and 65 or older.  It was postulated that younger patients may have 
differing or greater psychosocial problems to older patients, and may respond 
differently to the intervention.  The results are shown in Table 5.5.  Results are 
described here where a significant subgroup exists along with a significant 
subgroup interaction.  Results for the outcome of depression are significant 
overall, however as with other subgroups, the data analysed here is only 
available from datasets that have adequate individual patient data and does 
not represent the overall dataset.  For this reason, these results are not 
discussed here. 
 
Secondary Patient Outcomes 
1. Activities of Daily Living (ADL): Results for ADL were available for 2424 
participants dichotomised by age from 11 interventions (9 trials).  
Analysis by patient age (<65 or >65) revealed one positive subgroup 
for the outcome of activities of daily living in favour of the younger 
treatment group (n=706, SMD 0.15, 95% CI 0.00 to 0.30, p=0.05).  The 
older age group had a non-significant result in favour of the control 
group (SMD -0.04, 95% CI -0.14 to 0.05, p=0.38).  Chi2 Tests for 
heterogeneity were significant (<0.05) suggesting a significant 
subgroup interaction. 
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Table 5.5: Subgroup Analysis; Patient Age 
 
 N in 
analysis‡ 
Analysis Total [95% CI] Subgroup 
heterogeneity 
(Chi2) 
Subgroup Results  
 
  Overall  Under 65 Over 65 
Primary Outcomes for Patients 
      
Subjective Health Status 2503 SMD -0.06 (-0.14, 0.01), p=0.11 >0.05 -0.09 (-0.23, 0.05), p=0.20 -0.05 (-0.15, 0.04), p=0.29 
Extended Activities of Daily Living 2122 SMD 0.08 (0.00, 0.17), p=0.06 >0.05 0.15 (-0.03, 0.32), p=0.10 0.06 (-0.04, 0.16), p=0.21 
       
Secondary Outcomes for Patients 
      
Death 2856 OR 0.88 (0.69, 1.12), p=0.29 >0.05 0.60 (0.26, 1.39), p=0.23 0.91 (0.70, 1.18), p=0.47 
Place of Residence 
(Institutionalisation) 
1227 OR 1.12 (0.76, 1.65), p=0.56† >0.05 0.75 (0.23, 2.43), p=0.63 1.18 (0.78, 1.78), p=0.43† 
Activities of Daily Living 2424 SMD 0.01 (-0.07, 0.09), p=0.76 <0.05 0.15 (0.00, 0.30), p=0.05 -0.04 (-0.14, 0.05), p=0.38† 
Dependence (Barthel ≤19) 2150 OR 0.91 (0.75, 1.11), p=0.36 >0.05 0.80 (0.56, 1.14), p=0.21 0.97 (0.77, 1.22), p=0.78 
Depression 2384 SMD -0.08 (-0.16, 0.00), p=0.05 >0.05 -0.12 (-0.26, 0.03), p=0.11 -0.06 (-0.16, 0.04), p=0.21 
Anxiety 868 SMD 0.09 (-0.84, 1.02), p=0.85† >0.05 0.09 (-0.84, 1.02), p=0.85† 0.03 (-0.67, 0.74), p=0.92† 
       
Primary Outcome for Carers 
      
Subjective Health Status 1483 SMD -0.01 (-0.11, 0.09), p=0.87 >0.05 0.06 (-0.12, 0.24), p=0.53† -0.04 (-0.16, 0.08), p=0.53) 
       
Secondary Outcome for Carers 
      
Extended Activities of Daily Living 316 SMD 0.00 (-0.22, 0.22), p=0.99 >0.05 0.20 (-0.33, 0.73), p=0.47 -0.04 (-0.29, 0.20), p=0.72† 
Caregiver Mental Health 1051 SMD -0.03 (-0.15, 0.09), p=0.65 >0.05 0.10 (-0.15, 0.34), p=0.43† -0.07 (-0.21, 0.07), p=0.33 
Subgroup analysis stratified by patient age (Under 65, 65 or older). 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
#Intra-group heterogeneity present 
SMD = Standardised Mean Difference, OR = Odds Ratio 
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Patient Sex 
Data were dichotomised on the basis of sex.  It seemed reasonable to explore 
this sub grouping as men and women may respond to differently to an 
intervention with a significant psychological and social component.  It should 
be noted that for analysis of carer data, these are analysed according to the 
sex of the patient and may not reflect the sex of the carer.  For instance a 
carer may well be a daughter looking after a mother or a wife looking after a 
husband.  Data on carer sex was inadequate across the trials to analyse 
according to carer sex.  Results are presented in Table 5.6.  No significant 
subgroups or significant subgroup interaction was observed.  As before 
results for the outcome of depression are positive, but do not represent the 
totality of data and should be treated with caution. 
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Table 5.6: Subgroup Analysis: Patient Sex 
 
 N in 
analysis‡ 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results  
 
  Overall  Male Female 
Primary Outcomes for Patients 
      
Subjective Health Status 2491 SMD -0.05 (-0.13, 0.03), p=0.20 >0.05 0.00 (-0.11, 0.10), p=0.93 -0.11 (-0.22, 0.01), p=0.08 
Extended Activities of Daily Living 2118 SMD 0.03 (-0.06, 0.11), p=0.52 >0.05 0.05 (-0.6, 0.17), p=0.36 0.00 (-0.13, 0.12), p=0.96 
       
Secondary Outcomes for Patients 
      
Death 2658 OR 0.88 (0.69, 1.13), p=0.32 >0.05 1.06 (0.75, 1.52), p=0.73† 0.75 (0.54, 1.05), p=0.09 
Place of Residence 
(Institutionalisation) 
1055 OR 1.05 (0.68, 1.61), p=0.82† >0.05 1.41 (0.68, 2.90), p=0.36† 0.90 (0.53, 1.53), p=0.69 
Activities of Daily Living 2425 SMD 0.00 (-0.08, 0.08), p=0.91 >0.05 0.04 (-0.07, 0.15), p=0.51 -0.05 (-0.17, 0.07), p=0.38† 
Dependence (Barthel ≤19) 2363 OR 0.88 (0.73, 1.06), p=0.17 >0.05 0.94 (0.74, 1.21), p=0.64 0.80 (0.60, 1.06), p=0.13 
Depression 2325 SMD -0.08 (-0.17, 0.00), p=0.05 >0.05 -0.07 (-0.18, 0.04), p=0.23 -0.10 (-0.23, 0.02), p=0.10 
Anxiety 869 SMD -0.01 (-0.56, 0.55), p=0.99 >0.05 0.02 (-0.75, 0.80), p=0.96† -0.03 (-0.84, 0.77), p=0.93 
       
Primary Outcome for Carers 
      
Subjective Health Status 1483 SMD -0.01 (-0.11, 0.10), p=0.89 >0.05 0.06 (-0.08, 0.20), p=0.39† -0.10 (-0.25, 0.06), p=0.23 
       
Secondary Outcome for Carers 
      
Extended Activities of Daily Living 316 SMD 0.02 (-0.20, 0.24), p=0.86 >0.05 0.07 (-0.22, 0.37), p=0.62 -0.05 (-0.39, 0.29), p=0.76† 
Caregiver Mental Health 1051 SMD -0.04 (-0.17, 0.08), p=0.49 >0.05 0.03 (-0.13, 0.19), p=0.73† -0.15 (-0.34, 0.05), p=0.13 
Subgroup analysis stratified by patient sex. 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group) 
#Intra-group heterogeneity present 
SMD = Standardised Mean Difference, OR = Odds Ratio 
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Presence of a Carer 
 
It is theoretically possible that patients without identified carer support might 
be at higher risk of (as we have discussed in Chapter One).  It therefore 
follows that this subgroup might benefit the most from social support aspects 
of the intervention.  Within the trials there was varied involvement of carers.  
(See Table 5.7).  Some trials (Rhode Island, Adelaide) specifically recruited 
only patients who had an identified primary caregiver.  Other studies did not 
include or record caregiver involvement at all (Glasgow).  Clearly these trials 
do not allow us to test the hypothesis that the presence or absence of an 
identified primary caregiver results in different responses to the Stroke Liaison 
Worker intervention.  For this reason, these trials have been excluded from 
this subgroup analysis.   
The quality of recording of caregiver presence and proximity of involvement 
with the patient was variable.  Two trials reported carer relationship (Oxford, 
Utrecht).  Other trials did not collect this data.  To adequately analyse these 
trials, I hypothesised that the presence of carer data recorded by trialists 
formed a proxy for the clear identification of a caregiver.  This proxy has its 
limitations, as the proximity and level of involvement of a caregiver with a 
patient may vary considerably and not be sensitively measured by this 
dichotomisation.  Nevertheless it could be postulated that a closely involved 
carer is more likely to be contactable and therefore available for simple data 
collection.  Data were therefore dichotomised according to whether a carer 
was identified (Oxford, Utrecht) or whether carer outcome data was collected.  
Results are presented here for these two subgroups.  Clearly there can be no 
comparison of carer outcomes for this subgroup analysis.  Results are 
presented in Table 5.8.  No significant subgroup or subgroup interaction was 
observed. 
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Table 5.7: Trial Involvement of Carers 
Trial  
 
 
 
 
 
 
 N
o
 C
a
re
r 
C
a
re
r 
in
cl
u
d
e
d
 
C
a
re
r 
n
e
ce
ss
a
ry
 
 
Melbourne ●   
Glasgow ●   
 
Edinburgh  ●  
Bradford  ●  
Oxford  ●  
Leeds  ●  
Nottingham  ●  
Utrecht  ●  
Sheffield  ●  
Melbourne (SHIPS)  ●  
London  ●  
Liverpool  ●  
 
Adelaide   ● 
Philadelphia   ● 
Boston   ● 
Rhode Island   ● 
 
Classification of trials by their involvement of carers.
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Table 5.8: Subgroup Analysis: Presence or Absence of Main Carer 
 N in 
analysis‡ 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results  
 
  Overall  Carer present Carer absent 
Primary Outcomes for Patients 
      
Subjective Health Status 2296 SMD -0.05 (-0.13, 0.03), p=0.26 >0.05 -0.08 (-0.18, 0.02), p=0.14 0.01 (-0.13, 0.16), p=0.88† 
Extended Activities of Daily Living 2145 SMD  0.04 (-0.04, 0.13), p=0.34 >0.05  0.06 (-0.05, 0.17), p=0.32 0.02 (-0.11, 0.15), p=0.77 
       
Secondary Outcomes for Patients 
      
Death 1965 OR  0.99 (0.75, 1.31), p=0.95 >0.05  1.05 (0.56, 1.98), p=0.88†  0.98 (0.71, 1.34), p=0.88 
Place of Residence 
(Institutionalisation) 
637 OR  1.45 (0.91, 2.32), p=0.12† >0.05  1.36 (0.68, 2.69), p=0.39†  1.55 (0.82, 2.92), p=0.18† 
Activities of Daily Living 2673 SMD -0.05 (-0.13, 0.03), p=0.21 >0.05 -0.04 (-0.13, 0.06), p=0.43 -0.07 (-0.20, 0.06), p=0.29 
Dependence (Barthel ≤19) 
 
2889 OR  0.89 (0.75, 1.05), p=0.18 >0.05  0.86 (0.68, 1.08), p=0.19  0.93 (0.72, 1.19), p=0.57 
Depression 2223 SMD -0.08 (-0.16, 0.01), p=0.08 >0.05 -0.10 (-0.20, 0.00), p=0.06 -0.03 (-0.17, 0.11), p=0.69 
Anxiety 1127 SMD  0.08 (-0.43, 0.58), p=0.76† >0.05  0.06 (-0.57, 0.68), p=0.86†  0.12 (-0.74, 0.98), p=0.78† 
       
Subgroup analysis by presence of a carer. 
Unless otherwise stated the direction of effect favours the treatment group. (†Direction of effect favours control group.) 
SMD = Standardised Mean Difference, OR = Odds Ratio 
.   
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Patient Functional Status 
 
It has been assumed in most trials that the intervention of a Stroke Liaison 
Worker should be applied to all patients regardless of their level of disability or 
functional dependence.  Data from one trial (Bradford) has previously 
suggested that patients with mild to moderate disability (as measured by - 
Barthel Index 15 - 19) make the most gains from Stroke Liaison Worker input.  
It was decided therefore to evaluate this question by functional status 
according to Barthel measurement.  Patients were divided according to their 
Barthel index at recruitment (which usually equated to their Barthel at 
discharge from hospital).  They were divided into three subgroups: Barthel 20 
(independent), Barthel 15-19 (Mild to moderately dependent) and Barthel <15 
(dependent). 
Barthel indices at recruitment varied across the trials as might be expected 
and are illustrated in Figure 5.51.  Recruitment appeared highest in the more 
independent groups as might be expected for a trial evaluating psychosocial 
interventions in a population returning to the community.  Interestingly the 
patient population appears to trichotomise relatively equally.  (Figures 5.52, 
5.53) 
Results are shown in Table 5.9.  Where a significant subgroup effect was 
seen in conjunction with a significant subgroup interaction, the results are 
discussed here. 
 
Patient Secondary Outcomes 
 
1. Dependence (Barthel ≤19): Data were analysed for 2494 participants in 
12 interventions of 10 trials.  The subgroup Barthel 15-19 had a 
significant reduction in dependence (OR 0.60, 95% CI 0.44 to 0.83, 
p=0.002).  This effect size would equate to 10 less dependent patients 
(95% CI 17 less to 4 less) for every 100 patients with mild to moderate 
disability that were seen by the Stroke Liaison Worker.  Significant 
subgroup heterogeneity existed suggesting that this subgroup was 
responding differently to the intervention than the others (Chi2 <0.05).  
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The other subgroups did not show a significant effect of the Stroke 
Liaison Worker intervention however (Barthel <15 OR 1.21, 95% CI 
0.87 to 1.68, p=0.26; Barthel 20 OR 1.01, 95% CI 0.71 to 1.44, 
p=0.94).  (Figure 5.52). 
 
2. Death or Dependence:  It was decided after analysis of dependence 
data to look at this combined outcome.  The concern was that there 
might appear to be a reduction in dependence at the expense of 
increased mortality.  Data were combined using the same dependence 
data.  Overall data for this new outcome did not show a significant 
benefit from the Stroke Liaison Worker for a reduction in Death or 
Dependence (OR 0.87, 95% CI 0.73 to 1.04, p=0.12).  A significant 
subgroup effect was again seen (Barthel 15-19) as well as subgroup 
heterogeneity suggesting that this group responded differently to the 
Stroke Liaison Worker input. (OR 0.62, 95% CI 0.47 0.83, p=0.001).  
This risk difference equates to 11 less dead or dependent patients 
(95% CI 17 less to 4 less) as a result of Stroke Liaison Worker input for 
the group with mild to moderate disability.  Results for the other 
subgroups were not significant (Barthel <15 OR 1.06, 95% CI 0.79 to 
1.40, p=0.71; Barthel 20 OR 1.10, 95% CI 0.75 to 1.59, p=0.63; Chi2 
<0.05).  (Figure 5.53). 
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Figure 5.51: Barthel Index at Recruitment 
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Table 5.9: Subgroup Analysis; Patient Dependency 
 N in 
analysis‡ 
Analysis Total [95% CI] Subgroup 
Heterogeneity 
(Chi2) 
Subgroup Results   
 
  Overall 
 Barthel <15 Barthel 15-19 Barthel 20 
Primary Outcomes for Patients        
Subjective Health Status 2268 SMD -0.03 (-0.11, 0.05), p=0.46 >0.05 -0.06 (-0.19, 0.07), 
p=0.35# 
-0.11 (-0.27, 0.04), 
p=0.16 
 0.09 (-0.06, 0.24), 
p=0.26† 
Extended Activities of Daily Living 2138 SMD -0.02 (-0.10, 0.07), p=0.69† >0.05 -0.01 (-0.13, 0.11), 
p=0.83† 
 0.02 (-0.13, 0.18), 
p=0.78 
-0.09 (-0.28, 0.10), 
p=0.38† 
        
Secondary Outcomes for Patients        
Death 2801 OR  0.85 (0.66, 1.09), p=0.20 >0.05  0.82 (0.61, 1.10), 
p=0.18 
 0.68 (0.39, 1.18), 
p=0.17 
2.26 (0.88, 5.81), 
p=0.09† 
Place of Residence 
(Institutionalisation) 
1198 OR  1.17 (0.79, 1.74), p=0.44† >0.05  1.27 (0.80, 2.00), 
p=0.31† 
 1.04 (0.45, 2.43), 
p=0.93† 
0.16 (0.00, 4.87), 
p=0.29 
Activities of Daily Living 2540 SMD  0.00 (-0.08, 0.08), p=1.00 >0.05 -0.07 (-0.19, 0.05), 
p=0.27† 
 0.09 (-0.06, 0.23), 
p=0.25 
0.01 (-0.14, 0.16), 
p=0.88 
Dependence (Barthel ≤19) 2494 OR  0.89 (0.74, 1.08), p=0.25 <0.05  1.21 (0.87, 1.68), 
p=0.26† 
 0.60 (0.44, 0.83), 
p=0.002 
1.01 (0.71, 1.44), 
p=0.94 
Death or Dependence 2225 OR  0.91 (0.74, 1.12), p=0.37 <0.05  1.45 (0.99, 2.11), 
p=0.06† 
 0.55 (0.39, 0.78), 
p=0.0008 
1.02 (0.71, 1.45), 
p=0.93 
Depression 2205 SMD -0.07 (-0.15, 0.02), p=0.11 >0.05 -0.10 (-0.23, 0.02), 
p=0.11 
-0.03 (-0.18, 0.13), 
p=0.73 
-0.06 (-0.23, 0.11), 
p=0.48 
Anxiety 826 SMD  0.07 (-0.53, 0.66), p=0.83† >0.05  0.59 (-0.50, 1.69), 
p=0.29† 
 0.37 (-0.79, 1.52), 
p=0.53† 
-0.47 (-1.36, 0.42], 
p=0.30 
        
Primary Outcome for Carers        
Subjective Health Status 1509 SMD 0.01 (-0.10, 0.11), p=0.90 >0.05 0.10 (-0.06, 0.26), 
p=0.24† 
-0.07 (-0.26, 0.12), 
p=0.47 
-0.04 (-0.23, 0.15), 
p=0.67 
        
Secondary Outcome for Carers        
Extended Activities of Daily Living 495 SMD -0.01 (-0.19, 0.16), p=0.89 >0.05 -0.02 (-0.25, 0.21), 
p=0.87 
 0.03 (-0.37, 0.43), 
p=0.87† 
-0.04 (-0.42, 0.34), 
p=0.85 
Caregiver Mental Health 1387 SMD -0.02 (-0.13, 0.09), p=0.71 >0.05  0.00 (-0.17, 0.17), 
p=0.97 
-0.13 (-0.33, 0.07), 
p=0.20 
0.05 (-0.14, 0.24), 
p=0.62† 
Subgroup analysis stratified by baseline Barthel index (Barthel <15, Barthel 15-19, or 20). 
Results shown in boxes indicate statistically significant results.  Significant subgroup Chi2 results indicate significant subgroup interaction. 
Unless otherwise stated the direction of effect favours the treatment group.  (†Direction of effect favours control group.) 
#Intra-group heterogeneity present, SMD = Standardised Mean Difference, OR = Odds Ratio 
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Review: Stroke liaison workers for stroke patients and carers
Comparison:05 Stroke Liaison Workers Versus Usual Care - Patient Functional Status                                       
Outcome: 17 Barthel Dependency                                                                                         
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Barthel <15
 Leeds (Psychology)        53/60              42/54          2.33     2.16 [0.78, 5.98]        
 Leeds (Volunteers)        52/57              42/54          1.71     2.97 [0.97, 9.10]        
 Liverpool                 20/20              27/28          0.25     2.24 [0.09, 57.75]       
 Liverpool (Psych)          8/9               27/28          0.66     0.30 [0.02, 5.29]        
 Bradford                   1/1                1/1                 Not estimable         
 Oxford                    70/79              59/73          3.16     1.85 [0.75, 4.57]        
 Mansfield                 66/95              65/90          9.21     0.88 [0.46, 1.65]        
 Boston (FIRST)            56/79              68/86          8.57     0.64 [0.32, 1.31]        
 Preston                   32/35              34/37          1.28     0.94 [0.18, 5.01]        
 Utrecht                    7/14               2/10          0.53     4.00 [0.62, 25.96]       
 London                    47/50              42/45          1.20     1.12 [0.21, 5.85]        
Subtotal (95% CI) 499                506  28.89     1.21 [0.87, 1.68]
Total events: 412 (Treatment), 409 (Control)
Test for heterogeneity: Chi² = 11.29, df = 9 (P = 0.26), I² = 20.3%
Test for overall effect: Z = 1.13 (P = 0.26)
02 Barthel 15-19
 Leeds (Psychology)        27/42              31/42          5.00     0.64 [0.25, 1.62]        
 Leeds (Volunteers)        23/40              31/42          5.81     0.48 [0.19, 1.22]        
 Liverpool                 19/27              27/31          3.37     0.35 [0.09, 1.34]        
 Liverpool (Psych)         13/16              27/31          1.56     0.64 [0.12, 3.30]        
 Bradford                  21/22              19/19          0.61     0.37 [0.01, 9.56]        
 Oxford                     6/13              10/17          2.11     0.60 [0.14, 2.58]        
 Mansfield                 16/25              19/30          2.81     1.03 [0.34, 3.10]        
 Boston (FIRST)            17/46              16/45          4.61     1.06 [0.45, 2.50]        
 Preston                   12/20              18/22          3.10     0.33 [0.08, 1.36]        
 Utrecht                   21/73              38/78         11.83     0.43 [0.22, 0.83]        
 London                    24/30              25/32          2.19     1.12 [0.33, 3.82]        
Subtotal (95% CI) 354                389  42.99     0.60 [0.44, 0.83]
Total events: 199 (Treatment), 261 (Control)
Test for heterogeneity: Chi² = 6.25, df = 10 (P = 0.79), I² = 0%
Test for overall effect: Z = 3.06 (P = 0.002)
03 Barthel 20
 Leeds (Psychology)         3/14               8/28          1.89     0.68 [0.15, 3.11]        
 Leeds (Volunteers)         7/27               8/28          2.63     0.88 [0.27, 2.87]        
 Liverpool                 19/38              10/25          2.73     1.50 [0.54, 4.17]        
 Liverpool (Psych)         11/18              10/25          1.47     2.36 [0.68, 8.15]        
 Bradford                  59/79              62/85          6.83     1.09 [0.54, 2.20]        
 Oxford                     0/3                0/1                 Not estimable         
 Mansfield                  2/6                2/4           0.72     0.50 [0.04, 6.68]        
 Boston (FIRST)             2/9                1/4           0.49     0.86 [0.05, 13.48]       
 Preston                    1/8                2/3           1.15     0.07 [0.00, 1.73]        
 Utrecht                   18/146             24/163         8.99     0.81 [0.42, 1.57]        
 London                     7/14               5/12          1.22     1.40 [0.30, 6.62]        
Subtotal (95% CI) 362                378  28.12     1.01 [0.71, 1.44]
Total events: 129 (Treatment), 132 (Control)
Test for heterogeneity: Chi² = 6.27, df = 9 (P = 0.71), I² = 0%
Test for overall effect: Z = 0.08 (P = 0.94)
Total (95% CI) 1215               1273 100.00     0.89 [0.74, 1.08]
Total events: 740 (Treatment), 802 (Control)
Test for heterogeneity: Chi² = 32.53, df = 30 (P = 0.34), I² = 7.8%
Test for overall effect: Z = 1.14 (P = 0.25)
 0.1  0.2  0.5  1  2  5  10
 Favours treatment  Favours control
Figure 5.52: Patient Dependence 
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Review: Stroke liaison workers for stroke patients and carers
Comparison:05 Stroke Liaison Workers Versus Usual Care - Patient Functional Status                                       
Outcome: 07 Death or Dependence                                                                                        
Study  Treatment  Control  OR (fixed)  Weight  OR (fixed)
or sub-category  n/N  n/N  95% CI  %  95% CI
01 Barthel <15
 Leeds (Psychology)        53/60              42/54          2.70     2.16 [0.78, 5.98]        
 Leeds (Volunteers)        52/57              42/54          1.98     2.97 [0.97, 9.10]        
 Liverpool                 20/20              27/28          0.29     2.24 [0.09, 57.75]       
 Liverpool (Psych)          8/9               27/28          0.76     0.30 [0.02, 5.29]        
 Bradford                   1/1                1/1                 Not estimable         
 Oxford                    70/79              59/73          3.66     1.85 [0.75, 4.57]        
 Mansfield                 66/95              65/90         10.67     0.88 [0.46, 1.65]        
 Preston                   32/35              34/37          1.48     0.94 [0.18, 5.01]        
 Utrecht                    7/14               2/10          0.61     4.00 [0.62, 25.96]       
 London                    47/50              42/45          1.39     1.12 [0.21, 5.85]        
Subtotal (95% CI) 420                420  23.54     1.45 [0.99, 2.11]
Total events: 356 (Treatment), 341 (Control)
Test for heterogeneity: Chi² = 7.59, df = 8 (P = 0.47), I² = 0%
Test for overall effect: Z = 1.92 (P = 0.06)
02 Barthel 15-19
 Leeds (Psychology)        27/42              31/42          5.80     0.64 [0.25, 1.62]        
 Leeds (Volunteers)        23/40              31/42          6.73     0.48 [0.19, 1.22]        
 Liverpool                 19/27              27/31          3.90     0.35 [0.09, 1.34]        
 Liverpool (Psych)         13/16              27/31          1.80     0.64 [0.12, 3.30]        
 Bradford                  21/22              19/19          0.71     0.37 [0.01, 9.56]        
 Oxford                     6/13              10/17          2.44     0.60 [0.14, 2.58]        
 Mansfield                 16/25              19/30          3.25     1.03 [0.34, 3.10]        
 Preston                   12/20              18/22          3.59     0.33 [0.08, 1.36]        
 Utrecht                   21/73              38/78         13.70     0.43 [0.22, 0.83]        
 London                    24/30              25/32          2.53     1.12 [0.33, 3.82]        
Subtotal (95% CI) 308                344  44.46     0.55 [0.39, 0.78]
Total events: 182 (Treatment), 245 (Control)
Test for heterogeneity: Chi² = 4.30, df = 9 (P = 0.89), I² = 0%
Test for overall effect: Z = 3.36 (P = 0.0008)
03 Barthel 20
 Leeds (Psychology)         3/14               8/28          2.19     0.68 [0.15, 3.11]        
 Leeds (Volunteers)         7/27               8/28          3.05     0.88 [0.27, 2.87]        
 Liverpool                 19/38              10/25          3.16     1.50 [0.54, 4.17]        
 Liverpool (Psych)         11/18              10/25          1.70     2.36 [0.68, 8.15]        
 Bradford                  59/79              62/85          7.92     1.09 [0.54, 2.20]        
 Oxford                     0/3                0/1                 Not estimable         
 Mansfield                  2/6                2/4           0.84     0.50 [0.04, 6.68]        
 Preston                    1/8                2/3           1.33     0.07 [0.00, 1.73]        
 Utrecht                   18/146             24/163        10.41     0.81 [0.42, 1.57]        
 London                     7/14               5/12          1.41     1.40 [0.30, 6.62]        
Subtotal (95% CI) 353                374  32.00     1.02 [0.71, 1.45]
Total events: 127 (Treatment), 131 (Control)
Test for heterogeneity: Chi² = 6.25, df = 8 (P = 0.62), I² = 0%
Test for overall effect: Z = 0.09 (P = 0.93)
Total (95% CI) 1081               1138 100.00     0.91 [0.74, 1.12]
Total events: 665 (Treatment), 717 (Control)
Test for heterogeneity: Chi² = 31.55, df = 27 (P = 0.25), I² = 14.4%
Test for overall effect: Z = 0.90 (P = 0.37)
 0.1  0.2  0.5  1  2  5  10
 Favours treatment  Favours control
Figure 5.53: Patient Death or Dependence 
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Discussion 
 
Individual data meta-analysis confers considerable advantage in unpacking 
the potential benefits or harms of an intervention.  At a statistical level, it 
is less likely to overestimate the effect of an intervention, but also gives 
narrower confidence intervals, reducing the chance of missing a real benefit 
or harm (313).  They permit a greater understanding of the studies involved, 
which is vital where the interventions and trials are complex, as in this case.  
Additionally they allow greater flexibility in exploring subgroups (313).  This 
is important in this case as little is understood regarding the underlying 
mechanism of potential benefit for Stroke Liaison Workers and therefore it 
is hard to identify which intervention characteristics are most important and 
additionally which patient subgroup if any are most likely to benefit.  
However individual patient data meta-analysis is considerably more 
complex.   
Meta-analysis is secondary analysis of research where ethics approval has 
already been obtained.  Despite that however, some trialists did run into 
difficulties in sharing their data.  Two studies (Boston, Adelaide) described 
having to have permission to share their data with a third party.  In one case 
(Adelaide), the ethics committee would not give permission to share 
anonymised individual patient data with the collaborative group.  Instead, 
data for subgroup analysis were provided in aggregate form on request from 
the lead author.  In one case (Boston) awaiting approval from the data 
review board took approximately one year and represented considerable 
delay for the review process. 
 
It is important to state that in the planning of this analysis, the lack of a 
theoretical or pathophysiological rationale for Stroke Liaison Workers 
affected the selection of appropriate primary outcome measures.  Given 
that this is a broad or comprehensive intervention for a wide range of 
problems, it was unclear from the published trials (76;167;170;297) which 
outcome might be expected to be impacted most.  As a result, the published 
trials evaluated different primary outcome measures from activities of daily 
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living (101), satisfaction (296;297),  subjective health status (170;295) and 
extended activities of daily living (70) or none at all (76).  For this reason, 
two primary outcome measures were chosen, as it was argued that if the 
Stroke Liaison Workers aim was to return patients to normal roles that this 
might be measured in activities and perceived health.  It remains a relevant 
potential criticism that we chose the wrong outcome measure to evaluate 
effectiveness and that Stroke Liaison Workers might have an unanticipated 
impact in an entirely different domain. 
The intervention of a Stroke Liaison Worker did not affect the primary 
outcomes of subjective health status or extended activities of daily living.  
The implication is that patients who were seen by the Stroke Liaison Worker 
did not feel their health or quality of life to be better than controls, and 
they were not more independent.  There are two potential explanations for 
failing to demonstrate an impact.  The first concerns the intervention itself.  
The second concerns matters of methodology. 
The criticism of the intervention might appropriately be that it is poorly 
focused and too broad or diffuse to impact a single, specific outcome.  
Because these interventions were developed on a practical and intuitive 
basis, as has already been said, they lack a clear underlying mechanism of 
action.  This development of services to meet a wide range of problems post 
stroke may have been too ambitious and as a consequence poorly focused.  
The provision of information and education is a real need with a wider 
evidence base than in this review alone (133).  The impact of information 
might reasonably be expected to be measured in satisfaction first, rather 
than in behaviour change (as we have seen from Chapters One and Two).  
Liaison as a service offered for patients may be difficult to measure and is 
perhaps poorly addressed in the Stroke Liaison Worker trials.  It might be 
reasonable to expect that liaison between the patient and community 
services or health services might be measured in resource use.  
Unfortunately we were unable to assess resource use in this review due to a 
lack of standardised measures.  In addition the meaning of increased 
resource use must be evaluated.  It is unclear whether increased uptake of 
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community services for instance means increased access and enhanced 
resources, or conversely an increasing dependence.  Similarly in a health 
care context, it would be difficult to tell from crude data whether increased 
use of medical and therapy resources meant an attitude of active and self 
motivated health care or simply increasing ill health.  Social support, whilst 
being potentially hardest to define, may in fact be the one outcome that 
has the most measures of effectiveness.  Many of these outcomes are 
surrogates (e.g. measures of mental health, self efficacy, satisfaction, 
participation) and poorly correlated with what is a diffuse and poorly 
defined entity.  Some trials have tried to be more specific about social 
support and have included counselling as part of the intervention (101;257).  
Whilst it might be expected that this would more directly impact some 
measures (e.g. depression, anxiety etc.) it has not been so clear in either 
the trials or the review process. 
It has been assumed that all patients have information needs and share 
many of the psychological and social problems post stroke.  Similarly it has 
been assumed that the intervention should be targeted at all patients 
regardless of age, sex or stroke severity.  This assumption does not 
adequately take into consideration differences in risk between patients in 
terms of (for example) the onset of post stroke depression, social isolation, 
anxiety etc.  Patient subgroup analysis was only possible for those 
identifiers that allow division of patients into groups (e.g. age, sex, Barthel 
at recruitment etc.).  These patient descriptors may not adequately 
correlate with the risks of a poor outcome (e.g. age and depression) and 
therefore may not subdivide patient subgroups according to meaningful 
groups.  Despite these shortfalls, and because of the existing limitations 
with the data the subgroup analysis by age, sex, Barthel and the presence of 
a carer seems a robust and plausible exploration of the data.   
Only one study (Melbourne) recruited patients more than six months after 
stroke.  Data for this study were only obtained from published data for 
limited numbers of outcomes.  For this reason subgroup analysis for this 
description was felt to be unhelpful. 
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Subgroup analysis within the review process highlights some interesting 
areas of differences that may be important and may identify important 
aspects of either the intervention or the target population.  It is recognised 
in observational studies and trials that multiple analyses carry the risk of 
false positive results.  This risk should be lessened in meta-analysis, 
nevertheless it still remains a risk with multiple subgroup analyses.  For this 
reason we have only considered subgroup results where there is both a 
significant subgroup effect and a significant subgroup interaction. 
Analysis of the intervention effect by emphasis of the intervention highlights 
some differences between the intervention types that may be important.  In 
the analysis of subjective health status for instance, two subgroups 
(education and information provision as well as liaison) were significant in 
favour of the intervention, whilst one subgroup (social support) was non 
significant.  Importantly, the subgroups varied in size, with the education 
and information provision subgroup containing two studies, and the Liaison 
group containing only one.  The social support group contained 10 
interventions from eight trials.  The differences between the groups could 
be potentially accounted for by “regression to the mean” where the larger 
subgroup has more neutral results.  Heterogeneity tests were positive, 
suggesting that a subgroup interaction exists and that the subgroups are 
behaving differently for this outcome.  There is a risk of over interpreting 
subgroup data and given the overall non-significant result for Stroke Liaison 
Workers we cannot necessarily conclude that any one subgroup is effective.  
Despite this it is possible to conclude that interventions with a strong 
emphasis on social support are less effective at impacting subjective health 
status.   
Analysis of the same data by the profession of the Stroke Liaison Worker 
reveals a few interesting findings.  Patients whose Stroke Liaison Worker 
was a nurse by professional background appear to have a significant 
reduction in depression score when compared to controls.  This effect also 
differed significantly from the other subgroups suggesting that the 
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intervention, when delivered by a nurse, differed in nature from 
interventions delivered by other professions.    
If the intervention itself is does not appear to be effective for all patients, 
it is reasonable to explore patient subgroups to establish which groups of 
patients (if any) benefit, and which do not.  Analysis by age suggested 
differences between the two subgroups in how they responded to the Stroke 
Liaison Worker in the area of ADL.  Younger patients appeared to benefit in 
improvement in ADL score in the group reviewed by the Stroke Liaison 
Worker.  In addition, heterogeneity tests were positive suggesting that the 
younger (<65) and older (≥65) patients respond differently to the 
intervention of a Stroke Liaison Worker.  It is not possible to say whether 
these differences relate to differences in the way the Stroke Liaison Workers 
treated patients who were younger, or more probably because there are 
important differences in the patient group examined. 
Analysis of data by the presence or absence of a carer could be criticized for 
our choice of a surrogate for carer involvement.  The absence of data for a 
primary carer does not mean the absence of a good caregiving network.  
This may be a reason that no significant differences were found between 
the two subgroups.  Equally, the impact of a Stroke Liaison Worker’s social 
support on the effects of social isolation may be small.  Arguably, several 
short visits from a Stroke Liaison Worker may not be enough to mitigate 
against the risks of social isolation, depression and mortality that appear to 
be associated with reduced social support.  In an exploration of the 
difference between those who have a carer and those who do not, we 
compared the mortality of patients who had a carer with those who did not.  
Treatment and control groups were combined for each subgroup.  Results 
were striking, with patients who had an identified carer having a 90% 
reduction in mortality compared with those who did not have an identified 
carer (OR 0.10, 95% CI 0.07 to 0.15, p<0.00001).  These results must be 
treated with caution for a number of reasons.  Firstly, because 
heterogeneity tests were strongly positive (p<0.00001), largely due to one 
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trial (Oxford) that had a disproportionate difference in mortality in favour 
of those with carers.  Removal of this study from the analysis still results in 
an overall positive effect, but without the heterogeneity (OR 0.21, 95% CI 
0.14 to 0.31, p<0.00001, Chi2 heterogeneity p>0.05).  Secondly, and most 
importantly, this research methodology is not appropriate for exploring the 
relationship between risk and outcome in cohorts of patients.  Thirdly, the 
effect size is greater than that previously identified in the literature (37-
39;52).  Fourthly, patients enrolled in this study are not necessarily 
representative of the wider stroke population.  Patients may have been 
randomised who were considered isolated or at high risk.  Additionally, as 
we have already said the absence of data for a carer does not directly 
equate with reduced or absent social support.  We have assumed it to be 
suggestive, but cannot infer more than this.  Patients without carer data 
may have been more dependent and therefore not directly comparable to 
patients who had carer data.  It may be that this relationship between the 
presence of a strong carer relationship and mortality should be explored 
further in carefully designed cohort studies.  Key to the design of these 
studies must be some robust description or measure of the degree of social 
support. 
The final patient subgrouping is the functional status of the patient at 
recruitment.  This subgrouping was suggested by one of the trials (Bradford 
(167)) as identifying patients who would benefit most.  This trial had 
suggested that patients with mild-moderate dependence (Barthel 15-19) 
benefited most.  For this reason, we have used the same definitions of 
dependence.  It is plausible that patients with severe dependence may make 
minimal gains with information provision.  Similarly patients who are 
dependent may already have established connections with services (such as 
carers, social work, primary care etc.) and may have little to gain from 
liaison input.  Alternatively, you might expect that caregivers of patients 
who are dependent would need the most support and might be the most 
satisfied.  By contrast, independent patients might be expected to have the 
least risk of depression or morbidity, and the least to gain from social 
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support or liaison.  The finding of a reduction in dependence (or an increase 
in the number who were independent in ADL) was in some respects 
surprising.  The intervention was primarily a psycho-social one and was not 
expected to impact physical outcomes.  As has already been said, there was 
concern that the reduction in dependence could be at the expense of an 
increase in mortality.  For this reason a post hoc analysis of a combined 
outcome of death or dependency was considered necessary in order to rule 
out this concern.  This result was also considered surprising.   The effect 
size of this reduction in death or dependence is considerable equating to 11 
fewer dead or dependent patients for every 100 patients treated.  The 
mechanism of this effect is not clear.  It is interesting to note that the 
review of Early Supported Discharge after stroke also found that patients 
with mild to moderate disability (Barthel 10-20) made the most gains with 
Early Supported Discharge resulting in reductions in death or disability 
(223).  It is interesting to postulate whether the improvement seen in this 
group reflects the impact of the Stroke Liaison Worker per se (as opposed to 
any other form of rehabilitation intervention) or whether it reflects the 
sensitivity of this particular patient group to rehabilitation and to potential 
gains in independence.  None of the studies in the Stroke Liaison Worker 
review appears to have had input from an Early Supported Discharge 
service.  There may be potential benefit from further research exploring the 
rehabilitation potential of this patient subgroup and the most appropriate 
design of rehabilitation interventions. 
Data for the outcome of satisfaction appear to provide the only overall 
statistically significant results for the intervention.  Patients responded 
significantly to only one question: “Someone has really listened”.  This 
response would potentially fit well with the social support intentions of the 
intervention.  It is interesting to note however that there are a number of 
patient responses that show a trend towards significance in favour of the 
control group (“I have been treated with kindness and respect”, “I was able 
to talk to the staff about any problems I had” and “I am satisfied with 
outpatient services”).  There may be more than one explanation for these 
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findings (although in the absence of statistical significance we must be 
cautious about drawing conclusions).  One possible explanation is that in 
simple terms patients were as satisfied with the intervention as those who 
did not receive it.  One additional potential explanation reflects the 
complexity of using satisfaction as an outcome measure.  Satisfaction, it 
might be argued, is based in part on a participant’s expectations.  If 
expectations are low, participants may express high satisfaction with what 
is delivered.  If expectations are raised for example by a Stroke Liaison 
Worker educating patients on the importance of treatment and 
investigation, it might be expected that patients become less satisfied with 
service provision (e.g. outpatient services).  In addition, it is recognised that 
satisfaction questionnaires have a ceiling effect and that they may not be 
sensitive to discriminate between groups if overall satisfaction is high. 
Interestingly, carers appear to express satisfaction more frequently than 
patients.  The responses that reach significance appear to be related to the 
nature of the intervention and are therefore plausible.  For example the 
response - “I have received enough information about recovery and 
rehabilitation” and the response “I have received all the information I 
needed about the causes of the patient’s illness” would plausibly fit with 
the education and information provision aspects of the intervention.  
Similarly, the response “Someone has really listened” would fit with the 
social support aspects of the intervention and the response “I have not felt 
neglected” would fit with the liaison aspects of the service.  In some cases 
however the positive results are drawn from only two studies studying 
approximately 300 carers.  The results, although statistically significant are 
not robust, and the addition of as few as 10 positive responses to the control 
group could result in a change to a non-significant result (“Someone has 
really listened”). 
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Group details 
The Stroke Liaison Workers Collaboration are (in study alphabetical order): 
Michael Clark (Adelaide), Martha Fay, Thomas Glass (Boston - FIRST), Anne 
Forster (Bradford), Martin Dennis, Suzanne O’Rourke (Edinburgh), Graham 
Ellis, Peter Langhorne (Glasgow), Allan House (Leeds), Michael Leathley, 
Anil.Sharma, Caroline Watkins (Liverpool), Kate Tilling, Catherine Coshall, 
Charles Wolfe (London), Nadina Lincoln (Mansfield), Judith Frayne 
(Melbourne – SHIPS), Jonathan Mant (Oxford), Arthur Gershkoff (Philadelphia 
- STAIR), Chris Burton (Preston), Ivan Miller, Duane Bishop (Rhode Island), 
Han Boter, Thora Hafsteinsdottir (Utrecht). 
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Table 5.10: Study Characteristics - Adelaide 
Trial Location Adelaide      
Study 
methodology 
Randomised controlled trial. 
Randomisation Centralised randomisation procedure. 
Recruitment  Stroke patients and carers recruited from a stroke 
rehabilitation unit in Adelaide within two weeks of 
stroke onset (n=62 patients and 62 carers). 
Exclusion criteria Exclusion criteria: severe communication problems, poor 
English language, cognitive impairment and ongoing care 
or rehabilitation needs. 
Inclusion criteria Inclusion criteria: Confirmed stroke, co-resident with 
spouse and returning to the community. 
Patient 
characteristics 
Mean age 71 (SD 9) controls, 73 (SD 9) experiment, 
approximately 60% male. 
Intervention The intervention comprised an information package and 
three visits from a Social Worker trained in family 
counselling techniques.  Visits lasted on average one 
hour.  Final visits were conducted at five months. 
Comparison Control group patients and their spouses did not receive 
the information pack or the visits from the Social 
Worker.    
Outcome 
assessment 
Follow up was at six months, conducted by a research 
nurse independent of the interventions.  No blinding is 
described.  Patient outcomes assessed were: Subjective 
health status (SF-36); extended activities of daily living 
(Adelaide activities profile); Activities of daily living 
(Barthel); Mood (Geriatric Depression Score, Hospital 
Anxiety and Depression Scale - Anxiety component); 
McMaster Family Assessment Device Global Function 
Scale- Mastery Scale). 
Carers Involvement of a spouse was compulsory for entry into 
the study.  Carer outcomes were: Subjective health 
status (SF36; McMaster Family Assessment Device Global 
Functioning Scale).   
Allocation 
concealment 
A=adequate* 
Data Aggregated data was available on request. 
Publication 
status 
Published 
  
*Cochrane criteria
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Table 5.11: Study Characteristics - Boston 
Trial Location Boston (FIRST) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Centralised randomisation by computer generated 
random numbers and remote, telephone allocation.  
Recruitment  Stroke patients recruited from inpatient stroke unit care 
within 30 days of event. 
Exclusion criteria Exclusion criteria: age less than 45; resident out with 
area; terminally ill; severe communication problems; 
cognitive impairment; poor English language; 
institutional care; social isolation. 
Inclusion criteria Inclusion criteria: Confirmed stroke of mild or moderate 
severity; competent to consent. 
Patient 
characteristics 
(n=291, Mean age 70, Male 49%) 
Intervention Intervention: The intervention was provided by a clinical 
psychologist or a social worker who were formally 
trained.  The emphasis of the intervention was on 
recruiting families and naturally occurring social 
networks rather than formal or community-care based 
services.  15 Intervention visits were made according to 
protocol (approximately 90 minutes in duration). 
Comparison Control: The control group received usual care (not 
defined).  
Outcome 
assessment 
Outcome assessment was conducted at 3 and 6 months 
by a blinded outcome assessor. Patient outcome 
measures: These included Activities of daily living 
(Barthel, Instrumental activities of daily living); 
Dependency (Physical performance test); Mood (Centre 
for Epidemiological Studies Depression Scale CESD); 
Cognition (A cognitive summary score); Perceived health 
status (Self-rated health and quality of life). 
Carers Involvement of a carer was not compulsory. 
Allocation 
concealment 
A=adequate* 
Data Individual patient data obtained. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.12: Study Characteristics - Bradford 
 
Trial Location Bradford         
Study 
methodology 
Randomised controlled trial. 
Randomisation Allocation by random number tables and carried out by 
assistant not connected to study. 
Recruitment  Patients were obtained from hospital and primary care 
within six weeks of stroke (n=240). 
Exclusion 
criteria 
Exclusion criteria: Cognitive impairment; poor prognosis 
or placement in institutional care. 
Inclusion criteria Inclusion criteria: Acute stroke with some disability; 
aged over 60 and able to give informed consent.   
Patient 
characteristics 
Mean age 73 (SD 7), Male 53%. 
 
Intervention Intervention:  The intervention was delivered by senior 
nurses who visited 7 times according to a protocol and 
provided information, advice and support. 
Comparison Control:  The control group received no visits. 
Outcome 
assessment 
The outcomes were assessed at 3, 6 and 12 months. No 
blinding was attempted. 
Patient outcomes: Extended activities of daily living 
(Nottingham extended ADL); Activities of daily living 
(Barthel); Dependency (Functional ambulatory 
category); Subjective health status (Nottingham health 
profile). 
 
Carers Involvement of a carer was not compulsory.  Carer 
outcomes: Mental health and Subjective health status 
(GHQ28); Extended activities of daily living (Frenchay 
activities index). 
Allocation 
concealment 
A=adequate* 
Data Individual patient data obtained 
Publication 
status 
Published 
  
*Cochrane criteria
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Table 5.13: Study Characteristics - Edinburgh 
 
Trial Location Edinburgh 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Allocation by remote computer generated random 
numbers. 
Recruitment  Patients were recruited from both inpatient and 
outpatient settings within 30 days of stroke onset.  
Patient blinding was achieved through a process of 
delayed consent. 
Exclusion 
criteria 
 
Inclusion criteria  
Patient 
characteristics 
Number recruited = 417, mean age 68 (SD13), 50% male 
Intervention Intervention:  The intervention was delivered by a social 
worker, who contacted patients on average four times 
to provide social support, counselling and to identify 
unmet needs requiring services.   
Comparison Control:  Control patients received usual care which did 
not include contact with the stroke family care worker 
until after final follow up had been completed at six 
months. 
Outcome 
assessment 
Outcomes were recorded by a research psychologist 
blinded to treatment allocation at six months.  Patient 
outcomes: Extended activities of daily living (Frenchay 
activities index FAI); Activities of daily living (Barthel), 
Dependency (Oxford handicap scale); Mental \Health 
(GHQ30, Hospital Anxiety and Depression Scale, Mental 
adjustment to stroke scale, medical coping modes 
questionnaire); Satisfaction (Pound satisfaction scale). 
Carers Involvement of a carer was not compulsory.  Carer 
outcomes: Subjective health status (Caregiver hassles 
scale); Extended activities of daily living (Frenchay 
activities index, social adjustment scale); mental health 
(GHQ28); Satisfaction (Pound satisfaction scale).  
 
Allocation 
concealment 
A=adequate* 
Data Individual patient data was obtained for most outcomes. 
Publication 
status 
Published 
  
*Cochrane criteria
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Table 5.14: Study Characteristics - Glasgow 
 
Trial Location Glasgow 
Study 
methodology 
Randomised Controlled Trial. 
 
Randomisation Allocation by remote random number generation and 
sequentially numbered opaque envelopes. 
Recruitment  Patients were recruited on discharge from outpatient 
clinics and rehabilitation facilities.   
Exclusion 
criteria 
Exclusion:  Major illness; cognitive impairment; severe 
communication disorder. 
Inclusion criteria Inclusion criteria: Clinical diagnosis of stroke or TIA; 
presence of at least one modifiable risk factor; able to 
give informed consent.   
Patient 
characteristics 
Number = 205, mean age = 65 (SD 9), male = 51% 
Intervention Intervention:  Intervention patients received three 
appointments (30 minutes each) with a nurse to discuss 
lifestyle, risk factors and recovery from stroke.  In 
addition patients were given written information specific 
to them regarding risk factor targets etc. 
Comparison Control:  Control patients received one meeting with the 
stroke nurse to discuss risk factors prior to recruitment. 
Outcome 
assessment 
Outcomes were assessed at 5 months by a research nurse 
blinded to treatment allocation.  Outcomes:  Cumulative 
risk factor control; individual risk factor control; 
Subjective health status (Euroqol); mood (Geriatric 
Depression Scale) and satisfaction (Pound satisfaction 
scale). 
Carers Carers were not involved in this study. 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria
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Table 5.15: Study Characteristics - Leeds 
 
Trial Location Leeds     
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Remote random number sequence generation and 
telephone allocation. 
Recruitment  Patients were identified from admissions to hospital 
(n=450).  Consent was obtained after randomisation.  
Patients were blinded to other treatment or control 
arms. 
Exclusion 
criteria 
Exclusion criteria: Subarachnoid haemorrhage; too ill; 
poor communication; poor English language ability; 
cognitive impairment; serious concurrent illness. 
 
Inclusion criteria Inclusion criteria: First or recurrent stroke, local to area 
and able to give consent. 
 
Patient 
characteristics 
Mean age was 71 (SD 12), 54% male.   
Intervention The trial tested two separate interventions and one 
control group.  Psychology Intervention: The psychology 
arm of this trial was delivered by Psychiatric Nurses who 
aimed to improve patient's problem solving skills by 
working with patients at fortnightly visits.  The 
Pyschiatric Nurses were supervised fortnightly by a 
Senior Psychiatrist.  Volunteer Intervention: Volunteers 
were recruited through local charities and self help 
groups.  All attended a training session on the 
consequences of stroke. 
Comparison Control: Patients in the control group received usual 
care, although this was not standardised. 
Outcome 
assessment 
Outcomes were measured at 6 and 12 months by an 
outcome assessor blinded to patient allocation. 
Carers Involvement of a carer was not compulsory.   
Allocation 
concealment 
A=adequate* 
Data Individual patient data obtained from trialists. 
Publication 
status 
This study is published in abstract form only. 
 
  
*Cochrane criteria 
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Table 5.16: Study Characteristics - Liverpool 
Trial Location Liverpool 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Allocation by remote computer generated random 
numbers and telephone randomisation. 
Recruitment  Participants were recruited at discharge from hospital 
following admission with stroke to a larger multi centre 
study (Life after Stroke). 
Exclusion 
criteria 
 
Inclusion criteria  
Patient 
characteristics 
 
Intervention Three separate interventions were evaluated singly or in 
combination for this study.  They include the evaluation 
of a Stroke Family Support Worker (Social Intervention), 
a Psychologist (Psych) and an Occupational Therapist 
(Physical).  Only the social and psychological arms of 
this study have been used for analysis, where these 
were conducted alone and in comparison to the control 
group.  Social Intervention:  This involved the input of a 
Stroke Family Support Worker to provide verbal and 
written information, informal counselling and social 
support as well as liaison with other services.  On 
average the SFSW made 4 contacts per patient by 
telephone or visit. 
Psychology Intervention: The intervention was delivered 
by a Psychology Assistant, working under the supervision 
of an experienced Clinical Psychologist. It included 
assessing a patient’s mental and emotional state and 
delivering cognitive behavioural therapy for the patient 
as well as problem solving for the whole family.  On 
average the psychologists made 10 visits per patient. 
Comparison Control group:  The control group received usual care 
which did not include the Family Support Worker, 
Psychologist or the Occupational Therapist. 
Outcome 
assessment 
Outcomes were assessed at 12 months.  
Carers Involvement of a carer was not compulsory.   
Allocation 
concealment 
A=adequate* 
Data Individual patient data obtained. 
Publication 
status 
This study remains unpublished at this time. 
  
*Cochrane criteria 
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Table 5.17: Study Characteristics - London 
 
Trial Location London 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Allocation by fax to remote centre with computer 
generated random number table. 
Recruitment  Participants were recruited from admissions to hospital 
with first-in-a-lifetime stroke (n=340). 
Exclusion 
criteria 
Exclusion criteria: Unable to consent due to poor 
prognosis, cognitive impairment or poor communication 
and where assent was not available. 
Inclusion criteria Inclusion criteria: First stroke and resident in local area.
  
 
Patient 
characteristics 
Mean age was 78 (SD 10), 42% male. 
Intervention Intervention: A Stroke Association Family Support 
Organiser, offering emotional support, information and 
liaison to services and voluntary agencies.  They made 
contact, primarily through visits on average  15 times. 
Comparison Control:  The control group received no input from the 
Family Support Organiser but could receive usual care 
including other agency involvement. 
Outcome 
assessment 
Outcomes were evaluated at 12 months by a blinded 
outcome assessor.   
Patient outcomes:  Extended Activities of Daily Living 
(Frenchay Activities Index); Death; Residence; Activities 
of daily living (Barthel); Mood (Hospital Anxiety and 
Depression Scale); Participation (Reintegration to 
Normal Living Index); Satisfaction (Pound Satisfaction 
Scale); Hope and Acceptance scale. 
Carers Involvement of a carer was not compulsory. 
Carer outcomes: Subjective Health Status (Caregiver 
Strain Index); Extended activities of daily living 
(Reintegration to normal living index); Mental health 
(Hospital anxiety and depression scale); Hope and 
acceptance. 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.18: Study Characteristics - Mansfield 
 
Trial Location Mansfield    
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Telephone allocation from remote, computer generated 
list of random numbers. 
Recruitment  Patients admitted to hospital with an acute stroke 
(n=250).   
 
Exclusion 
criteria 
Exclusion criteria: Unconscious on admission; 
Institutional care; Severe disability; Resident outwith 
local area. 
Inclusion 
criteria 
Inclusion criteria: Confirmed stroke within 4 weeks of 
onset. 
Patient 
characteristics 
Mean age 69 (SD 11), 54% male. 
Intervention Intervention: A Psychologist with training by the Stroke 
Association as a Family Support Organiser delivered an 
information pack, and identified unmet information 
needs, concerns and emotional needs.  In addition they 
acted as liaison to the stroke team.  The FSO visited on 
average twice with additional telephone liaison.  The 
intervention was provided for up to 9 months. 
Comparison Control: Control group patients received no contact 
from the Family Support Organiser. 
Outcome 
assessment 
Outcomes were recorded at 4 months and 9 months by 
an independent assessor who was blinded to treatment 
allocation.  Patient outcomes: Subjective health status 
(GHQ12); Extended activities of daily living (Nottingham 
extended ADL); Activities of daily living (Barthel); 
Mental health (GHQ12); Satisfaction (Modified Pound 
satisfaction scale). 
Carers Involvement of a carer was not compulsory. 
Carer outcomes: Subjective health status (Carer strain 
index); Mental health (GHQ12); Extended activities of 
daily living (Nottingham extended ADL). 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.19: Study Characteristics - Melbourne 
 
Trial Location Melbourne 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Methods of allocation and randomisation are not 
defined. 
Recruitment  Patients were recruited from a previous population 
incidence study, two years after the onset of stroke. 
(N=213). 
Exclusion 
criteria 
 
Inclusion 
criteria 
Stroke (patients were recruited from a previous 
population incidence study). 
Patient 
characteristics 
 
Intervention Intervention:  This was provided by a social worker who 
provided liaison with health and community services and 
social support.  On average seven visits to a clients 
home were carried out. 
Comparison Control: The control group had no social work input. 
Outcome 
assessment 
Outcomes were recorded at one year.  No attempt was 
made at blinding outcome assessment. 
Patient Outcomes: Death; Days in Institutional care, 
local, undefined measures of activities of daily living 
and dependency. 
Carers  
Allocation 
concealment 
B=unclear* 
Data Published data only.  No successful contact could be 
made with the authors. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.20: Study Characteristics – Melbourne (SHIPS) 
 
Trial Location Melbourne (SHIPS) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation No information was available on methods of 
randomisation or allocation concealment. 
Recruitment  Patients were recruited from hospital (n=96). 
Exclusion 
criteria 
 
Inclusion criteria  
Patient 
characteristics 
 
Intervention Intervention: Regular visits and phone calls from a nurse 
who provides support, education and liaison to patients 
and carers. 
Comparison Control: Patients and caregivers in the control group 
received no home visits until after the end of the nine 
month trial follow up. 
Outcome 
assessment 
Patient outcomes: Subjective health status (Assessment 
of quality of life scores); Activities of daily living 
(Barthel); Dependency (Modified Rankin score); health 
service usage. 
Carers Carer involvement does not appear to have been 
compulsory. 
Allocation 
concealment 
B=unclear* 
Data  
Publication 
status 
This study finished early due to funding shortages.  No 
individual patient data was available.  This data remains 
unpublished. 
  
*Cochrane criteria
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Table 5.21: Study Characteristics - Oxford 
 
Trial Location Oxford 
Study 
methodology 
Randomised controlled trial. 
Randomisation Allocation by telephone randomisation to remote 
individual; with sequentially numbered opaque 
envelopes. 
Recruitment  Patients were recruited from hospital presenting within 
six weeks of  stroke. 
Exclusion 
criteria 
Exclusion criteria: Institutional care, dominant medical 
problems or severe illness. 
Inclusion criteria Inclusion criteria: Confirmed stroke aged 18 or over local 
in area and with close family carer. 
Patient 
characteristics 
(n=323, mean age = 74 (SD 13), 52% male).   
 
Intervention Intervention: Patients assigned to the intervention group 
were visited by the Family Support Organiser (trained by 
the Stroke Association) who provided written and verbal 
information and advice, support and liaison with 
services. On average, patients received 2 visits and three 
telephone contacts. 
Comparison Control: The control group did not receive any input 
from the Family Support Organiser. 
Outcome 
assessment 
Outcomes were assessed at six months by a researcher 
blinded to treatment allocation.  Patient outcomes: 
Subjective health status (Dartmouth CO-OP chart); 
Death; Place of residence; Activities of daily living 
(Barthel, Rivermead mobility index); Dependency 
(London handicap scale); Mental health (Hospital anxiety 
and depression scale); Satisfaction (Local satisfaction 
scale). 
Carers Carer outcomes: Subjective health status (Carer strain 
index, SF36); Extended activities of daily living 
(Frenchay activities index); Mental health (GHQ28); 
Satisfaction. 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.22: Study Characteristics – Philadelphia (STAIR) 
 
Trial Location Philadelphia (STAIR) 
Study 
methodology 
Randomised controlled trial. 
Randomisation Randomisation by random number table but allocation 
concealment unclear. 
Recruitment  Patients were recruited from in-patient wards within 3 
months of stroke onset. 
Exclusion 
criteria 
Exclusion criteria:  Severe co-morbidity; cognitive 
impairment; communication problems; institutional 
care. 
Inclusion criteria Inclusion criteria: Aged over 65; recent stroke; returning 
to community; caregiver identified; able to give 
informed consent.  
Patient 
characteristics 
n=55, 52% Male 
Intervention Intervention: Patients were assigned a case manager 
who visited monthly and telephoned weekly.  They 
provided access to information, identified psychosocial 
stresses and provided liaison to community or hospital 
resources. 
Comparison Control:  The control group did not receive visits from 
the case manager or input from the multi-disciplinary 
team. Outcomes were recorded at 12 months by a 
researcher blinded to treatment allocation.  
 
Outcome 
assessment 
Patient outcomes: Extended activities of daily living 
(Frenchay activities index, Social Functioning 
Examination, Older American Resources and Services 
Scales-Social Resources (OARS-SR)); Activities of daily 
living (FIM, OARS-ADL, OARS-Physical health, SFE, FAI); 
OARS-Economic resources. 
Carers Carer involvement was necessary for the study.  Carer 
outcomes: Subjective health status (Questionnaire on 
resources and stress (QRS)); Mental health (Centre for 
epidemiological studies-depression scale (CESD)). 
Allocation 
concealment 
B=unclear* 
Data Some aggregated data were available in addition to the 
paper, but not individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.23: Study Characteristics - Preston 
 
Trial Location Preston      
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Allocation by telephone to remote centre with 
concealed random number sequence. 
Recruitment  Patients with a clinical diagnosis of stroke were 
recruited from admission to hospital. 
Exclusion 
criteria 
Exclusion criteria: Depression prior to stroke, cognitive 
impairment, poor prognosis, substance addiction. 
 
Inclusion 
criteria 
Inclusion criteria: clinical diagnosis of stroke. 
Patient 
characteristics 
(n=176), mean age =75 (SD 10), 52% male. 
 
Intervention Intervention: Patients were visited by a stroke nurse 
who visited on average 3 times over 2 months and 
provided information and advice, emotional support and 
liaison with services. 
Comparison Control: The control group received inpatient case 
management and multidisciplinary rehabilitation, but no 
home visits on discharge. 
Outcome 
assessment 
Outcomes were recorded at 3 and 12 months by a 
researcher blinded to treatment allocation. Patient 
outcomes: Subjective health status (Nottingham health 
profile); Extended activities of daily living (Frenchay 
activities index); Activities of daily living (Barthel); 
Mental health (Beck depression inventory). 
 
Carers Involvement of a carer was not compulsory. Carer 
outcomes; Subjective health status (Carer strain index). 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.24: Study Characteristics – Rhode Island 
Trial Location Rhode Island    
Study 
methodology 
Randomised controlled trial.   
 
Randomisation There was no information on the method of 
randomisation or allocation concealment. 
Recruitment  Patients and carers were recruited in hospital following 
stroke.   
Exclusion 
criteria 
Exclusion criteria: Subarachnoid haemorrhage; 
Institutional care; no caregiver. 
Inclusion criteria Inclusion criteria: Age over 35 with confirmed stroke, 
competent to consent and caregiver present. 
Patient 
characteristics 
Number = 215, mean age 65(SD 13), 55% male. 
 
Intervention Intervention: Patients received on average 13 telephone 
calls (lasting 15-20 minutes) from the stroke liaison 
worker who provided education, social and emotional 
support and counselling. 
Comparison Control group: Control group patients were allocated to 
usual care. 
Outcome 
assessment 
Outcomes were recorded at 3, 6, 12 and 18 months by 
staff blinded to treatment assignment.  Patient 
outcomes: Subjective health status (SF36); Extended 
activities of daily living (Frenchay activities index, FIM); 
mental health (Geriatric depression scale); Family 
function (Family assessment device). 
 
Carers Involvement of a carer was compulsory.  Carer 
outcomes: Subjective health status (Caregiver strain 
index, SF36); Mental health (CES-D). 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
This trial is unpublished at present. 
  
*Cochrane criteria 
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Table 5.25: Study Characteristics – Utrecht (HESTIA) 
Trial Location Utrecht (HESTIA) 
Study 
methodology 
Randomised controlled trial. 
 
Randomisation Randomisation was performed by telephone to a remote 
centre. 
Patient blinding was achieved by a process of delayed 
consent. 
Recruitment  Patients were recruited from 12 hospitals prior to 
discharge following a first-in-a-lifetime stroke. 
Exclusion 
criteria 
Exclusion criteria: Recurrent stroke; age under 18; poor 
prognosis; severe dependency; lives out with area; 
institutional care. 
Inclusion 
criteria 
Inclusion criteria: Age 18 or over with first ever stroke, 
resident in area with no or only mild dependency, 
discharged to community and expected to live more 
than one year. 
Patient 
characteristics 
n=536, mean age 63 (SD 15), 49% male. 
Intervention Intervention: Senior nurses made three telephone 
contacts and visited the patient in their homes.  They 
provided information, support and liaison to primary 
care. 
 
Comparison Control group:  The control group received the same in-
patient care but were not contacted on discharge. 
Outcome 
assessment 
Outcomes were recorded at six months by postal 
questionnaire and telephone interview by an assessor 
blinded to treatment allocation. Patient outcomes: 
Subjective health status (SF36); Activities of daily living 
(Barthel); Dependency (Modified rankin scale); Mental 
health (Hospital anxiety and depression scale); Use of 
services; satisfaction (Satisfaction-With-Stroke-Care 
questionnaire SASC 19). 
Carers Involvement of a carer was not compulsory.  Carer 
outcomes: Subjective health status (Carer strain index); 
Extended activities of daily living (Social support list - 
discrepancies (SSL-D)); Mental health (Sense of 
competence questionnaire (SCQ)). 
Allocation 
concealment 
A=adequate* 
Data Individual patient data. 
Publication 
status 
Published 
  
*Cochrane criteria 
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Table 5.26: Primary Patient Outcomes 
Primary Outcomes 
Study Subjective Health Status 
  
EADL 
Adelaide SF36 - physical health  Adelaide Activities Profile  (cumulative) 
Boston (FIRST) 
 Instrumental Activities of Daily Living  
Bradford Nottingham Health Profile Frenchay Activities Index 
Edinburgh GHQ30 Frenchay Activities Index 
Glasgow EuroQOL  
Leeds GHQ Frenchay Activities Index 
Liverpool GHQ12 Nottingham Extended ADL 
London 
 Reintegration to normal living  
Mansfield GHQ12 Nottingham Extended ADL  
Melbourne 
 Local tool 
Melbourne (SHIPS) AQOL Barthel  
Oxford COOP Frenchay Activities Index  
Philadelphia 
(STAIR) 
 Frenchay Activities Index 
Preston Nottingham Health Profile Frenchay Activities Index  
Rhode Island SF36 (general health subsection) Frenchay Activities Index  
Utrecht SF36 (general health subsection) Barthel 
Analysis plan with outcomes for each trial in the categories for the review 
process.
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Table 5.27: Table of Secondary Outcomes 
Analysis plan with outcomes for each trial in the categories for the review process  
 
 
Secondary Outcomes 
Study Death Place of 
Residence 
ADL Dependency Mental Health - 
Generic 
Mental Health - 
Depression 
Mental Health - 
Anxiety 
Knowledge 
about stroke 
Use of 
Services 
Participation Other 
Adelaide 
  Barthel  GDS GDS HADS  anx      
Boston (FIRST) 
  Barthel Physical 
Performance 
Recovery Efficacy Recovery 
Efficacy 
   Received  
Social Support 
 
 
Bradford Yes  Barthel Functional 
Ambulatory 
Category 
       
Edinburgh Yes Yes Barthel Modified Rankin  HADS cumulative HADS dep HADS  anx   Yes RLOC SAS 
Glasgow Yes    GDS GDS   Yes   
Leeds Yes  Barthel  GHQ  GHQ      
Liverpool 
  Barthel  GHQ12 GHQ12   Yes   
London 
  Barthel  HADS cumulative HADS dep HADS  anx    RNLI  
Mansfield 
  Barthel     Local    
Melbourne 
  Local Local     Yes   
Melbourne (SHIPS) 
  Barthel         
Oxford Yes Yes Barthel London 
Handicap Scale 
HADS cumulative HADS dep HADS anx Local Yes London  
Handicap Scale 
 
 
Philadelphia 
(STAIR) 
  FIM      Yes FAI  
Preston Yes Yes Barthel  Beck Depression 
Inventory 
Beck Depression 
Inventory 
     
Rhode Island 
    GDS GDS      
Utrecht Yes  Barthel Modified Rankin HADS cumulative HADS dep HADS  anx   Yes   
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Table 5.28: Table of Outcomes for Carers 
 
Analysis plan with outcomes for each trial in the categories for the review 
process
Carer Outcomes - 
Analysis Plan 
Primary Outcomes Secondary Outcomes 
Study Subjective Health 
Status 
EADL Mental Health 
Adelaide SF36 (physical health)   SF-36 mental 
health 
Boston (FIRST) Caregiver Burden     
Bradford GHQ28 Frenchay Activities Index  GHQ28 
Edinburgh Caregiver Hassles Scale Frenchay Activities Index 
from published medians 
GHQ28 
Glasgow 
      
Leeds Carer Strain Index    GHQ28 
Liverpool Carer Strain Index    GHQ12 
London Carer Strain Index    HADS  
Mansfield Carer Strain Index    GHQ12 
Melbourne 
      
Melbourne (SHIPS) Carer Strain Index      
Oxford Carer Strain Index  Frenchay Activities Index  GHQ28 
Philadelphia 
(STAIR) 
Questionnaire and 
Resources 
  CES-D  
Preston Carer Strain Index      
Rhode Island Carer Strain Index  Frenchay Activities Index  CES-D 
Utrecht Carer Strain Index    Sense of 
Competence 
208 
 
  Table 5.29: Identifying Relevant Satisfaction Questions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*High score indicates dissatisfaction, †High score indicates satisfactions 
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I have been treated with kindness 
and respect by staff at the hospital 
● ● ●   ● ● 
The staff attended well to my 
personal needs whilst in hospital 
● ● ●   ● ● 
I was able to talk to the staff about 
any problems I might have had 
● ● ●   ● ● 
I have received all the information I 
want about the causes and nature of 
my illness 
● ● ● ● ● ● ● 
The doctors have done everything 
they can to make me well again 
● ● ●   ● ● 
I am happy with the amount of 
recovery I have made 
● ● ●   ● ● 
I am satisfied with the type of 
treatment the therapists have given 
me 
●  ●   ● ● 
I have had enough therapy ●     ● ● 
I was given all the information I 
needed about allowances or services 
I might need after leaving hospital 
● ● ● ● ● ● ● 
Things were well prepared for my 
return home 
●  ●   ● ● 
I get all the support I need from 
services such as meals on wheels, 
home help etc. 
●  ● ●  ● ● 
I am satisfied with the outpatient 
services provided by the hospital 
● ● ●    ● 
I am satisfied with the practical help I 
have received since I left hospital 
●      ● 
I have received enough information 
about recovery and rehabilitation 
after stroke 
●   ● ●  ● 
Somebody has really listened and 
understood my needs and problems 
since I left hospital 
● ● ● ●   ● 
I have felt neglected since I left 
hospital 
●   ●   ● 
I have had enough emotional support 
since I left hospital 
● ● ●  ●  ● 
I have received enough special 
equipment 
●   ●   ● 
I know who to contact if I have 
problems relating to my stroke 
● ●  ●   ● 
I think the ambulance service is reliable ●  ●     
I am satisfied with the amount of contact 
I have had with the hospital since I have 
attended 
 ●    ●  
reducing the risk 
   ● ●   
I am satisfied with the service I have 
received from my GP 
  ●     
I am satisfied that my family were 
encouraged to be involved in my care 
  ●     
I was given enough information about 
voluntary organisations 
  ●     
overall satisfaction 
   ●    
hospital services summary score 
     ●  
community services summary score 
     ●  
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Chapter Six:  
Identifying Stroke Liaison Roles in Scotland 
 
Introduction 
As we have seen from Chapter 5, the evidence for Stroke Liaison Workers is 
at the very least complicated and without a clear, simple message.  Despite 
this lack of clear evidence, Stroke Liaison Worker roles have multiplied 
throughout the United Kingdom including Scotland.  Many of these posts are 
paid for by charities such as the Stroke Association in England and Chest 
Heart and Stroke, Scotland (CHSS).  To some degree this may have been 
driven in the charity sector by a perception that mainstream NHS services 
are failing to provide for patients and carers felt needs simply because 
evidence and cost effectiveness cannot be easily demonstrated for these 
services.  In that respect satisfaction described by patients and carers may 
be felt to be adequate grounding for the provision of such services. 
Some services are part of mainstream NHS provision, but guidance on the 
roll out of services is limited (12;332).  It would appear that in the absence 
of a clear evidence basis or mechanism of effect for SLW-like interventions 
that roles and posts have proliferated (stroke nurse website).  What unites 
or separates these roles currently is a definition by title or terminology 
without a standardised or agreed definition of job plans for these posts (i.e. 
who does what in what way to whom, when and where).  It is apparent at 
national forums (National Stroke Forum) where these roles are discussed 
that important differences emerge in the provision of input to patients and 
carers. 
Additionally in personal communication with Stroke Liaison Workers and on 
presentation of the evidence in scientific communications to conferences 
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(333) it is apparent that despite potentially disappointing results, that 
individual Stroke Liaison Workers have a high degree of confidence in the 
effectiveness of their work. 
It is therefore legitimate to consider exploring two central questions in 
mapping the existing evidence to current health service practice. 
1. Firstly, can current Liaison Roles be quantified and evaluated in 
Scotland?  Do they bear any comparison to the interventions 
described in the research or have the roles and services evolved to 
make current evidence invalid for current services? 
2. Secondly, what are the beliefs of those who carry out these roles 
regarding the effectiveness of their work and its applicability to some 
or all patients. 
Answering these questions requires both quantitative data and semi-
qualitative data. 
No central register exists within the NHS Scotland to locate and contact 
these health workers.  In addition, because many of the services have 
evolved from local needs and local contexts, it was apparent that some 
degree of description and classification would be required in order to 
identify comparable roles independent of titles and superficial descriptives.  
The Scottish Stroke Nurses Forum (SSNF) was established in 2003 to provide 
a forum for the professional development and promotion of high quality 
nursing standards and education amongst nursing professionals in Scotland. 
It is currently the most comprehensive network of nursing clinicians and 
researchers in Scotland and as such provides a forum to contact and 
evaluate role development across Scotland. 
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Methods 
 
Questionnaire Development 
No single definition of a Stroke Liaison Worker exists and no single job 
description or profession has been defined by services nationally or locally.  
For this reason identifying and evaluating these roles proves difficult.  In 
practice, a number of screening questions are likely to be required to 
identify individuals who work with patients after stroke providing liaison, 
social support and information.  A questionnaire was developed to map 
existing services in Scotland and mirror the roles described in the Stroke 
Liaison Workers literature.  These questionnaires asked for information 
under a series of domains including geographic, employment (profession and 
grade), and the scope of the individuals work (e.g. inpatients only, 
outpatients etc). 
SSNF members who identified that they worked with patients in the 
community after a stroke were asked a series of further questions.  These 
related to the areas of a Stroke Liaison role as identified in the review 
process.  Specific questions were asked of the type of social support, liaison 
and information provision provided by each respondent.  Respondents were 
asked to categorise their approach to the individual patient (i.e. proactive 
and structured or reactive and flexible) and their type of interaction with 
the patient or carer (Focussed or Comprehensive).  Definitions were given 
for each of these terms (see Table 5.1, Appendix J) and respondents were 
asked to prioritise their responses according to which was their most 
common method of approach.  Care was taken to avoid pejorative 
terminology that might influence respondents.  Those respondents who were 
identified by screening questions to be in relevant roles were asked their 
personal belief of whether their role was effective for all or only some of 
their clients.  Additional questions allowed respondents to record free text 
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where they felt important.  Additional questions were asked of respondents 
regarding the three commonest problems they dealt with day to day. 
Questionnaires were piloted with staff members known to the author to 
work in this type of post.  Following this minor modifications were made to 
the questionnaire to clarify definitions etc.  The questionnaires were then 
sent to all 209 members of the Scottish Stroke Nurses Forum.  In response to 
the initial mailing, 89 questionnaires were returned.  A second mailing was 
therefore carried out, prompting a further 21 responses. 
From all the responses, only initial demographic data were retained for this 
analysis.  Respondents who were identified through the screening question 
to be dealing with the relevant patient and carer group were analysed 
separately.  Their results are presented here.   
 
Results 
In total 110 questionnaires were returned (52.6%), of which 58 met the 
screening criteria for a Stroke Liaison Worker role.   
The regional distribution of respondents is shown in Figure 6.1. 
Quantitative data 
All respondents who identified themselves as potential Stroke Liaison 
Workers were from the nursing profession.  Most were from senior nursing 
grades; 35% (n=20) grade F, 28% (n=16) grade G and 16% (n=9) grade H, with 
the majority (59%, n=34) working with both in-patients and outpatients, 
implying an immediate role in discharge liaison.  Responders were asked 
who they dealt with.  All 58 respondents identified that they dealt with 
patients, with 97% (57) dealing additionally with carers and families. 
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Respondents were then asked to identify which aspects of stroke liaison they 
were involved in (education and information provision, liaison, social 
support), with 90% identifying themselves as delivering all three roles. 
Respondents were then asked to identify within these general areas, which 
specific areas of information provision they provided, or what form of social 
and psychological support they provided and with whom they regularly 
liaised. 
These questions had been developed by the author and used within the 
review process described in Chapter Five to try and classify the specific 
types of intervention delivered. 
In general terms, response rates were very high to all questions, with most 
nurses responding to nearly all areas (Table 6.1). 
The Stroke Liaison Worker approach is illustrated in Table 6.2.  Respondents 
were asked to identify their primary mode of approach or interaction with a 
patient or carer.  A number of respondents scored both approaches as 
equal, hence the overlap of statistics. 
Visits were primarily conducted in the community in the patients homes 
(80%), with some liaison contacts additionally being made by telephone 
(81%) or at visit to the hospital (e.g. at outpatient clinics – 48%). 
Respondents were asked if they believed their role to be effective.  62% (36 
respondents) believed that their role was effective for all their patients.  
22% (13) suggested that their role in their opinion benefited most patients, 
whilst 14% (8) believed that it benefited only some. 
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Qualitative data 
Responses to the questions regarding the three commonest problems dealt 
with by Stroke Liaison Workers were reviewed.  I looked for common threads 
or themes that might group the responses together.  The four dominant 
themes identified were:  
a) Psychological or emotional issues,  
b) Informational or educational issues,  
c) Practical or service related needs and  
d) Medical or physical needs.   
Other issues including problems relating to service provision and staffing 
issues were grouped under “other responses”.   
A count of the frequency of problems in these five themes was conducted, 
illustrating that the commonest theme was psychological or emotional needs 
(103 responses) followed by informational and educational needs (30 
responses), practical or service needs (23 responses) and medical or physical 
(20 responses).  13 responses were listed that did not relate to patient care 
or support. 
Psychological or emotional needs 
Responses in this category illustrate a number of separate themes.  These 
include psychological adjustment to the effects of stroke. 
“Helping patients and relatives deal with the life changing events 
of stroke.“                                                                                                                           
“Patient, carer/relative not coming to terms with stroke and its 
effect.”     
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“Life changes”                                                                                                      
Nurses also identified anxiety and depression as a frequent theme: 
“Patient/carer depression and anxiety”                                                                                    
“Depression”                                                                                                                             
“Fear of re-stroke”                                                                                                                    
“Anxiety (especially re recurrence)” 
A number of other issues and themes were also identified as important: 
“Communication problems - social isolation”                                                                                                                             
“Loneliness”                                                                                                                                                                                             
“Physiological issues”                                                                                                                 
“Motivation”                                                                                                                             
“Change in family dynamics”                                                                                                                                                                               
Informational or educational needs 
Respondents identified a number of issues as having an educational or 
informational basis. These include behaviour modification and lifestyle 
factors related to reducing risk factors: 
“How to change lifestyle e.g. smoking cessation, exercise and 
diet”                                                                                                                                        
“Secondary prevention e.g. medication compliance and 
understanding”                                                                                                                             
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“Management of risk factors - especially smoking” 
Other informational needs were more general: 
“Lack of understanding of stroke and recovery” 
“Patients not understanding all the aspects of stroke”                                                                      
“Educating other family members”                                                                                                                             
Specific information needs were also identified in relation to driving and 
returning to work. 
Practical or service needs 
A number of responses indicated a variety of needs relating to support or 
rehabilitation services in the community and problems where nurses were 
clearly being required to provide liaison: 
“Benefits advice”                                                                                                                             
“Problems communicating with GP, social work etc.”                                                                                                                             
“Lack of support for patients from AHPs in community”                                                                                                                             
“Advice re local support services” 
Financial issues relating to benefits was the most frequent single issue 
identified. 
Medical or Physical needs 
These included issues in relation to physical rehabilitation: 
 “Patients not carrying over their functional level in the home 
setting and physical regression”                                                                                                        
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“Communication/swallowing”                                                                                                                             
Physical needs:   
“Fatigue”       
“Bowel and bladder problems”                                                                                                                             
“Pressure area problems”                                                                                                                             
“B/P control”                                                                                                                                                         
And issues in relation to specific treatments and treatment modification: 
“Medication problems - e.g. dosage, how long”                                                                                                                            
“Side effects of stroke or medication”                                                                                                                             
Discussion 
 
Overall, 53% of respondents identified themselves as potentially fitting the 
category of Stroke Liaison Worker.  The screening question appears to 
correctly identify the nurses who provide the key aspects of Stroke Liaison 
Workers. 
Overall, results from the nurses who responded are broadly similar.  Most 
respondents report that they are offering all three of liaison, education and 
information provision and social support.  Specifically nearly all respondents 
offer a broad range of information and education.  In addition, the nurses 
employ a range of methods of social support to patients and their families, 
with the general exception of formal counselling methods.  Most 
respondents have a comprehensive role in liaison between the patients and 
other services.  One of the limitations of this patient survey might be its 
lack of definition of the specific differences for example between; informal 
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emotional support, informal counselling and formal counselling.  The 
questions were listed as though to illustrate a continuum of different 
methods of support, and despite the lack of a formal definition, the 
response rate was high, and broadly similar, suggesting that despite this 
limitation, nurses appeared to respond in a consistent way. 
Attempts to specifically define the intervention prove challenging when 
trying to compare it to the established literature in this area.  Asking 
respondents to identify their primary mode of approach (reactive or 
proactive) proved difficult with a number of respondents rating both 
approaches as of equal frequency.  There is a risk that the way in which the 
question is constructed implies that one approach sounds more positive (e.g. 
pro-active) and another pejorative (reactive).  Attempts were made to avoid 
negative language where possible.  This question attempted to dichotomise 
interventions to mirror some of the trials in the literature that were either 
reactive (76) or proactive (297).  Additional dichotomisation was attempted 
to identify trials that focussed on a specific problem or defined area (e.g. 
risk factor control or mood and emotional health) (279;298) or attempted to 
be comprehensive and cover a broad range of areas (32).  These differences 
become important if evidence suggests that a particular method of working 
as well as role proves to be effective. 
One further area of potential difficulty relates to the team associations that 
the Stroke Liaison Nurses have.  Traditionally Stroke Liaison Nurses have had 
a more independent role, operating between primary and secondary care 
and tending not to be a part of a multidisciplinary team.  Attempting to map 
existing Scottish roles to therapy teams was not clearly distinguished by the 
questionnaire.  Respondents identified that they were related to a hospital 
stroke team (35, 60%), as part of community support teams (12, 21%) or 
other service structures (9, 16%).  Further questions about the nature of the 
team structure and the frequency of team meetings and multidisciplinary 
discussion could have highlighted the degree to which Stroke Liaison Nurses 
were integrated to or independent from multidisciplinary teams. 
219 
Scottish nurses who responded to this survey to identify Stroke Liaison 
Worker roles appear to offer a service comparable to each other in terms of 
the intervention delivered.  Minor differences appear in relation to the 
approach taken by Stroke Nurses and their interaction with patients.  The 
roles performed by the nurses appear to compare with those in the original 
trials.  Overall, Scottish Stroke Nurses appear to offer a multifaceted service 
with a high level of confidence that it is effective; that is, that in some way 
their role meets needs that would not otherwise be met.  The themes 
identified by the Stroke Nurses appear to be broadly consistent with the 
existing literature and primarily identify psychological and emotional issues 
as the dominant ones. 
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Figure 6.1: Region of Stroke Liaison Workers 
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Table 6.1: Specific Interventions Provided by Scottish Stroke Liaison Workers 
 
Specific help Yes  
n=58 (%) 
Information Provision and Education   
Stroke Information 
(general) 
56 (97) 
Risk Factors 57 (98) 
Stroke consequences and complications 52 (90) 
Stroke services and benefits 50 (86) 
Stroke treatments and therapies 51 (88) 
Social Support  
Informal emotional 56 (97) 
Informal counselling 54 (93) 
Formal counselling 6 (10) 
Family support and problem solving 56 (97) 
Individual problem solving 55 (95) 
Organising other social support 53 (91) 
Liaison  
…with patient 57 (98) 
…with community services 54 (93) 
…with primary care 54 (93) 
…with secondary care 52 (90) 
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  Table 6.2: Scottish Stroke Liaison Workers Primary Approach 
Stroke Liaison Approach and Interaction Primary (%) 
n=58 
Stroke Liaison Approach  
Pro-active and Structured 
“I tend to seek out to meet or talk with everyone.  I tend to 
bring up subjects even when not brought up by the patient (or 
carer), or I work through a list of potential problem areas.” 
30 (52) 
Reactive and Flexible 
“I respond to patients needs and adjust my workload or 
discussions around the problems that they bring up.  The 
amount of time or follow-up will depend on need.” 
33 (57) 
  
Stroke Liaison Workers interaction  
Focussed 
“I am quite specific about which areas we talk about (e.g. my 
role is to talk about risk factors or to talk about psychological 
problems etc.)” 
12 (21) 
Comprehensive 
“I cover a broad range of subjects and provide broad support 
for different aspects of living with stroke” 
49 (85) 
Results show the proportion of respondents who identified an approach as their primary approach or interaction with a 
patient.  In some cases, despite being asked to choose only one approach, respondents identified both approaches 
as equal. 
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Chapter Seven 
 
Conclusions and Recommendations 
We have seen from the existing literature that there is a strong association 
between specific problems post stroke (e.g. social isolation, depression etc.) 
and poorer outcomes for both patients and their carers (e.g. mortality, 
depression etc.)  It seems legitimate therefore to explore specific 
interventions that might be seen to buffer these post stroke problems and 
limit their consequences.  The context therefore exists for trials of (for 
example) information provision and social or psychological support. 
In Chapter Two, we evaluated the short term outcomes from a brief 
intervention of education, information provision and liaison.  We 
hypothesised that a better informed and better supported stroke patient 
might take more active control of their risk factors and be more satisfied 
with their care.  This intervention did not appear to improve overall risk 
factor control despite modest effects on systolic blood pressure.   Patients 
did appear to describe improved satisfaction with some aspects of their 
care.  The evaluation in Chapter Three of the longer term benefits was 
limited by the significant drop out rate of both the intervention and control 
group subjects.  Either for this reason, or because the effects of the 
intervention were limited, there was no evidence of benefit from the 
intervention described in Chapter Two at over three years later.  One 
interesting observation was the relatively high persistence with secondary 
prevention therapy in both groups.  One potential confounding factor in the 
intervening period between Chapters Two and Three is the development of 
a local primary care initiative for Chronic Disease Management.  This is a 
programme that seeks to regularly review patients with Stroke, Ischaemic 
Heart Disease and Diabetes and aim to modify or improve their risk factors.  
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It is possible to postulate that this may have had an effect on both 
intervention and control groups.   
The results in Chapters Two and Three could represent a Type II statistical 
error.  Whilst larger scale studies may address this uncertainty, meta-
analysis of similar studies can enable meaningful conclusions to be drawn 
from the existing literature. In order to establish what randomised 
controlled trials existed in this area of stroke research and to assess their 
combinability, we needed to develop a descriptive framework that would 
allow comparability.  In the absence of an underpinning science, 
intervention characteristics for comparison must be based on external 
descriptors such as those discussed in Chapters Four and Five. To a great 
extent, this is because the Phase One modelling described in the MRC 
framework (page 67) has not been carried out.  This limits our 
understanding of the intervention aims and effects to external factors.  
Nevertheless randomised trials currently exist evaluating a comparable 
group of interventions and therefore meta-analysis of these trials was 
warranted despite these limitations.  The process of identifying the current 
evidence for possible comparability highlighted an emerging group of 
interventions that have developed in recent years with the sole purpose of 
addressing the needs of carers.  This emerging group of trials merits further 
evaluation, but this is beyond the scope of this thesis.   
 
In attempting to combine appropriate randomised controlled trials for meta-
analysis we sought to add to the external descriptives of Chapter Four 
additional information gleaned directly from the trialists.  We hoped that 
this would improve our accuracy in understanding the interventions and 
ensure if they could be appropriately combined and sub-grouped.  In many 
respects, given that little was known about how these interventions might 
work, our analysis could be described as exploratory.  For this reason, the 
wide range of outcome measures is appropriate.  Despite this broad 
approach, no clear evidence of effectiveness for the current model of Stroke 
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Liaison Workers appears to emerge.  Interesting and potentially important 
themes do exist however. 
 
Stroke Liaison Worker interventions result in greater satisfaction with 
certain aspects of service provision (such as information provision and 
liaison) but do not appear to result in changes to patient subjective health 
status, extended ADL or carer subjective health.  Subgroup analysis suggests 
that patients with mild to moderate dependence in activities of daily living 
may benefit with reductions in dependence as well as improved independent 
survival. 
 
It would appear that this complex intervention with its broad intentions 
does not result in significant benefits when applied to all patients and 
carers.   
Further research in this area may not be warranted on the existing model of 
Stroke Liaison Worker - that is a multidimensional intervention delivered to 
all patients and carers.  Further work to explore alternative interventions 
however is urgently needed.  This research and evaluation must include 
where possible, more detailed modelling (or phase one) work and take into 
account the themes emerging from this thesis.  In essence it must consider: 
• Being more focussed on a specific problem or impairment 
o E.g. depression 
• Or focussing on a specific sub-group of patients 
o E.g. mild to moderately dependent patients 
o Carers 
•  Or working in combination with existing proven interventions 
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o E.g. Early supported discharge teams  (Since the development 
of these trials Early Supported Discharge services have become 
more widespread and we do not as yet know the potential 
interaction between these two interventions.) 
 
What does appear to emerge as a clear message is that Stroke Liaison 
Worker roles as they currently exist do not have an adequate evidence base 
to justify their continued support.  Despite this, as we have seen from 
Chapter Six, there is a widespread belief in their effectiveness and current 
roles in Scotland appear to map well to the models of Stroke Liaison 
Workers that were evaluated in the trials.  The research and stroke 
community needs to consider the significance of this evidence and its 
implications for practice. 
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Appendix A: Initial Consent and Patient Questionnaire 
 
Enrolment Data-set        Page 1 
Please fill in the white boxes. 
 
Date: 
 
1. 
Demographics Enrolment Number 
Name: 
Address: 
 
Post Code: 
Unit Number: 
D.O.B. 
Sex Male  1 
 Female  2 
 
2. 
Diagnosis  Tick Coding 
TIA  1 
CVA  2 
Cerebrovascular 
Disease 
 3 
Other  4 
  
        PLEASE FILL IN 
3. 
 
Risk 
Factors 
 Tick Coding CURRENT RISK 
Smoking  1 No per day: 
Hypertension  2 Current BP Sys Dia  
NIDDM / IDDM / 
IGT 
 3 Current / Most recent RBG HbA1c 
Previous TIA  4  
Previous CVA  5 
AF  6 On Warfarin? Yes: No: 
High 
Cholesterol 
 7 Level: 
Alcohol Excess  8 Units per week: 
Obesity  9  
IHD  10 
PVD  11 
Other  12 (Specify) 
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INFORMATION SHEET       Page 2 
 
Patient Number: 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
THE IMPACT OF A STROKE NURSE SPECIALIST ON RISK FACTOR 
MODIFICATION IN A TIA CLINIC: A RANDOMISED, CONTROLLED TRIAL 
 
You are being invited to enrol in a study that we are currently conducting in our 
"TIA" clinic. 
This study forms part of research we are conducting into the effects of advice 
we give to our patients who are at risk of a stroke. 
 
We hope to find out whether different kinds of approach to advice-giving can 
make a difference to our patients in terms of their health, understanding of their 
illness and satisfaction. 
 
As part of the study patients will be randomly allocated to two different groups.  
One group will receive monthly appointments with our specialist stroke nurse.  
The other group will not receive these appointments.  You will already have 
been allocated to one of these groups.  We are unable to influence which group 
you will have been allocated to.  All patients will be seen in four months time 
when they will be given a further questionnaire, have their blood pressure 
measured and blood tests taken.  Many of these blood tests and blood pressure 
measurements may have been necessary as part of your normal care.  For a few 
patients however, these tests will be purely for the purposes of research. 
 
Research in medicine helps us to discover new or better ways of helping patients 
like yourself, and your participation would be greatly appreciated.  Participation 
in the study may be of little or no benefit to you, but the results may help other 
patients in the future. 
 
If you do agree to take part in the research project, your own General 
Practitioner will be told and will be given details about any care which you are to 
receive. 
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Consent Form        Page 3 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
Please place your initials in the boxes provided to indicate that you understand the statements 
that are being made. 
 
The Doctor or Sister named below has       
explained the study to me.   
 
I know that I can withdraw from the study      
at any time without having to give a reason. 
 
I know that should I withdraw, this will not      
in any way affect my care.  
 
I consent to take part in this study.       
 
 
Patients Name: 
Address: 
 
Signature: 
Date: 
 
Doctor/Sisters Name: 
Signature: 
Date: 
234 
Questionnaire        Page 4 
 
Patient's Name: 
Date of Birth: 
Postcode: 
We would like to know some information about your quality of life at the 
beginning of our study. 
 
1. Quality of life 
Please tick the box which you think best describes your current state of health. 
Mobility 
 
1. No problems in walking about      
2. Some problems in walking about      
3. Confined to bed        
 
Self-care 
 
1. No problems with self-care      
2. Some problems washing or dressing self     
3. Unable to wash or dress self      
 
Usual Activities 
 
1. No problems with performing usual activities     
(E.g. work, study, leisure, family etc.) 
2. Some problems with performing usual activities    
3. Unable to perform usual activities      
 
Pain/Discomfort 
 
1. No pain or discomfort       
2. Moderate pain or discomfort      
3. Extreme pain or discomfort      
 
Anxiety/Depression 
 
1. Not anxious or depressed       
2. Moderately anxious or depressed      
3. Extremely anxious or depressed     
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Questionnaire        Page 5 
 
Patient's Name: 
Date of Birth: 
Postcode: 
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Appendix B: Concluding Data-set and Patient Questionnaire  
  
Concluding Data-set        Page 1 
 
Date: 
1. 
Demographics Enrolment Number Patient Phone No: 
Name: GP: 
Address:  
  
Post Code:  
Unit Number:  
D.O.B.  
Sex  Male  1 
  Female  2 
2. 
Diagnosis  Tick Coding 
TIA  1 
CVA  2 
Cerebrovascular Disease  3 
Other  4 
  
3. 
Risk 
Factors 
 Tick Coding CURRENT RISK 
Smoking  1 No per day: 
Hypertension  2 Current BP Sys Dia  
NIDDM / IDDM / 
IGT 
 3 Current / Most recent RBG HbA1c 
Previous TIA  4  
Previous CVA  5 
AF  6 On Warfarin? Yes: No: 
High Cholesterol  7 Level: 
Alcohol Excess  8 Units per week: 
Obesity  9 Weight: Height: 
IHD  10  
PVD  11 
Other  12 (Specify) 
4. 
 Questionnaire completed? Bloods taken where indicated? 
Blood Pressure Recorded? Results available? 
5. 
Clinical 
Data 
Further event not leading to admission? 
Cause?  
Admission to Hospital since enrolment? 
Diagnosis?  
Death? 
Cause?  
Other event? 
Details:  
Key TIA=1 CVA=2 Other=3 (Please specify) 
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Questionnaire        Page 2 
 
Patient's Name: 
Date of Birth: 
Postcode: 
Now that you have completed your period in the study we would like to know 
some information about your quality of life, medications, mood and satisfaction 
with the service you have received. 
 
2. Quality of life 
Please tick the box which you think best describes your current state of health. 
Mobility 
 
4. No problems in walking about      
5. Some problems in walking about      
6. Confined to bed        
 
Self-care 
 
4. No problems with self-care      
5. Some problems washing or dressing self     
6. Unable to wash or dress self      
 
Usual Activities 
 
4. No problems with performing usual activities     
(E.g. work, study, leisure, family etc.) 
5. Some problems with performing usual activities    
6. Unable to perform usual activities      
 
Pain/Discomfort 
 
4. No pain or discomfort       
5. Moderate pain or discomfort      
6. Extreme pain or discomfort      
 
Anxiety/Depression 
 
4. Not anxious or depressed       
5. Moderately anxious or depressed      
6. Extremely anxious or depressed     
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Questionnaire        Page 3 
 
Patient's Name: 
Date of Birth: 
Post Code: 
 
2. Your satisfaction with the service you have received 
 
Please tick the box which best describes how you feel about the statements below: 
 Strongly 
Agree 
Agree Disagree Strongly 
Disagree 
I have been treated with kindness and 
respect by staff at the hospital. 
    
The staff attended well to my needs 
when I was at the hospital. 
    
I was able to talk to the staff about any 
problems I might have had. 
    
I have received all the information I want 
about the causes and nature of my illness. 
    
The doctors have done everything they 
can to make me well again. 
    
I am satisfied with the outpatient services 
provided by the hospital. 
    
I have received enough information 
about my risk factors for stroke. 
    
Somebody has really listened and 
understood my needs and problems since 
I attended the hospital. 
    
I am satisfied with the amount of contact 
I have had with the hospital since I have 
attended. 
    
I have had enough emotional support 
since I attended the hospital. 
    
I know who to contact if I have 
problems relating to my TIA/stroke. 
    
I am happy with the amount of recovery 
I have made. 
    
I was given all the information I needed 
about the allowances or services I might 
need. 
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Questionnaire        Page 4 
 
Patient's Name: 
Date of Birth: 
Post Code: 
3. Your medications 
Please list in the boxes below all the medications you are taking and how 
frequently. 
E.g. Medicine E.g. 1 tablet E.g. 2x per day 
   
   
   
   
   
   
   
   
4. Your mood 
Please answer the following questions by circling either YES or NO. 
 
1.  Are you basically satisfied with your life?    YES / NO 
2.  Have you dropped many of your activities   
     and interests?       YES / NO 
3.  Do you feel that your life is empty?     YES / NO 
4.  Do you often get bored?      YES / NO 
5.  Are you in good spirits most of the time?    YES / NO 
6.  Are you afraid that something bad is going 
     to happen to you?       YES / NO 
7.  Do you feel happy most of the time?    YES / NO 
8.  Do you often feel helpless?      YES / NO 
9.  Do you prefer to stay at home rather than 
going out and doing new things?     YES / NO 
10. Do you feel you have more problems 
with memory than most?      YES / NO 
11. Do you think it is wonderful to be alive now?   YES / NO 
12. Do you feel pretty worthless the way you are now?  YES / NO 
13. Do you feel full of energy?      YES / NO 
14. Do you feel your situation is hopeless?    YES / NO 
15. Do you think most people are better off 
than you are?        YES / NO 
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Appendix C: Concluding Letter to GP after Final Follow-up 
 
 
 
Date:  
 
 
 
 
Dear Doctor, 
 
Your patient ________________________________has been enrolled in a trial of 
health education in secondary TIA / Stroke prevention. 
 
They have now finished follow up.  Their results are shown below along with our 
recommended targets. 
 
Modifiable Risk Factor Result Our Recommendation 
Blood Pressure  <140/85 
Cholesterol  <5.0 
Blood Sugar 
HbA1c 
 Random Blood Glucose <8 
HbA1c <7.5 
Smoking  Cessation 
 
As a secondary preventative measure we would recommend that their risk factors are reduced to 
within these levels.   
 
If you have any questions regarding their treatment or the trial I will be happy to try 
and answer these, as will the trial supervisor, Dr McAlpine. 
 
Yours Sincerely, 
 
 
 
 
 
 
 
Graham Ellis 
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Appendix D: Example of Patient Held Record 
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Appendix E: Examples of Literature Given to Patients 
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Appendix F: The Impact of Stroke Nurse Specialist Input on Risk 
Factor Modification: A Randomised Controlled Trial – Age & Ageing 
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Appendix G: Meta-Analysis Trial Grid 
  
 
Stroke Liaison Workers Collaborative Review 
 
Trial Details 
Contacts 
Trialists 
  
Year  
Place  
Trial Name  
 
Participants 
Population from 
which patient 
selected 
 
Carers involved?  
Inclusion criteria  
Exclusion Criteria  
Numbers Patient (Treatment)  Patient (Control)  
Carer (Treatment)     Carer (Control)  
 
Methods 
Method of generating random sequence? 
 
Method of treatment allocation and allocation concealment? 
 
Intention to treat analysis? 
 
Blinding (e.g. patient/healthcare staff/outcome assessor/follow up/single/ 
double/none) 
 
Time from stroke onset to enrolment 
 
Length of follow-up 
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Intervention 
Please indicate which one of the following domains you consider the most key in 
your intervention. 
Education and Information Provision  
Social and Family Support  
Liaison  
 
We have attempted as far as possible to classify the interventions to allow grouping or 
comparisons.  Please indicate which descriptions you feel most fit your trial intervention. (You 
may select as many boxes as you feel appropriate.) 
Education and Information Provision 
Stroke (general)  
Stroke risk factors or preventing another stroke  
Stroke consequences and complications  
Stroke services and available benefits  
Stroke treatment and therapies  
Other (please give details)  
 
Social and Family Support 
Informal and emotional support  
Informal counselling  
Formal counselling  
Family support/problem solving  
Individual support and problem solving  
Organising of other social support  
Other (please give details)  
 
Liaison 
With patient/carer  
With community services  
With primary care  
With secondary care  
Other (please give details)  
 
Mean number of visits/contacts? 
Visits:  
Phone calls:  
 
Background of Stroke Liaison Worker 
Please describe the professional background of the Stroke Liaison Worker(s) 
 
Did the Stroke Liaison Worker receive any formal training? 
 
Any other information you feel relevant regarding the intervention? 
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Outcome Measures 
The following is a list of the main outcome measures of the review.  Please 
indicate which measure you used for each domain, listing them in the order 
of priority. 
Patients 
Primary Outcomes 
Subjective Health Status  
Extended activities of 
daily living 
 
 
Secondary Outcomes 
death Yes / No 
place of residence Yes / No 
activities of daily living  
dependency  
mental health (including 
anxiety and depression) 
 
knowledge about stroke  
use of services  
satisfaction with services  
participation  
other  
 
Carers 
Primary Outcomes 
Subjective Health Status 
(including measures of 
carer strain) 
 
 
Secondary Outcomes 
Extended activities of 
daily living  
 
mental health  
knowledge about stroke  
satisfaction with services  
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Data 
I am happy to have my relevant individual patient data used as specified  
I am unhappy to have my relevant individual patient data used as specified  
I am happy to have some of my data used with the following qualifications: 
 
 
 
 
 
NB. If you have used a local outcome questionnaire or instrument, which is not 
widely available (e.g. satisfaction questionnaire) It would be very helpful if you 
were able to forward one to me. 
Data format (e.g. software)  
Please also note if the data labels on your database are not obviously apparent, 
a copy or note of the field labels would be very helpful. 
 
 
Contact details 
I require assistance with travel: 
I require accommodation: 
I am most easily contacted 
at/by: 
(please note email is our 
preferred method of contact) 
Phone 
Email 
Mobile 
Fax 
My most up to date email is:  
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Appendix H: Minutes of Stroke Liaison Workers Collaborative Meeting 
 
Minutes of Stroke Liaison Workers Collaboration 
Royal College of Physicians and Surgeons of Glasgow 
4th March 2005 
 
Present: J Mant, M Dennis, S O’Rourke, V Miller, N Lincoln, A Forster, C Burton, A 
Sharma, G Ellis, P Langhorne 
 
Apologies: T Hafsteinsdottir, M Clark, J Frayne, and D Bishop 
 
Absent: T Glass, D Christie, and G Goldberg 
 
Presentations: 
Introduction to protocol (Jonathan Mant) 
 
Literature Search and Taxonomy of Interventions (Graham Ellis) 
 
There was some brief discussion around the changes in the protocol and the 
exclusion of carer only interventions as well as the appropriate inclusion of TIA 
patients. 
 
Discussion around taxonomy and subgroup classification: 
 
The model proposed by GE was discussed. 
With the breadth of interventions, and in some cases the flexibility required in a 
particular context, these classifications were felt to be somewhat arbitrary. 
It also became clear that apparently similar trials had a reasonable degree of 
variation. 
A further model was proposed, based on whether the intervention was responding 
to individual problems and needs, whether it was relatively fixed and systematic in 
its approach or whether it was theory driven and focussed in a particular area. 
 
These categories would be as follows: 
1. Proactive and Structured  
a. Preston 
b. Bradford 
c. Utrecht 
d. Rhode Island 
2. Reactive and Flexible 
a. Edinburgh 
b. Adelaide 
c. Oxford 
d. London 
e. Liverpool 
f. Nottingham 
g. Melbourne 
h. Melbourne (SHIPS) 
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3. Proactive and Focused 
a. Glasgow 
b. Leeds (Volunteer) 
c. Leeds (Psychiatric Nurse) 
d. Boston (FIRST) 
e. Philadelphia 
 
Other sub-groupings were discussed: 
 
Service related 
1. According to what intervention or services the control group received 
2. In-patient versus outpatient (never admitted) 
3. Related to outcome of question (e.g. Psychological to mental health 
outcomes) 
4. Prior stroke unit admission versus none 
These were in addition to the previously stated suggestions: 
5. Intervention characteristics 
6. Prior profession of Stroke Liaison Worker (and specialist versus non 
specialist) 
7. Direct versus remote services  
8. Early Versus Late (Cumulative add in analysis were suggested to reflect 
range) 
9. Intensity (Cumulative add in?) 
10. Duration (Cumulative add in?) 
 
 
Patient related 
1. First Versus Recurrent stroke 
2. Admitted Versus Never Admitted 
3. TIAs Versus Stroke 
4. Prior depression 
These were in addition to previously stated suggestions: 
5. Prior functional / Baseline functional status 
6. Age 
7. Sex 
8. Carer (or first degree relative?) Versus None (3 Groups – first degree, other 
support, none?) 
 
Outcome measures 
Discussion continued around dichotomisation/continuous data comparisons. 
The possibility of individual patient dichotomisation was discussed, although the 
pragmatics of this seemed challenging. 
Discussion continued on the theme of the satisfaction outcomes and whether 
these be grouped or taken individually.  In addition there was discussion around 
the use of relevant satisfaction outcomes to appropriate intervention. 
Additional comment was made on the worth of giving mention to the inclusion of 
qualitative data in the review.  
The possibility of combining similar and comparable outcomes was discussed. 
 
Publication and Authorship issues 
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Data Ownership 
There was some discussion around the use of data from unpublished trials. 
It was reiterated that the rights to ownership and use of this data were with the 
individual trialists or group and that we did not intend to jeopardise individual trial 
publication.  For this reason (where timescales are important), it was decided that 
at the point of completion of data analysis, the use of the relevant data would be 
discussed with the individuals or groups concerned.  Where this presents a 
problem, that data would be excluded if requested.  For reasons of efficiency and 
practicality it was requested that data be submitted for analysis now, but on the 
agreement that its public release not be permitted until further discussions take 
place with the trialists affected. 
 
Group Authorship 
It was agreed that where the journals permitted, a group name would be used for 
the primary publication, with recognition of the contribution of individual authors. 
Where further subsequent papers of additional analysis were involved, the 
authorship would be represented by a statement such as: 
Y, Y and Z on behalf of the Stroke Liaison Workers collaboration. 
 
The meeting was concluded with thanks expressed to all for their co-operation 
and helpfulness. 
 
Sweepstake: 
Nadina  Caregiver strain 
Peter   Satisfaction with services 
   Caregiver strain index 
Chris   Satisfaction with Services 
   Caregiver Strain index 
Anne   Caregiver satisfaction 
Anil   Satisfaction with services 
Martin   Caregiver satisfaction 
Jonathan  Caregiver satisfaction with knowledge 
Van   Satisfaction with services 
Suzanne  Patient satisfaction with liaison 
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Appendix I: Cochrane Protocol 
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Appendix J: Scottish Stroke Nurse Questionnaire 
 
 Stroke Liaison Worker Questionnaire 
 
My region is: 
Argyll and Clyde  Grampian  
Ayrshire and Arran  Highlands  
Borders  Lanarkshire  
Dumfries and Galloway  Lothian  
Fife  Shetland  
Forth Valley  Tayside  
Glasgow  Western Isles  
Other (please specify below)  Orkney  
 
 
I am a: 
Nurse  Health Visitor  
Volunteer  Social Work  
AHP (please specify)   
Other (please specify)   
 
Grade:  
 
I work with: 
Inpatients only  
Inpatients and outpatients (including ward discharges)  
Only outpatients (including ward discharges)  
Not applicable (e.g. no patient contact)  
 
If your answer above is “inpatients only”, or “not applicable” jump to page 4 
“Questions for everyone” 
 
We are particularly interested in these three areas and in how your role might 
include these aspects of care.  We would like you to try and identify which are 
most relevant to your work. (Tick ALL that apply to you) 
 
My role with patients/carers in the community is: 
Liaison  
(This may mean referring the patient on to appropriate clinicians, or 
simply acting as a point of contact.) 
 
 
Social Support  
(This can be anything from simple support to offering advice about family 
problems or more in depth counselling.) 
Education and Information Provision  
(This could mean anything from giving leaflets to taking seminars with 
patients and carers or counselling about lifestyle and risk factors.) 
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We would like to explore a little more, aspects of your practice with patients or carers.  Which of 
the following apply to your work?  If you wish to add comments at the end, please do so. 
(Please tick ALL  that apply) 
I provide: 
Education and Information provision in the following areas: 
Stroke (general information)  
Stroke risk factors or preventing another stroke  
Stroke consequences and complications  
Stroke services and benefits  
Stroke treatments and therapies  
Other  
Social Support of the following kinds: 
Informal emotional support  
Informal counselling  
Formal counselling (e.g. as a trained counsellor 
using established techniques) 
 
Family support / problem solving  
Individual support / problem solving  
Organising of other social support  
Other  
Liaison: 
With patient / carer  
With community services  
With primary care  
With secondary care  
Other  
Other comments 
 
 
 
 
 
 
 
 
My approach is: 
We would like you to put a 1 in the box that best describes what approach you would use most of 
the time.  If you sometimes use the other approach, put a 2 in the other box.  If you rarely or 
never use the other approach, leave it blank.  
Pro-active and Structured  
I tend to seek out to meet or talk with everyone.  I tend to bring up 
subjects even when not brought up by the patient (or carer), or I work 
through a list of potential problem areas. 
 
Reactive and Flexible  
I respond to patients needs and adjust my workload or discussions around 
the problems that they bring up.  The amount of time or follow-up will 
depend on need. 
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My interaction and discussions with patients are: 
We would like you to put a 1 in the box that best describes what approach you would use 
most of the time.  If you sometimes use the other approach, put a 2 in the other box.  If you 
rarely or never use the other approach, leave it blank. 
Focussed  
I am quite specific about which areas we talk about (e.g. my role is to talk 
about risk factors or to talk about psychological problems etc.) 
Comprehensive  
I cover a broad range of subjects and provide broad support for different 
aspects of living with stroke. 
 
My involvement with patients is by: 
Tick ALL that apply to your work 
Visit to their home  
Phone  
They come to me at hospital  
Other (please specify)  
 
 
Colleagues: 
Tick ONLY ONE description that sounds closest to your work 
I work in a community support team (such as community 
rehabilitation or discharge support) 
 
I am a member of the hospital stroke team, but not a member of a 
community team as above. 
 
Other  
 
 
I deal with: 
Tick ALL that  apply to your work 
Informal Carers  
Patients  
Families  
Other (specify)  
 
 
Does it work?  
Tick ONLY ONE 
I believe my work has a positive impact on all the patients/carers I see  
I am uncertain if all patients/carers benefit from my work but think that 
most will 
 
I am convinced that some patients benefit from my work.  
I am not sure if my role is beneficial  
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Questions for everyone 
 
I think the following are the most important aspects of my work: 
 
 
 
 
 
 
 
I believe I am most likely to have a beneficial impact on the following 
people: 
 
 
 
 
 
 
The commonest three problems I deal with are: 
 
1______________________________________________________________ 
 
2______________________________________________________________ 
 
3______________________________________________________________ 
 
 
Comments on your role: 
 
 
 
 
 
Other Comments: 
 
 
 
 
 
 
 
If you are willing to be interviewed on your role in stroke care, please contact Louise Craig 
by phone (0141 330 5645) or email (lec5t@clinmed.gla.ac.uk) of by providing contact details 
below. 
Name:     Contact details: 
 
Thank you for your time in completing this questionnaire. 
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